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ABSTRACT
The completion of a substantial number of complete genome sequencing 
initiatives has produced more than a million protein sequences. Analysis of these 
protein sequences is possible using recent advances in computing and bioinformatics 
techniques.
This thesis describes a novel automated protein classification protocol which 
groups proteins into families and identifies protein domain architectures via domain 
assignment. This data is presented in the Gene3D database which is used for 
subsequent analysis.
The analysis of the distribution of protein family and protein domain data shows 
a power-law like distribution that is typically seen in many biological data distributions 
and is indicative of the small world networks that underlie biological systems biology. 
Kingdom distribution of superfamilies and protein families in Gene3D has been used to 
describe the evolutionary mechanisms that determine genome diversity through protein 
diversity. Domain occurrence profiles have been used to identify protein domain 
superfamilies that are correlated with genome size in bacteria. These superfamilies are 
shown to exhibit a balance between metabolic and regulatory roles along 
microeconomic principles that may determine bacterial genome size.
Domain families identified in Gene3D enable a determination of the total 
number of protein folds in nature. Sub-clustering of domain families permits domain 
family sub-cluster occurrence profiles to be determined. These profiles are shown to be 
capable of detecting correlations and anti-correlations between domain families that are 
undetectable using superfamily occurrence profiles alone. Clusters of correlated 
domain subclusters are shown to identify functionally linked clusters of proteins. 
Finally, the data in Gene3D is used to functionally annotate the CATH database and 
provide functional predictions for un-annotated proteins, providing more comprehensive 
functional repertoire and greater accuracy than other functional prediction methods.
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CHAPTER ONE
Introduction 
1.1 Introduction
Biology has entered a genomic age. The development of high-throughput 
automated experimental techniques has uncovered biological data at a faster rate than 
ever before and this looks likely to continue for the foreseeable future. The huge 
amount of data generated daily necessitates the use of computational methods for 
organisation, classification and analysis. Biology is exploring complex biological 
networks by genome level investigation. Functional and comparative genomics aim to 
understand how species have evolved and determine the function of proteins and non­
coding genomic regions, primarily through identifying and comparing homologues. 
Structural genomics aims to use the results from genome sequencing projects and 
advances in structural determination to define fold space through organisation and 
analysis of protein structures. Resources which classify protein structures and family 
relationships across multiple genomes can provide useful information for functional, 
comparative and structural genomics. This chapter introduces the biological molecules 
which are core to evolution and function in organisms, and methods that have been 
developed to compare and describe their different physical characteristics, genomic 
context and biological functions.
1.1.1 Deoxyribonucleic Acid
In 1944, Avery, MacLeod and McCarty (Avery et al., 1944) showed that the 
molecule deoxyribonucleic acid (DNA) carried inheritable information by building on 
the work of Frederick Griffith who had showed in 1928 that heat-killed virulent bacteria 
could transfer their virulence to non-virulent bacteria.
The observation of the relative levels of nucleotide bases in DNA, made by 
Erwin Chargaff in 1950, showing that the amount of adenine was equal to the amount of 
thymine, and that the amount of guanine was equal to the amount of cytosine, combined
12
with the insight by Rosalind Franklin (Franklin and Gosling, 1953) and Maurice 
Wilkins (Wilkins et al., 1953) that the DNA molecule was shaped like a helix, 
containing two ‘strands’ joined by ‘rungs’, led to the discovery of the molecular 
structure of DNA in 1953 by Francis Crick and James Watson (Watson and Crick, 
1953).
The DNA molecule consists of two polymeric strands in a right-handed helix, 
joined together by hydrogen bonds between complementary nucleotide base pairs. Each 
polymer strand consists of nucleotides, which are made of a phosphate group bound to a 
deoxyribose sugar, which is bound to a nitrogenous base. There are four different kinds 
of nitrogenous base in DNA; these are the pyrimidines, cytosine (C) and thymine (T), 
and the larger purines, adenine (A) and guanine (G). Polymerisation of nucleotide 
subunits occurs with covalent phosphodiester bonds formed between the 5' and 3’ 
hydroxyl groups on the deoxyribose sugar and phosphate groups, forming an alternating 
sugar-phosphate backbone. Base pairs are formed between a complementary purine and 
a complementary pyrimidine, where adenine always binds to thymine and cytosine 
always binds to guanine.
Two anti-parallel polynucleotide chains form a DNA molecule with hydrophilic 
sugar-phosphate backbones on the outside of the helix and the hydrophobic hydrogen 
bonded base pairs stacked perpendicular to the helix axis, on the inside of the helix 
(shown in figure 1.0). The DNA helix can adopt three different conformations in 
nature, depending on base pair composition and hydration/ion levels. The common 
form is the B-helix, with ten nucleotides per helix turn and both a major and minor 
groove present on the helix surface. G-C rich DNA forms Z-helices, where the helix 
becomes left-handed, longer, and thinner, with twelve nucleotide bases per helix turn 
and only a single groove on the helix surface. Lastly the A-helix conformation is seen 
at low hydration levels or high cation concentrations. This conformation has eleven 
nucleotides per helix turn and two grooves present on the helix surface.
13
BASE PAIRS
*  •  V
DNA HELIX
*»•)*
Figure 1.0 Structure of DNA. Ball-and-stick and space-filled models showing the 
structure o f nucleotide base pairs cytosine-guanine (G-C, top left), adenine-thymine (A- 
T, top right) and the double-helical structure o f the deoxyribonucleic acid molecule 
(bottom). Figure shows structure ofPDB 1DK6 (Klewer et al., 2000).
The structure of DNA, consisting of complementary sequences of the four 
nucleotide base pairs led George Gamov (Gamov et al., 1956) to postulate that to 
encode the twenty essential amino acids would require at least nucleotide base triplets to 
encode each amino acid. Experiments by Nirenberg and Matthaei in 1961 (Nirenberg 
and Matthaei, 1961), and later by Nirenberg and Leder in 1964 (Nirenberg and Leder, 
1964; Leder and Nirenberg, 1964), showed that the genetic code consists of sixty-one 
codons (nucleotide triplets), encoding specific amino acids and three codons encoding 
termination (of the process of translation). The genetic code has built in redundancy, in 
that multiple codons can encode some amino acids. Only two amino acids, methionine
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and tryptophan, are encoded by a single codon. In some organisms, one or two stop 
codons may also encode amino acids, for example in many genomes, including humans, 
one of the stop codons sometimes encodes selenocysteine.
1.1.2 Transcription and Translation
There are many differences in prokaryotic and eukaryotic nuclear material 
packaging and cellular structure, but both prokaryotes and eukaryotes employ the same 
genetic code and translation/transcription mechanisms, known as the Central Dogma 
(shown in figure 1.1), to express protein from DNA:
T ranscriptiorP^ > RNA
\  /
r
RNA
/
Translation Protein
Figure 1.1 Central Dogma. In cellular systems, genetic information transfers from 
DNA to RNA to Protein, and cannot be transferred from Protein to either Protein or 
DNA or RNA
The triplet codes in DNA are transcribed into RNA by RNA polymerase. This 
enzyme binds to transcription factors that bind to promoter regions 5’ terminal to coding 
DNA, which open the helix to allow the RNA polymerase to proceed in a 3’-5’ 
direction down one polynucleotide strand of the DNA molecule. In eukaryotes, where 
DNA is packaged into protein complexes, these complexes are unwound and then re­
wound once the RNA polymerase has passed. As the RNA polymerase proceeds down 
the DNA strand it matches complimentary ribonucleotides to the sequence of 
nucleotides in the DNA strand. Polymerisation of these ribonucleotides forms a 5’-3’
15
ribonucleic acid polymer (RNA) strand, complimentary to the 3*-5* DNA strand. There 
are several types of ribonucleic acid: mRNA functions as a coding template for 
translation; rRNA functions as part of the ribosome, an rRNA/protein complex required 
for translation; and tRNA which bind amino acids to form aminoacyl-tRNA, used for 
translation, which possess specific ribonucleotide triplet codes linked to a specific 
amino acid.
In prokaryotes and about 10-15% of translation in eukaryotes, translation occurs 
simultaneously with transcription. The remaining translation in eukaryotes occurs 
outside the nucleus, and so mRNA is first transported to the cytoplasm. Translation 
begins when the ribosome binds 5' terminal to the coding region of the mRNA strand. 
The ribosome proceeds in a 5’-3’ direction down the mRNA strand, at the start codon 
(AUG, the first coding ribonucleotide triplet) the ribosome binds the aminoacyl-tRNA 
molecule containing a complementary ribonucleotide triplet (TAC) and a specific amino 
acid (methionine in eukaryotes, formylmethionine in bacteria). The aminoacyl-tRNA 
molecule complementary to the next ribonucleotide triplet on the mRNA strand then 
binds to the ribosome, and a peptide bond is formed between its amino acid and the 
initiator aminoacyl-tRNA amino acid (at which point the first bound tRNA molecule is 
released. As the ribosome proceeds down the mRNA strand, each aminoacyl-tRNA 
complementary to the next triplet in the coding region is bound, a new peptide bond is 
formed and the amino acid chain produced elongates. When the ribosome gets to a 
termination triplet, no aminoacyl-tRNA molecule is bound and both the ribosome and 
the newly translated peptide are released.
1.1.3 Gene Identification
The region of DNA encoding an RNA molecule is called a gene. The peptide 
sequence, the primary structure of a protein, can be identified by translating the genetic 
code from a DNA sequence encoding a gene (shown in figure 1.2). The coding region 
in prokaryotic and several eukaryotic genes is a continuous open reading frame of 
triplets, but the vast majority of eukaryotic genes have discontinuous coding regions, 
where coding exons are separated by non-coding introns.
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DNA - gene
Promoter 5’UTR Exon Intron Exon 3’ UTR
RNA - preprocessing
5’UTR Exon Intron Exon 3’ UTR
RNA - postprocessing
5’UTR Exon Exon 3’ UTR
Protein -  prim;ary structure
Peptide Sequence
Figure 1.2 Gene Structure. DNA sequence regions are transcribed into RNA, which is 
processed to remove non-coding intronic sequences. Translation o f the resulting RNA 
produces the protein's primary structure.
In prokaryotes the continuous coding regions make peptide sequence prediction 
from DNA sequences relatively straightforward. Identification of start codons and stop 
codons, and translation of the intervening coding region allows the vast majority of 
prokaryotic proteins to be predicted. To reduce erroneous protein predictions caused by 
DNA sequencing errors and shadow reading frames, additional evidence that the DNA 
sequence actually does encode a protein is desirable. Sequence similarity or similar 
sequence characteristics (codon bias, G-C content) to known expressed proteins or 
identification of a ribosomal binding site or promoter region increase the reliability of 
protein predictions.
The presence of exons and introns in eukaryotic genes, which often produces 
complex and diverse mRNA variations, makes accurate peptide sequence prediction 
more of a challenge. In some eukaryotes, for example the yeast Saccharomyces 
cerevisiae, only about 5% of genes contain introns (Patthy, 1999) whilst in other 
eukaryotes intronic genes are far more widespread. Up to 95% of coding DNA can be
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identified, but only around 40% of genes have all their exon/intron boundaries correctly 
predicted in eukaryotes (Reese et al., 2000).
A myriad of different gene prediction programs have been developed, using ab 
initio methods or homology based methods, or a combination. The first gene 
identification program was Grail (Uberbacher and Mural, 1991). The original release 
of Grail used ab initio methods to predict genes, the latest release, GrailEXP, improves 
predictions by the use of homology-based methods, where putative gene regions are 
aligned against a library of known gene regions. Programs such as Glimmer (Salzberg 
et al., 1998) and GeneMarks (Borodovsky and Mclninch, 1993) use Markov modelling 
of known gene regions to score putative gene regions. These programs require a 
training set of known genes, but are capable of correctly predicting more than 98% of 
prokaryotic genes. GenScan (Burge and Karlin, 1997) combines compositional 
parameters from exons, introns and intergenic regions with known signal sequences to 
predict genes.
1.1.4 DNA Sequencing
Two methods of DNA sequencing, Maxam-Gilbert (Maxam and Gilbert, 1977) 
and Sanger-Coulson (Sanger et al., 1977) were independently developed in 1977. Both 
methods used four independent reactions to identify the four different types of 
nucleotide bases in DNA. Maxam-Gilbert sequencing labels DNA with 32-P; 
nucleotide base-specific chemical degradation then produces DNA fragments of varying 
length. Sanger-Coulson sequencing labels DNA with 35-S; enzymatic synthesis using 
nucleotide base-specific didesoxylribonucleotide terminators produces DNA fragments 
of varying length.
These DNA fragments are gel-electrophoresised in four lanes, each lane 
corresponding to chemical degradation or termination reaction for each nucleotide base 
in DNA. A radiographic film of the gel can then be used to determine the sequence of 
nucleotide bases in the DNA. In 1987, Prober et al. (Prober et al., 1987) modified the 
Sanger-Coulson sequencing method using fluorescent dideoxyribonucleotide 
terminators. This enabled a single reaction to identify all four nucleotide bases, since 
each could be labelled a different colour, and permitted single lane gel-electrophoresis.
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In addition this development eliminated the need to work with radioactivity. The 
development of pulsed field gel-electrophoresis (Schwartz and Cantor, 1984), PCR 
(Mullis et al., 1986) and the first automated DNA sequencing machine (Smith et al., 
1986) paved the way for DNA sequencing at the genomic level.
1.1.5 Genome Sequencing
The first genome to be completely sequenced was the genome of bacteriophage 
MS2 RNA, only 3,569 bases in length and containing just four genes (Fiers et al., 
1976). Just six years later, the comparatively much larger DNA genome of 
bacteriophage lambda, containing 48,502 bases and almost 100 genes was sequenced 
(Sanger et al., 1982). The first free living organism to be completely sequenced was the 
bacteria Haemophilus influenzae, containing 1,830,137 bases and over 1,700 genes 
(Fleischmann et a l, 1995). The invention of shotgun sequencing (Venter et al., 1996) 
accelerated the sequencing of the larger genomes of cellular organisms, and as of June 
2005, 21 archaea, 207 bacteria, 33 eukaryota and over 1500 virus genomes have been 
sequenced, including higher eukaryotes such as human, mouse and rat (GOLD database, 
Bernal et al., 2001). There are also numerous sequencing projects that sequence 
eukaryotic expressed RNA, these projects are fundamental to the development of more 
accurate gene prediction programs that can be trained with these expressed sequences in 
order to predict eukaryotic genes in genomic sequencing projects more accurately.
1.1.6 Sequence Databases
The International Nucleotide Sequence Database Collaboration consists of three 
sequence databases -  GenBank (Benson et al., 2005), EMBL (Kanz et al., 2005) and 
DDBJ (www.ddbj.nig.ac.jp). All three databases exchange their sequence data on a 
daily basis, and as such contain virtually the same sequence data, but have different data 
formats. As of June 2005, GenBank release 148.0 contained 49,398,852,122 nucleotide 
bases from 45,236,251 sequences. Protein translations of these nucleotide sequences 
are also deposited in these databases. GenPept release 148.0 (translations from 
nucleotide files in GenBank) as of June 2005 contains 748,555,190 amino acids from 
2,440,496 protein sequences. However, these sequence collections often contain
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redundant entries, where entries may be truncated, identical, or contain small 
sequencing errors. In order to increase the quality and remove redundancy from protein 
sequence collections, several human curated databases have been developed. For 
example, release 11 (May 2005) of the RefSeq database (Pruitt et al., 2005) at the NCBI 
contains 1,425,971 protein sequences. SWISSPROT (Bairoch and Apweiler, 2000; 
Boeckmann et al., 2003) and PIR (Wu et al., 2004) are also human curated databases. 
Redundant translations are removed and protein annotations are carefully verified. 
However, this process is time consuming, release 47.3 (June 2005) contains only 
185,639 protein sequences. The TrEMBL (Boeckmann et al., 2003) database 
complements SWISSPROT, and contains automatically generated translations of EMBL 
nucleotide sequences not yet included in SWISSPROT. Release 30.3 (June 2005) 
contains 1,782,502 protein sequences. The PIR database is descended from the first 
protein sequence database, the Atlas of Protein Sequence and Structure, created in 1965 
(Dayhoff, 1965) and has been largely superseded by iProClass (Wu et al., 2004) which 
consists of PIR, SWISSPROT and TrEMBL. Release 2.71 (June 2005) contains 
1,891,813 protein sequences hierarchically classified into 36,000 PIR superfamilies and 
145,300 families. In 2002, SWISSPROT, TrEMBL and PIR were merged into a single 
resource, the Universal Protein Resource (UniProt, Bairoch et al., 2005).
1.1.7 Protein Structure Determination
Compared to the number of nucleotide and protein sequences, relatively few 
protein structures have been solved. All published protein structures are deposited into 
the Protein Data Bank (PDB, Bernstein et al., 1977; Deshpande et al., 2005). As of 
June 2005, the PDB contains 30,041 protein structures. 3,945 of these structures were 
determined by Nuclear Magnetic Resonance (NMR), the vast majority of the remainder 
were determined by x-ray crystallography.
X-ray crystallography determines the structure of a molecule from its diffraction 
pattern. X-rays are passed through a crystal containing a regular array of the molecule 
of interest producing a characteristic x-ray diffraction pattern, indicating the 
arrangement of molecules in the crystal. NMR can be performed on proteins in 
solution, and so avoids the crystallisation problems of x-ray crystallography. NMR 
exploits the phenomenon whereby some atoms will resonate when placed in a magnetic
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field. In an NMR spectrometer this resonance is detected and amplified, the exact 
frequency of the resonance can be used to identify the type of atom. NMR analysis 
identifies distance constraints on residues that allow reconstruction of the underlying 
structure. NMR is restricted to smaller proteins, but can study protein conformational 
changes during protein folding or substrate binding.
Solving a protein structure is a time consuming and costly enterprise. The 
average cost for solving a single protein structure is about $250,000-$300,000. In an 
effort to affect a rapid increase in the number of solved protein structures, the National 
Institute of General Medical Sciences initiated a program in 2000 to solve 10,000 
protein structures over ten years. This Protein Structure Initiative program, a 
collaboration between several structural genomic centres, has been running for five 
years. Around 1000 protein structures have been solved. The cost per protein structure 
was initially as much as $670,000, due mostly to high initial start-up costs. As these 
high-throughput centres progressed, the cost has dropped to around $180,000 and is 
expected to drop further to around $100,000 per protein structure as high-throughput 
pipelines are streamlined and become more efficient (Service, 2005).
1.1.8 Protein Structure
Proteins have a huge variety of functions and forms. Proteins can be 
characterised and compared in terms of protein structure. A protein’s primary structure 
is the translated sequence of amino acids that form the peptide chain. The secondary 
structure of a protein is the local conformation of the peptide chain. The main units of 
secondary structure are the alpha helix and the beta strand. A typical helix ranges from 
as few as 5 to as many as 30 amino acid residues. The close packing of the helix 
minimises contact between hydrophobic carbon atoms and the surrounding water, and 
facilitates hydrogen bonding between amino acid amine group hydrogen atoms and 
carbonyl group oxygen atoms that stabilise the helical structure. 3.6 amino acid 
residues form a full turn of the alpha helix. A beta strand is also stabilised by hydrogen 
bonds, often several beta strands form a beta sheet. The beta strands hydrogen bond to 
each other to stabilise the beta sheet. As in the alpha helix, hydrophobic amino acid 
groups are packed on the internal face of a beta sheet, to minimise contact with water in 
the surrounding medium. Secondary structure elements interact with each other using
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stabilising hydrophobic interactions. The tertiary structure of a protein describes the 
orientations of the secondary structures and their connectivity in three-dimensional 
space. Secondary structure elements can be closely packed in the tertiary structure. 
Helices can pack closely together to shield hydrophobic amino acid side chains, beta 
strands can pack together to form beta sheets, which in turn can pack against helices 
(shown in figure 1.3). In general the tertiary structure of a protein tends to pack 
hydrophobic amino acid residues internally, leaving hydrophilic amino acid residues 
accessible. Some proteins consist of more than a single peptide chain. Quaternary 
protein structure describes the relationship between different peptide chains of the same 
protein.
Figure 1.3 Protein Structure. Tertiary structure (left) showing arrangement o f alpha 
helices (green) and beta sheets (yellow) in a Ribonuclease Inhibitor domain. 
Quaternary structure (right) showing all four domains (blue, pink, brown, green) o f 
Ribonuclease Inhibitor-Angiogenin Complex (PDB: 1A4Y, Papageorgiou et al., 1997).
Many proteins form compact globular structures, some proteins appear to consist 
of distinct compact globular units linked together. These distinct protein subunits are 
termed domains. The exact definition of a domain ranges from ‘a distinct globular 
protein subunit’ to ‘an evolutionary independent protein subunit’. These definitions can 
reflect both the physical properties of protein domains, as well as the evolutionary 
mechanisms by which proteins are thought to evolve. A protein domain may consist of 
a continuous region of a peptide chain, or may be formed by a discontinuous region of a 
peptide chain. A protein domain may even consist of more than one peptide chain.
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1.1.9 Structure is more Conserved than Sequence
Chothia and Lesk (1986) first demonstrated the degree to which protein structure 
appears more conserved than sequence during evolution. This observation is reaffirmed 
by recent analyses of larger structural classifications (Orengo and Thornton, 2005), see 
figure 1.4 below.
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Figure 1.4 Sequence Identity versus Structure Similarity. Sequence identity plotted 
against SSAP structural comparison score (from 0-100) for all pairs o f homologous 
domain structures in the CATH domain structure database (red circles represent 
proteins with identical functions, blue squares represent proteins with different 
functions).
Since structures are more highly conserved than sequences, structural similarity 
is more able to detect distant protein relatives than sequence similarity. Even with 
advances in sequence comparison methods, some remote homologues in the ‘midnight 
zone’ with less than 15% sequence identity can only be detected through protein 
structure comparison (Todd et al., 2001; Orengo et al., 2001). Structure based 
classifications that are able to incorporate these distant homologues provide protein
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family datasets that permit further-reaching analyses of protein family evolution than 
sequence based resources alone.
The Protein Data Bank (PDB), based in the Research Collaboratory of Structural 
Biology (RCSB) Rutgers University, contains structures of over 30,000 proteins. These 
proteins are decomposed into over 60,000 protein domains of known structure. These 
structures can be clustered into protein families and superfamilies, producing 
hierarchical databases of protein structures, such as CATH and SCOP, which rely on a 
combination of manual expert classification and structural comparison methods.
Many of the very distant relatives below 20% sequence identity are paralogues, 
arising from duplication of a domain within the genome. Paralogous genes frequently 
evolve a new function. This is illustrated in figures 1.4 above and figure 1.5 below 
which illustrates the extent to which function changes in more distantly related relatives. 
By recognising such relationships, the structural based protein family classifications 
provide important insights into the evolution of protein function within protein families.
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Figure 1.5 Structure is more Conserved than Sequence. Functional diversity in 
distant homologous relatives in CATH. Whilst orthologues and paralogues are in the 
same Homologous Superfamily in the CATH database, the analogues have the same 
fold but are in different Homologous Superfamilies. Orthologues, paralogues and 
analogues can have very different sequence identities (green arrows) and functions 
(had -  G1 subunit, Bos taurus; lcip -  G1 subunit, Rattus norvegicus; lhe8 -  PI-3 
kinase, Homo sapiens; ln6h -  Rab-5a kinase, Homo sapiens; le98 -  Thymidylate 
kinase, Homo sapiens; lsrr -  Sporulation response protein, Bacillus subtilis). Adapted 
from Orengo & Thornton, 2005.
Function may be inherited at different levels of sequence identity with different 
degrees of confidence. For example Todd et al. (2001) analysed the relationship 
between EC number conservation and sequence identity and concluded that for single 
domain proteins, enzyme function as defined by the first three EC numbers is almost 
completely conserved between protein relatives which have a sequence identity of 40% 
or more, whereas in multi-domain proteins, the same level of conservation is seen 
between protein relatives which have a sequence identity of 60% or more (shown in
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figure 1.6 below). Todd et al. conclude that this conservation of function allows 
functional prediction between protein relatives with at least 30% sequence identity with 
95% accuracy in single domain proteins; whereas in multi-domain proteins below 40% 
sequence identity there is a significant reduction in conservation of function. This is in 
agreement with the analysis of Devos and Valencia (2000) who conclude that below 
50% sequence identity, completely correct functional annotations cannot be inferred. 
However, Rost (2002) concludes that even at 50% sequence identity between proteins; 
complete EC number conservation only occurs in 30% of pairwise relationships.
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Figure 1.6 Functional Conservation versus Sequence Identity in CATH.
Conservation o f functional annotation with sequence identity between pairs o f related 
enzyme structures in CATH homologous superfamilies with at least two members. 
Percentage o f total pairs conserved to four (green), three (blue), two (mauve), one 
(light grey) or no (dark grey) levels in the EC classification scheme. Pairs containing 
an un-annotated member are shown in black. Taken from Todd et al., 2001.
1.1.10 Protein Structure Classification
Protein structures in the PDB are classified by several different resources (e.g. 
SCOP (Murzin et al., 1995; Andreeva et al., 2004); CATH (Orengo et al., 1997; Pearl et 
al., 2005); and the Dali domain dictionary (Holm and Sander, 1996; Dietmann et al.,
2001)). Most protein structure classifications initially deconstruct whole proteins into
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protein domains. Some classification systems, such as the SCOP database, define 
protein domains as evolutionary conserved protein units. It has been estimated that 
around 65% of prokaryotic and up to 80% of eukaryotic proteins contain multiple 
domains (Apic et al., 2001). Several algorithms have been written for recognising 
domains in protein structures (Jones et al., 1998), often exploiting the fact that there are 
more contacts between amino acids within a domain than between different domains, or 
searching for hydrophobic clusters that could represent domain cores (DETECTIVE, 
Swindells, 1995). However, most classifications rely on manual intervention to some 
extent to determine domain boundaries.
Most protein structure classifications first classify according to the overall 
secondary structural component of protein domains, dividing proteins into alpha, beta, 
alpha/beta, alpha+beta (segregated alpha and beta regions), and low secondary structure 
classes, as shown in figure 1.7. Structural domains are then further classified into fold, 
architecture, topology, and homologous groups, where the domains are thought to be 
descended from a common ancestor. Individual classification systems are discussed in 
detail in later chapters.
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Figure 1.7 Protein Structure Classification. Secondary structure denomination of 
proteins into Alpha (top left, PDBAppr, Hofmann et al, 1996), Beta (top right 
PDB:4bcl, Tronrud and Matthews, 1993), Alpha/Beta (bottom left PDB:lg61, Groft et 
al., 2000) and Low secondary structures (bottom right PDB: ljfw, Peloponese et al, 
2000) classes.
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1.2 Homology
Homology means a common origin can be inferred between two entities. In 
protein terms, homologous proteins are proteins thought to have a common evolutionary 
ancestor. Organising sequences and structures into homologous groups not only helps 
to classify the ever increasing amounts of biological data presently being generated, but 
has practical implications for the study of biological relationships within and between 
families of homologous proteins. Statistically high levels of similarity between proteins 
can be used to infer homology between them. Methods of detecting homology between 
proteins inferred from protein sequence similarity and protein structure similarity are 
described below. Context based methods that use genomic information to infer 
functional relationships between proteins that may indicate a linked evolutionary 
history, but not necessarily a common evolutionary ancestry, are also described.
1.2.1 Sequence Based Hom ology Detection Methods
Pairwise sequence similarity methods can be divided into local similarity 
methods and global similarity methods. Local similarity algorithms (for example Smith 
and Waterman, 1981) identify conserved regions between two sequences and ignore 
regions with little or no similarity, whereas global similarity algorithms (for example 
Needleman and Wunsch, 1970) optimise the overall alignment of two sequences and 
include regions with little or no similarity. Sequences are aligned and scored according 
to sequence identities (identical residue pairs), acceptable substitutions, and gaps in the 
alignment. However, there may be very many different possible alignments between 
long sequences and scoring each alignment could be computationally intensive. This 
problem is solved using dynamic programming. Dynamic programming is a technique 
that divides the alignment problem into stages. The initial stage creates a matrix grid 
where the residues in one sequence run along the x-axis, and the residues in the other 
sequence run along the y-axis. A scoring matrix is generated, whereby each square in 
the matrix is sequentially filled, by calculating a running score of the similarity between 
the residues leading to that square. The last stage traces a path back through the scoring 
matrix to find the optimum scoring path. This path through the matrix can be converted 
into an alignment between the two sequences. For global alignments, the entire path
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through the matrix is calculated, for local alignments, only a subsequence region 
corresponding to the highest partial score need be reported.
1.2.1.1 BLAST1
For searching large sequence databases for sequence relatives, aligning all the 
sequences in the database to the query sequence using dynamic programming is still too 
time consuming. Heuristic approaches that approximate the scoring matrix and optimal 
path can speed this process. The BLAST1 algorithm (Altschul et al., 1990) shortens the 
search time for an optimal path by looking for non-gapped alignments. The query 
sequence is broken into word fragments (default word size is four), each word is scored 
against a substitution matrix (PAM 120, Dayhoff et al., 1978) and all substitutions for 
each word that score above a threshold are then used to scan against each sequence in 
the sequence database. Every time a word matches a database sequence, the word 
alignment, or maximal segment pair (MSP), is extended at either end and scored. The 
highest scoring MSP (known as the HSP) is then returned. The FASTA algorithm 
(Lipman and Pearson, 1985) is similar to BLAST1 in that it also sacrifices precision for 
speed. FASTA looks for exact matches between short sequence regions. If enough 
short regions of identity are found, FASTA uses dynamic programming to find the 
optimal path through the matrix. The size of the exact matches determines the speed 
and accuracy of the method. The longer the size requirement, the faster an optimal path 
can be calculated, but the less likely the optimal path is to contain such a long exactly 
matching region.
1.2.1.2 BLAST2
Both FASTA and BLAST 1 look for non-gapped alignments. BLAST2 (Altschul 
et a l, 1997) is a modification to BLAST1 that permits gapped alignments (Gapped- 
BLAST) and iterative searches (PSI-BLAST). BLAST2 uses a two-hit method, 
whereby two words need to be found within a threshold distance of each other before 
word extension is permitted. This dramatically reduces computational time as fewer 
word extensions need to be performed. Permitting gapped alignments reduces the 
number of word searches of database sequences, since a word alignment is more likely
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to be extended further since gaps in the alignment are permitted. Successive iterations 
of sequence searching and alignment produce position specific scoring matrices 
(PSSM’s) that reflect conserved sequence regions, whilst allowing sequence variation in 
non-conserved sequence regions. This can be used to score successive iterations of 
sequence searches. This iterative searching method makes BLAST2 more sensitive in 
detecting sequence relatives with low sequence similarity than a single iteration search. 
The position specific scoring matrix (PSSM) generated by BLAST2 describes the 
proteins that align with significant scores to the query sequence during the iterative 
process. In sequence databases containing families of related sequences, a PSSM can 
be generated to profile each family. A library of PSSMs can then be quickly searched 
to identify query matches to each family without having to search the entire sequence 
database (IMPALA, Schaffer et al., 1999).
1.2.1.3 Expectation Values
The significance of any pairwise alignment between two sequences can be 
quantified using an expectation value (E-value), which gives an indication of the 
likelihood of an alignment score (S) occurring by chance. An E-value is determined by 
multiplying the size of the database being searched by the p-value. In an alignment of 
two proteins of length m and n (where length is determined by the number of amino 
acid residues in each protein sequence), the p-value is calculated from the equation: p- 
value = Kmne"larabdaS. Where the parameter Ke'lambdaS represents the probability of an 
HSP with score S occurring by chance. This value is pre-calculated by fitting the tail of 
the distribution of scores returned by random, unrelated sequences (which produces an 
extreme value distribution in which the tail decays more slowly than for a normal 
distribution). K and lambda are empirically derived parameters, the values of which are 
functions of the alignment scoring matrix used, and can be thought of as natural scales 
for the search space size and the scoring system respectively. When searching 
databases using BLAST, the size of the database being searched is represented in the 
parameter n, calculated as the total length of all sequences in the database, effectively 
considering the database sequences being searched against as one long single sequence. 
Thus the the database size parameter n is multiplied by the pairwise p-value to produce 
a BLAST E-value in the equation above. This generates an E-value that decreases 
exponentially with score. BLAST E-values do not refer to the whole query sequences,
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but rather to the fragment of the query sequence that is given in the match (i.e. the 
HSP). A useful guide to E-values can be found at the NCBI 
(http://www.ncbi.nlm.nih.gov).
1.2.1.4 Hidden Markov Models
Profiles generated from multiple sequences better describe conserved and 
variant sequence regions. PSI-BLAST and IMPALA profile libraries are capable of 
detecting distant, yet significant sequence similarity proteins that pairwise methods like 
BLAST1 are unable to distinguish. More recent developments of profile methods 
include Hidden Markov models (HMMs, Eddy 1998). A Markov model describes a set 
of 'states’, each state being defined by a probability distribution. Markov models are 
subject to three assumptions: the next state is dependent only on the previous state(s); 
state transition probabilities are independent of time; and observed state outputs are 
statistically independent of previous outputs. State transition probabilities can be 
described in a matrix describing all possible transition probabilities between each state 
in the model.
An HMM describes two sets of states that are closely linked, one set of known 
states and another set of unknown, or hidden states. In protein sequence terms, each 
observed state represents an amino acid in a protein family. Known states are the 
observed amino acid frequencies at a given position in the model, and unknown states 
are the mechanisms and processes responsible for the observed sequence variation. 
Unlike other profile methods, HMMs can be built from unaligned protein families. In 
addition to a state transition matrix, an HMM is enhanced by a confusion matrix, 
describing the probability of observing a particular known state given that the hidden 
model is in a particular hidden state.
A linear HMM for a protein family is a model describing observed states 
corresponding to columns in a multiple alignment (shown in figure 1.8). The transition 
and confusion matrices are generated from the observed amino acid residues of protein 
family members. Each observed state has three hidden states that model matches, 
insertions, and deletions. This allows an HMM to model position dependent amino acid 
distributions and position dependent insertion and deletions (Krogh et al.t 1994).
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Figure 1.8 Linear HMM. Amino acid residues in family members are represented by 
observed states (diamonds). The transition matrix (full lines) describe the probability of 
traversing between each hidden state (octagons) based on the previous state. The 
relationship between observed and hidden states M (match), D (deletion) and I 
(insertion) is described by the confusion matrix (dashed lines).
Query sequences are searched against libraries of HMMs representing protein 
families, or protein domains. Query sequences are scored against each HMM by 
calculating the probability of the observed amino acid at each model state. The 
optimum path through an HMM can be identified in a similar way to finding the 
optimum path through a scoring matrix, by using the Viterbi algorithm (Viterbi, 1967). 
The Viterbi algorithm can be used to calculate both local and global optimum paths.
1.2.1.5 Comparison of BLAST 1. BLAST2 and HMMs
There are two main software packages available for building and scanning 
HMMs. SAMT (Karplus et al., 1998) and HMMER (Eddy, 1998) both use linear 
HMMs. These packages have been compared to each other and BLAST 1/BLAST2 by 
Madera and Gough (Madera and Gough, 2002) using an all against all search of 2873 
domains of known structure and less than 40% sequence identity, where the 
evolutionary relationships between the domains are known (a total of 36 612 possible
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true homologous pairwise relationships). Comparisons between each method were 
made by comparing the number of remote homologues detected at an error rate of 1%. 
The authors conclude that SAMT consistently produces better models than HMMER 
and detected 24% of possible remote homologues, 10% more remote homologues than 
HMMER and BLAST2. The remote homology detection rate reported by Madera and 
Gough is slightly lower than the 34% reported by Park and colleagues (Park et a l,
1998) in a similar detection test. Four years later, more recent benchmarking studies for 
HMM libraries used in this thesis detect 76% of remote homologues (Sillitoe et a l, 
2005; described in section 2.4.2.2). This increase in remote homology detection rates is 
due to the increase in the size of sequence databases used to produce HMMs and more 
sensitive HMM building methods.
1.2.2 Structure Based Homology Detection Methods
Proteins sharing extremely low levels of sequence similarity can still possess a 
high level of structural similarity, from which homology can be inferred, see example in 
figure 1.9. Studies of protein structural families have shown that homologues share on 
average only 15% sequence identity (Todd et al., 2001).
Figure 1.9 Structural Similarity in the Absence of Sequence Similarity. The
structure o f human haemoglobin (left, PDB: lhho, chain A, Shaanan, 1983) and insect 
haemoglobin (right, PDB: leco, Steigemann and Weber, 1979) show similar 97 amino 
acid core structure (cRMS=2.08A), with a sequence identity o f 12.4%.
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1.2.2.1 Structural Alignment
Structure comparison and alignment algorithms were first introduced in the early 
1970s. The rigid body superposition methods (Rossmann and Argos, 1976) allow 
structures to be superposed and a similarity measure calculated. Structures are 
compared by superposition of equivalent peptide chain carbon-alpha atoms, or whole 
secondary structures. Structures are translated and rotated relative to one other until the 
difference between putative equivalent residues or secondary structure elements is 
minimised. Similarity can be scored by calculating the root mean square distance 
(RMSD) between equivalent peptide chain carbon-alpha atoms (cRMS), residues or 
secondary structure elements. Superposition methods are limited when aligning distant 
homologues that may contain large insertions and deletions or changes in the 
orientations of equivalent secondary structures. More sensitive alignment algorithms 
based on dynamic programming, secondary structure alignment and fragment 
comparison have been developed. Many protein structure classifications use secondary 
structure based comparison (GRATH, Harrison et al. 2003; SEA, Rufino and Blundell 
1994) to identify putative structural relatives and then apply slower, more accurate 
residue based methods. More computationally intensive residue based comparisons 
(COMPARER, Sali and Blundell 1990; SSAP, Taylor and Orengo 1989; STAMP, 
Russell and Barton, 1992; DALI, Holm and Sander, 1993; CE, Shindyalov and Bourne
1998) result in accurate structural alignments. Rather than attempting to superpose 
equivalent residues between protein structures, many of these methods compare the 
internal distances between residues within the same structure to align residues with 
similar sets of internal distances.
1.2.2.2 Threading
Threading techniques (for example, Jones et al., 1992; Bryant and Lawrence, 
1993) attempt to position a protein sequence onto a structural template by identifying 
the most energetically stable fit to the template. Threading techniques require a 
database of known structural templates to scan against, an energy function for 
measurement of the energy of the protein sequence-structural template alignment, an
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algorithm for identifying the optimal alignment and finally a scoring system to measure 
the reliability of the structural prediction. Threading assumes that since many different 
protein sequences are known to fold into a limited number of protein folds, by 
attempting to thread a protein sequence into each member of a known structural 
template library, protein sequences can be assigned a structural fold. Threading scores 
the likelihood of two residues occurring at a certain distance relative to each other in 
space for each residue pair in the query-template alignment. Because threading 
techniques also incorporate some structural data, they are used for predictions at very 
low sequence identities (<25%) where sequence-based homology methods may not 
function. The performance of different threading approaches is assessed every two 
years in CASP fold recognition predictions (Kinch et a l , 2003). Threading is 
computationally expensive and most threading-based methods are too slow for large- 
scale genomic annotation projects (Cherkasov and Jones, 2004). However, some 
annotation protocols incorporate threading potentials. For example, GenThreader 
(McGuffin and Jones, 2003) consists of a neural network trained to combine BLAST2 
alignment profiles (seeded with structural alignments), secondary structure predictions 
and energy potentials derived from threading.
1.2.3 Context Based Functional Prediction Methods
Implication of a functional linkage between proteins can be evidenced by 
methods other than sequence or structure similarity. A variety of different methods 
have been developed to describe contextual relationships between proteins. Most of 
these methods rely on genomic information to infer a functional linkage between 
proteins.
1.2.3.1 Rosetta Stone
The Rosetta Stone method identifies homology between proteins when 
homologues are found fused together in another organism. If two proteins are located 
apart in one genome, but can be identified fused together in another genome, homology 
between them can be implied. Eisenberg et a l (Eisenberg et al> 2000) cite the example 
of yeast proteins involved in tryptophan biosynthesis, TrpG and TrpF, the Escherichia
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coli homologues of which are found fused together in a tryptophan biosynthesis single 
protein, TrpC. Other examples include Caenorhabditis elegans protein Ade5,7,8 
involved in the biosynthesis of purines, which is homologous to two separate protein 
sequences, Pur2 and Pur3 in the yeast genome that perform the same function.
12.3.2 Protein-Protein Interaction
Proteins that interact physically are functionally linked in that both proteins are 
likely to be involved in similar functions. Homologous sequences are likely to share 
similar interactions. Evidence of physical interactions between proteins can be obtained 
from high-throughput technologies such as large-scale two-hybrid screens, protein 
microarrays, and mass spectrometry of protein complexes. However, the interactions 
identified from these multiple experiments can be contradictory (Mrowka et al., 2001), 
requiring development of methods to assess the reliability of protein-protein interaction 
data (von Mering et al., 2002, Saito et al., 2003).
1.2.3.3 Svntenv
Especially in prokaryote genomes, genes that are in close proximity to one 
another in several genomes are likely to be functionally linked (Dandekar et al., 1998). 
Such linkage has been demonstrated by genes in the purine biosynthetic pathway, 
tryptophan biosynthesis, glycolysis and signal transduction pathways (Overbeek et al.,
1999). Studies indicate that a minimum of 10 genomes are required in order to detect 
even small functional clusters by conservation of gene proximity alone (Overbeek et al.,
1999), since gene proximity is not often conserved above proximal gene pairs of 
proteins (Bansal, 1999). Gene proximity correlations have been found to a lesser extent 
in eukaryotes (Barbazuk et al., 2000). Gene proximity can be combined with other 
techniques to detect more diffuse but significant clusters of genes showing functional 
linkage (Kolesov et al., 2001).
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1.2.3.4 Phylogenetic Profiles
The presence or absence of a protein homologue in multiple genomes is called a 
phylogenetic profile. Eisenberg et al. (Eisenberg et al., 2000) note that when 
considering presence or absence profiles, there are far more possible phylogenetic 
profiles than protein families, so that the phylogenetic profile of a protein is an almost 
unique pattern of its genomic distribution, and any proteins with similar profiles are 
likely to be functionally linked. Phylogenetic profile comparison has been used to 
identify proteins functionally related to ribosomal proteins (Pellegrini et al., 1999), 
relationships that are not detectable by sequence comparison. Phylogenetic profiles 
consisting of a range of values, rather than the simpler presence/absence profiles are 
able to discern more subtle profile relationships (Date and Marcotte, 2003).
1.2.3.5 Expression Profiles
High-throughput microarray protein expression experiments allow proteins to be 
associated by co-expression profile analysis. Proteins that are found to have correlated 
expression profiles are likely to be functionally related. For example, Baldessari et a l 
(Baldessari et al., 2005), describe the identification of thirteen groups of functionally 
related synergistically expressed proteins involved in diverse molecular processes 
including RNA processing, cell cycle, respiratory chain and protein biosynthesis, in a 
large scale microarray analysis of gene expression in Xenopus laevis. Analysis and 
comparison of expression profiles across multiple microarray experiments is often 
complicated by the range of different statistical normalisation and clustering techniques, 
experimental conditions and different microarray platforms (Cope et al., 2004; 
McShane et al., 2002; Pavlidis and Noble, 2001).
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1.3 Functional Annotation
The different functional roles performed by different proteins can be 
characterised experimentally. However, only a small number of proteins have had their 
function determined experimentally, the vast majority of proteins are functionally 
annotated by inheriting annotations from functionally characterised homologues. 
Functional annotation has been shown to be reliably inherited between proteins with as 
little as 30-40% sequence identity (Hegyi and Gerstein, 2001). However, Todd et al. 
(Todd et al.t 2001) document examples of proteins with very low sequence identity 
sharing similar functions (for example chymotrypsin and subtilisin) and similar proteins 
with different functions (for example lactalbumen and lysozyme). However, exhaustive 
analysis over a large dataset showed that typically one needs 40% sequence identity in 
single domain proteins (60% sequence identity in multidomain proteins) to reliably 
inherit function at 95% confidence.
1.3.1 Defining Function
Different experimental approaches to determine protein function identify 
different kinds of functional associations between proteins. Protein expression 
experiments determine cellular process functions whereas protein-protein interaction 
experiments define a molecular association between proteins. Whilst cell biologists 
might use cellular processes to define protein function, molecular biologists may use 
molecular chemistry to define a protein’s function. Functional databases try to 
formalise and standardise functional terminology. Many functional ontologies employ a 
hierarchical classification of function, for example the Enzyme Commission (Webb, 
1992). Some protein functions are difficult to classify in a linear hierarchy: 
multifunctional proteins require linkages between hierarchical elements of the ontology, 
and different functional descriptors cannot be integrated into a single hierarchy. The 
Genome Ontology (GO, Ashbumer et a/., 2000) tries to overcome these problems in 
two ways. Firstly, protein functions are defined by three separate ontologies. Each 
defines a different kind of functional descriptor: molecular function, biological process 
and cellular component. These three ontologies allow different kinds of functional 
terms to be assigned to the same protein. And secondly, instead of a linear hierarchical 
classification scheme, GO functions are organised into directed acyclic graphs, allowing
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multiple linkages between hierarchical terms. This data structure allows classification 
and comparison of proteins with multiple functional terms or capable of multiple 
functions. Some functional resources are described below.
1.3.2 Enzyme Commission
The Enzyme Commission (Webb, 1992), was initiated in 1955 by the 
International Union of Biochemistry (IUB) in consultation with the International Union 
of Pure and Applied Chemistry (IUPAC) with the intent ‘to consider the classification 
and nomenclature of enzymes and coenzymes, their units of activity and standard 
methods of assay, together with the symbols used in the description of enzyme kinetics’. 
The resulting classification scheme, EC Numbers, is a hierarchical classification of 
enzyme catalysed reactions, consisting of four numbers for each hierarchical level. The 
highest level consists of six groups: oxidoreductases, transferases, hydrolases, lyases, 
isomerases, and ligases. The next two numbers indicate the actor and acceptor 
molecular groups involved in the reaction. The last number specifies the substrate.
1.3.3 Kyoto Encyclopaedia o f Genes and Genomes
The Kyoto Encyclopaedia of Genes and Genomes (KEGG, Kanehisa et al.,
2004) is a collection of databases including descriptions of biological processes 
(PATHWAY database), chemical reactions (LIGAND databases) and gene/protein 
sequence data (GENES database).
1.3.4 Clusters o f Orthologous Groups
The Clusters of Orthologous Groups (COG, Tatusov et al., 2003) database 
contains 4873 groups of protein orthologues from 66 completely sequenced prokaryotic 
and unicellular organisms. The database also contains 4852 clusters of orthologues 
from 7 eukaryotic genomes (KOG). Clusters are defined by identification of genome- 
specific best hits between proteins using all against all BLAST2 comparison. COGs 
and KOGs are divided into 23 broad functional process classes (the largest of which
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include: E - amino acid metabolism and transport, C -  energy production and 
conversion, J -  translation, G -  carbohydrate metabolism and transport, L -  replication 
and repair, and T -  signal transduction) obtained from GenBank and other public 
databases and by searching primary literature. Functional annotation of COGs and 
KOGs is undertaken on a case by case basis, using published data, protein domain 
analysis, phyletic patterns and gene order conservation.
1.3.5 Genome Ontology
The Genome Ontology (Ashbumer et al., 2000) was initiated by eukaryotic 
model organism databases (FlyBase, Saccharomyces Genome Database and the Mouse 
Genome Database) in 1988. It now includes many databases representing prokaryotes 
and eukaryotes. GO consists of three separate hierarchical ontologies describing 
molecular functions, biological processes and cellular component. GO ontologies are 
organised into directed acyclic graphs where a child term may have multiple parent 
terms.
1.3.6 Affvmetrix
Affymetrix is a manufacturer of microarrays. The company provides annotation 
for each gene represented on each microarray. This annotation is derived from public 
databases and includes gene identifiers and description from the NCBI, domain 
classifications from SCOP and Pfam, EC Numbers and KEGG annotations. Affymetrix 
microarrays are used by many different research groups. This permits expression data 
deposited in public databases (for example the NCBI Gene Expression Omnibus, 
Barrett et a l, 2005) to be collated between different microarray experiments from 
multiple sources.
1.3.7 STRING
STRING (von Mering et al., 2005) contains predicted and known protein- 
protein interaction data. These interactions may be physically interacting proteins or
functionally linked proteins via linkages inferred through genomic context, microarray 
co-expression experiments, and the COG and KEGG databases. STRING currently 
contains 730,000 proteins from 180 genomes.
1.3.8 Reliability o f Annotation
Experimentally determined data can produce remarkably little consistency 
between different experimental methods. For example, in two large-scale mass 
spectrometry protein-protein interaction studies in yeast, only 19.2% and 27.5% of the 
interactions identified using each method were identified by both methods (von Mering 
et al., 2002). Aside from errors caused by the inconsistency of experimental methods, 
assigning annotation to proteins by inheriting annotations from related proteins can 
cause annotation quality problems (Bork and Koonin, 1998). In smaller databases 
curated by experts, annotation is likely to be manually checked and verified, where 
possible, against the literature. However, since few annotations are directly 
experimentally characterised, the majority of databases contain large amounts of 
inherited annotation (Karp et al., 2001). The mechanism of annotation by inheritance, 
by its very nature leads to error propagation. The protection given to sequence 
annotations in primary databases (whereby only the submitter of the sequence can alter 
it’s annotation) means that it is difficult to correct errors once identified, and that errors 
persist. Even once corrections to the original entry are completed, erroneously 
annotated homologues may still persist. There are several annotation analysis programs 
that aim to identify erroneous annotations in database collections (Wieser et al., 2004; 
Kaplan and Linial, 2005), whilst other approaches focus on assigning reliability scores 
to annotations (Valencia, 2005).
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1.4 Objectives
The following five chapters divide this research into different sections; but all 
these chapters are primarily concerned with describing the distribution and relationships 
between protein families and domain families in completely sequenced genomes. 
Chapter two describes the construction of Gene3D, a resource containing completely 
sequenced genomes that are annotated with protein family, domain family and 
functional information. Chapter three describes the distribution of protein families and 
domain families across these completed genomes. Chapter four is concerned with how 
well the domain families identified in the genomes have been characterised, and how 
many more families would be required to be better characterised in order to more 
accurately describe the domain complement of these completed genomes. Chapter five 
is divided into two main sections. The first section describes the distinct distributions of 
domain families identified within bacterial genomes. The second section introduces a 
novel phylogenetic profile method that can be used to infer evolutionary and functional 
relationships between domain families. Finally, chapter six summarises the conclusions 
of this thesis, and suggests future work to improve and expand these analyses.
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CHAPTER TWO
Construction of the Gene3D Resource of Complete Genomes 
Annotated with Protein Family, Domain Family and 
Functional Information
2.1 Introduction
2.1.1 The Repertoire of Completed Genomes
The advent of completely sequenced genomes permits the complete protein 
component of certain organisms to be identified and opens new avenues of research in 
the biological sciences. Currently, the Genomes On-Line Database (GOLD, Bernal et 
al., 2001) reports 261 published completely sequenced genomes (plus an additional 
-1500 viral genomes) and over 1000 ongoing genome sequencing projects (as of June
2005). The number of completely sequenced genomes has risen steadily and is currently 
increasing at a rate of about one per week (shown in figure 2.0).
1200
■ Incomplete
■  C om plete
Figure 2.0 Increase in Genomic Data. Increase in the number o f completely 
sequenced genomes and the number o f ongoing sequencing projects. Taken from the 
Genomes On-Line Database.
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Completely sequenced genomes from all three kingdoms of life are available. 
There are currently 33 complete eukaryotic genomes (including chromosomes) ranging 
from single cellular yeasts to multicellular fungi, plants and animals; 207 complete 
bacterial genomes; and 21 complete archaeal genomes. The proteins encoded by these 
genomes may be clustered into families and decomposed into domains. Analysis of the 
distribution of these families and domains and of the combinations of domains that are 
found can tell us much about the evolution of genomes at the molecular level (Vogel et 
al., 2004).
2.1.2 Protein Annotation
The massive increase in protein sequence databases (for example, GenBank 
grows exponentially, currently doubling in size every 12 to 15 months, NCBI News, 
Summer/Fall 2004 edition) requires fast, automated methods of protein annotation. 
Protein clustering into families of related proteins permits inheritance of annotation 
from a consensus of multiple related proteins, which can be more reliable than from 
individual pairwise comparison (Devos and Valencia, 2000). These approaches and 
technologies are discussed below.
2.1.3 Protein Clustering Methods
Sequence clustering involves the measurement of all pairwise sequence 
similarities within the group of protein sequences to be clustered. Proteins are then 
assigned to clusters based upon sharing of significant sequence similarity with existing 
cluster members. There are several problems when clustering protein sequences into 
families, most notably multi-domain proteins, promiscuous protein domains and 
fragmented proteins (shown in figure 2.1).
Multi-domain proteins often cause unrelated proteins to be clustered together, if 
they share a significant proportion of similar domains (Doolitte, 1995; Smith and 
Zhang, 1997). Detection of shared protein domains does not necessarily indicate that 
the proteins have a biochemical function in common (Henikoff et al., 1997), unless the 
domain context of the proteins is shared (Hegyi and Gerstein, 2001). Promiscuous
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domains, for example SH2, WD40 and DnaJ domains that occur with high frequency in 
many proteins with different functions can produce significant sequence similarity 
between otherwise unrelated proteins. Fragmented proteins, incomplete protein 
sequences in protein databases, can render accurate protein domain determination by 
sequence comparison methods unreliable and incomplete. Some clustering methods 
attempt to overcome these problems by identifying protein domains within multi­
domain proteins, for example by using BLAST reports (Guan, 1997), domain libraries 
(Pfam -  Bateman et al., 2004; ProDom -  Servant et al., 2002) and iterative sequence 
comparisons (GeneRAGE -  Enright et al., 2000). However some of these methods still 
require manual intervention to cluster multi-domain proteins correctly or are too 
computationally intensive for use on large protein datasets. Of the more recent 
clustering methods, TribeMCL (Enright et al., 2002), ADDA (Heger and Holm, 2003) 
and CHOP (Liu and Rost, 2004), described below, are notably able to work efficiently 
and reasonably accurately with very large data sets (e.g. SWISSPROT/TrEMBL) and so 
make it feasible to cluster large collections of complete genomes.
Matching domains in 
multidomain proteins
Promiscuous domains
Fragments of 
multidomain proteins
Figure 2.1 Problems Associated with Clustering. Matching domains in multidomain 
proteins, promiscuous domains and fragments o f multidomain proteins can erroneously 
indicate protein relatedness between otherwise unrelated proteins via regions with 
sequence similarity (arrows).
2.1.3.1 Subclustering Families
Subclustering within families on the basis of sequence identity allows 
identification of more closely related relatives within a family. There are three main
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approaches: single linkage, multi-linkage and directed multi-linkage clustering, which 
can produce very different subclusters within a protein family.
Using the same sequence dataset, three different approaches yield different 
clusters. Single linkage clustering permits membership of a cluster when significant 
sequence similarity exists to any existing cluster member, giving more diffuse clusters 
since not all cluster members are required to have significant sequence similarity to 
each other. Multi-linkage clustering however, requires that all existing cluster members 
share significant sequence identity to each other, producing smaller, tighter clusters. 
Multilinkage clustering can be dependent on the order on which sequences are 
clustered; a change in the order can produce different clusters. Directed multi-linkage 
clustering is based upon the same principle as multi-linkage clustering but in addition, 
clusters are ordered by descending similarity; the most similar sequences are clustered 
together first. Directed clustering is thus not effected by the order in which sequences 
are added to clusters.
2.1.4 H om ology Detection
Early protein family classifications were principally based upon detection of 
homology via pairwise sequence comparison. Pairwise comparison becomes unreliable 
in the Twilight Zone* of less than 30% sequence similarity (Doolittle, 1990), however, 
more sensitive family-based sequence pattern matching profiles and motifs can be 
constructed ffom protein families identified via pairwise sequence comparisons (for 
example PRINTS, Attwood et a l , 2003). Sequence profiles and motifs often represent 
highly conserved residue signatures within a protein sequence that may be associated 
with a particular evolutionary family or biological function. Using these profile 
methods can often detect homologues at low levels of sequence identity where pairwise 
comparison becomes unreliable.
Profile methods representing whole protein sequences, for example PSI-BLAST, 
are able to describe position specific probabilities of protein residue insertions and 
deletions occurring within families. The most recent development in profile methods 
are hidden Markov models. These models are better at modelling insertions and
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deletions and are capable of detecting more remote homologues in large databases than 
previous methods (described previously, see section 1.2.1).
2.1.4.1 Building Hidden Markov Models using SAMT
There are two well established HMM program suites, HMMER and SAMT 
(described previously, see section 1.2.1.5). Both these program suites allow building of 
HMM libraries and searching databases with HMM libraries. At the time of starting 
this project, the SAMT program suite was used since it had been shown to be more 
powerful than HMMER in detection of remote homologues and at the time was slightly 
faster to search databases with HMM libraries (James Bray, PhD thesis). In the SAMT 
HMM software package (Karplus et al., 1998) model building process (shown in figure 
2.2), an initial BLAST is performed to identify a set of close relatives and a set of more 
distant relatives. The sequence set containing close sequence relatives is used to 
generate an initial sequence alignment for the seed sequence. An initial model is 
produced to represent the states in this alignment. This model is used to score all the 
sequences in the sequence set of distant relatives. In this first iteration of scoring, a 
very stringent E-value cut-off is used. Sequences in the distant relatives sequence set 
that score below this cut-off are pulled into the initial alignment to produce a first 
iteration alignment.
In the second iteration and in subsequent iterations of the model building 
process, the E-value cut-off for inclusion of new sequences into the alignment is 
successively increased. Increasing the E-value cut-off allows more distant sequence 
relatives to be gradually incorporated into the alignment and thus the model. New 
sequences are given less weighting in the alignment and model building process so that 
the sequence alignment signature of the close relatives from the initial iteration is 
preserved, and yet the sequence diversity of distant relatives is expanded in the model. 
After the sixth iteration the resulting model is the HMM representing the seed sequence 
family. The SAMT program suite allows the HMM model building process to be subtly 
altered by changing many different variables including the number of iterations, the cut­
off E-values at each iteration and the weight given to new sequences in the alignment at 
each iteration.
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Figure 2.2 Iterative Nature of the HMM Build Process. At each iteration an 
augmented alignment is produced that generates an improved model describing the 
sequence diversity o f more distant relatives whilst maintaining the core sequence 
diversity o f close relatives from the initial iteration.
2.1.5 Protein Family Resources
Protein sequence mutations such as point mutations or larger insertions and 
deletions during evolution have given rise to families of proteins within which relatives 
share a common evolutionary ancestor, but may have diverse protein sequence and 
structure, and subsequent modification of protein function, although some protein 
families, notably the globins retain a common biological function despite high sequence 
diversity.
The term protein family has been in use since the 1960s e.g. (Dayhoff (ed) 1965- 
1978, Atlas of Protein Sequence and Structure) and definitions vary. The term is used 
here simply to refer to groups of proteins related by common ancestry, including close 
and distant relatives. Close relatives in the same protein family often possess similar or
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identical biological functions. In more distant relatives functions may have changed 
(Todd et al., 2001; Rost, 2002; Devos and Valencia, 2000). Protein family 
bioinformatics resources may be used for inheriting functional information from 
experimentally characterised genes to their sequence and structural relatives. Grouping 
proteins into families also serves to integrate information on cellular and molecular 
function.
2.1.5.1 Sequence Based Protein Family Resources
Protein sequences often comprise several domains. Apic et a l (2001) predict 
that about four fifths of proteins in eukaryotes and two thirds of proteins in prokaryotes 
are multidomain proteins. Many resources cluster whole protein chains into protein 
families, for example ProtoNet and TRIBES. However some resources, for example 
Pfam and ADDA, identify separate domains within proteins and construct protein 
domain families. A single protein may consist of several protein domains that belong to 
different domain families. Hence protein domain family classifications are a useful tool 
in determining the evolutionary relationships between proteins, especially within a 
genomic context. Table 2.0 summarises some major sequence family databases.
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Table 2.0 Summary of Example Sequence Family Databases
Resource or 
Clustering 
Method
Reference Source(s)
Families
(00/04)
Method
ADDA Heger & Holm
SWISSPROT, 
TrEMBL, PIR, 
PDB, 
WORMPEP, 
ENSEMBL
34.000 
families (plus
60.000 
singleton)
BLAST
CHOP Liu & Rost
62 complete 
genomes
63,300 clusters 
(plus 118,108 
singletons)
PSI-BLAST
COG/KOG Tatusov et al.
66 unicelluar and 
7 eukaryotic 
complete 
genomes
4873 COG, 
4852 KOG
Bidirectional 
best hit by 
BLAST
DIVCLUS
Park and 
Teichmann
6 genomes, 12013 
sequences
13076 
duplication 
modules in 
1622 clusters
Multiple
sequence
comparison
methods
InterPro Mulder et al.
UniProt, 
PROSITE, 
PRINTS, Pfam, 
ProDom, 
SMART, 
TIGRFAMs, PIR 
SuperFamily, 
SUPERFAMILY, 
Gene3D
11,007 entries 
(2573 
domains, 8166 
families)
Multiple 
methods 
(HMM, PSI- 
BLAST, 
Regular 
Expression)
iProClass Huang et al.
PIR, 
SWISSPROT, 
TrEMBL, Pfam, 
BLOCKS, 
PRINTS, ProSite, 
PDB, COG
36,000 PIR 
superfamilies, 
100,000 
families
N/A
Pfam Bateman et al.
SWISSPROT,
TrEMBL
7459 families HMM
PRINTS Attwood et al.
SWISSPROT,
TrEMBL
1800 entries 
10,931 motifs
Iterative motif 
searches
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ProDom Servant et al.
SWISSPROT,
TrEMBL
501,917 
families 
(186,303 non­
singleton)
PSI-BLAST
ProtoNet Kaplan et al.
SWISSPROT,
TrEMBL
User-defined BLAST
SMART Letunic et al. Selected proteins 667 domains HMM
SwissPROT
Boeckmann et 
al.
Primary database
153,871
proteins
N/A
SYSTERS Meinel et al.
SWISSPROT, 
TrEMBL, 
ENSEMBL 
(complete 
genomes), the 
Arabidopsis 
Information 
Resource, SGD 
and GeneDB
158,153
disjoint
clusters
BLAST
TIGRFAMs Haft et al.
SWISSPROT,
TrEMBL
1976 families HMM
TRIBES Enright et al.
83 Complete 
Genomes
60,934 or 
82,692 
depending on 
granularity
TribeMCL 
clustering 
using BLAST
2.1.5.2 Families of Whole Protein Sequences
The TRIBES database (Enright et al., 2003) clusters proteins from 83 complete 
genomes into between 60,934 and 82,692 families depending upon the level of 
granularity of clustering that is chosen. TRIBES uses the TribeMCL (Enright et al.,
2002) clustering program, developed from the Markov cluster (MCL) algorithm (van 
Dongen, 2000) to cluster protein sequences. TribeMCL simulates flow in a similarity 
graph consisting of pairwise sequence similarities (BLAST E-value cut-off of 0.0001) 
of all proteins in the dataset and then assigns complete protein sequences into families 
based on the density and strength of links between them. This novel approach does not 
suffer greatly from the problems caused by multi-domain proteins, promiscuous
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domains and fragmented proteins as outlined previously. The method makes no attempt 
to decompose the sequences into their component domains but rather produces clusters 
that correlate well with the overall domain architecture of the sequences.
ProtoNet developed by Linial and co-workers (Kaplan et al., 2005), clusters 
SWISSPROT proteins in the UniProt database on the basis of sequence similarity. 
Proteins from the TrEMBL repository are later added into these initial protein clusters. 
The ProtoNet protocol can produce protein family clusters from three different 
clustering methods: harmonic, geometric and arithmetic. These different clustering 
methods vary by putting more emphasis on either strong sequence similarities between 
cluster members (harmonic > geometric > arithmetic), or conversely on weak similarity 
between cluster members (arithmetic > geometric > harmonic) when merging clusters 
(Sasson et al., 2003).
The PRINTS database (Attwood et al., 2003) is a collection of protein 
‘fingerprints’: regular expressions describing conserved sequence motifs used to 
characterise a protein family. These motifs are generated via multiple protein sequence 
alignments by identifying regions of local sequence conservation. They can 
subsequently be used to scan a larger sequence set (SWISSPROT and TrEMBL, 
Boeckmann et al., 2003) to recruit new family members. The majority of families are 
defined by multiple motifs and all must be present for a relative to be added to the 
group.
COG and KOG (Tatusov et al., 2004) are databases of clusters of orthologous 
groups of proteins, defined by bi-directional best hitting groups of three or more 
proteins in complete genomes (described previously in section 1.3.4).
The SYSTERS (Meinel et al., 2005) database uses graph-based methods to 
generate protein families of varying granularity.
The number of families identified by those resources performing automated 
clustering of large sequence repositories varies from 65,000 to 186,000 depending on 
the clustering philosophy. Kunin and co-workers recently revealed that each newly 
sequenced genome leads to an increase in the total number of protein families 
characterised (Kunin et al., 2003). A proportion of protein sequences (between 10 and
53
25%), in every genome, are singletons or belong to families not present in any other 
sequenced genome. This may reflect limitations in the current sequence based 
homologue detection algorithms; or alternatively these may be genuinely novel families 
that have arisen following speciation. These organism-specific families may be 
important for expanding the functional repertoire and phenotype of the organism, 
perhaps by providing new biological processes or changes in gene/protein regulation.
2.1.5.3 Families of Protein Domain Sequences
A number of resources exist which automatically cluster protein sequences from 
the completed genomes or from the large sequence repositories (e.g. GenBank or 
SWISSPROT-TrEMBL) into putative domain families. The ProDom resource (Servant 
et a l 2002) contains protein sequence families derived from sequences in UniProt and 
TrEMBL. These protein sequences are chopped into protein domains using an iterative 
PSI-BLAST domain boundary prediction program.
DIVCLUS (Park and Teichmann, 1998) is part of the Genome Analysis and 
Protein Family Maker software package that identifies homologous domains in single 
and multi-domain proteins. DIVCLUS uses an iterative checking process that compares 
pairs of aligned sequences and separates single linkage clusters into duplication module 
families according to sequence similarity and overlap criteria to produce clusters 
containing homologous proteins.
Pfam (Bateman et a l 2004) is a highly comprehensive resource providing a high 
quality set of Hidden Markov Model profiles for protein domain families. Families are 
built from ProDom identified clusters. These families are defined in Pfam using 
multiple sequence alignments and HMMs, the largest domain families are built first. 
Pfam consists of two parts, the first is the curated part of Pfam (Pfam-A), the second is 
an automatically generated supplement called Pfam-B.
TIGRFAM (Haft et a l, 2003) protein families are built in a similar fashion to 
Pfam but also contain whole protein chains.
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Holm and co-workers recently developed the ADDA algorithm to cluster 
sequences into domain families by exploiting the principal of domain recurrence in 
different protein sequences (Heger and Holm, 2003). A related algorithm, CHOP (Liu 
and Rost, 2004), assigns domain boundaries by BLAST sequence comparison and then 
clusters the subsequent domain-like fragments into sequence families using the CLUP 
(Liu and Rost, 2004) clustering method (these methods are discussed in section 4.1).
SMART (Letunic et al., 2002) (Simple Modular Architecture Research Tool) 
describes over 600 domain families, which have been selected with a particular 
emphasis on mobile eukaryotic domains and as such are widely found among nuclear, 
signalling and extracellular proteins. SMART domain families are defined by hand 
curated multiple sequence alignments. An HMM library of these domain families 
allows fast sequence annotation with SMART domains. SMART domain families are 
annotated with function, sub-cellular localisation, phylogenetic distribution and tertiary 
structure.
The InterPro database (Mulder et a l , 2005) is an important recent development 
since it integrates major protein family classifications and provides regular mappings 
from these resources to primary sequences in the UniProt protein sequence database. 
Databases in the InterPro collaboration include UniProt, PROSITE, PRINTS, Pfam, 
ProDom, SMART, TIGRFAMs, PIR SuperFamily, SUPERFAMILY and more recently 
Gene3D.
2.1.5.4 Structure Based Protein Family Resources
There are two major protein structure classifications, both of which require a 
varying degree of manual intervention, CATH and SCOP, which classify protein 
domains of known structure into evolutionary superfamilies. Each superfamily is 
classified in a hierarchy corresponding to Class (proportion of alpha helices and beta 
strands in the structure) and Fold Group (structures sharing significant global secondary 
structural element composition and connectivity). Architecture, (overall shape of 
structures, i.e. orientation of the secondary structures, for example layered sandwich or 
barrel like), is an additional hierarchical level in the CATH classification. Domains 
adopting similar Class, Fold Group and Architecture can be further clustered into
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Homologous Superfamilies according to further evidence of an evolutionary 
relationship, for example shared functional characteristics and/or sequence motifs. 
Table 2.1 summarises both manual and automated structure based resources.
Table 2.1 Protein Structure Family Resources
Database Coverage (07/04)
Structural Comparison 
Method
Description
CAMPASS
7580 domains 
1409 superfamilies
COMPARER
SEA
Structure-based 
alignment of 
SCOP
superfamilies
CATH
67,054 domains 
1572 superfamilies, 
907 folds
SSAP
GRATH
Automatic structural 
and sequence 
comparison with 
manual validation of 
superfamily 
alignments and 
domain boundaries
CE All chains in PDB CE
Fully automatic, 
nearest neighbours
DALI Domain 
Dictionary
1,062 superfamilies DALI
Fully automatic 
classification using 
PUU, DALI 
algorithms
DHS 1459 superfamilies
SSAP
CORA
Fully automatic 
multiple structural 
alignments of close 
relatives in CATH
HOMSTRAD
7500 domains 
1032 superfamilies
COMPARER
Manual
classification of 
close protein 
homologues
MMDB
28,000 structures, 
87,000 domains
VAST
Fully automatic, 
nearest neighbours
SCOP
65,122 domains 
1325 superfamilies, 
805 folds
Manual
Manual
classification
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The SCOP database (Andreeva et al, 2004) uses almost entirely manual 
validation for recognising structural similarities between distantly related protein 
structures to generate evolutionary superfamilies, resulting in a very high quality 
resource. In the CATH database, (Pearl et al., 2005), a combination of manual and 
automated approaches is used. Whilst structure comparison methods (SSAP, Orengo 
and Taylor, 1996; CORA, Orengo, 1999; GRATH, Harrison et al., 2002) have been 
developed to recognise structural relatives, evolutionary relationships are only assigned 
following manual assessment of all available data. Table 2.1 above shows that SCOP 
and CATH recognise around 805 - 907 fold groups and around 1325 - 1572 
superfamilies in the current set of protein structures.
In contrast to the manually curated SCOP and CATH classifications, the DALI 
domain database (Dietmann et al., 2001) is produced by a completely automated 
classification protocol. Domain boundaries are recognised using the PUU algorithm 
(Holm and Sander, 1994) and domains are assigned to fold groups and superfamilies 
using the robust DALI structure comparison algorithm (Holm and Sander, 1994).
The NCBI Molecular Modelling DataBase (MMDB, Chen et al., 2003) classifies 
all non-theoretical PDB structures. Fully automatic classification in the MMDB is 
achieved using all against all structural comparison by secondary structure element 
superposition (VAST, Gibrat et al., 1996). MMDB structures are linked to other NCBI 
databases containing sequences, taxonomy, literature references and both sequence and 
structure relatives.
CE (Shindyalov and Bourne, 1998) classifies PDB structures by structural 
comparisons using the CE algorithm that compares alpha carbon atom positions in the 
peptide chain to identify aligned fragment pairs. The optimal alignment of aligned 
fragment pairs is calculated by minimising RMSD.
Functional annotation of structural domains in CATH is achieved in the 
Dictionary of Homologous Superfamilies (DHS, Bray et al., 2000). The DHS contains 
multiple structural alignments of all the known domain structures in each CATH 
homologous superfamily. Functional annotation is provided by BLASTing domain 
sequences against the UniProt database to identify 95% sequence identity relatives. 
Functional annotations from KEGG, COG, GO and EC numbers are then inherited from
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the annotated UniProt sequence relative to the CATH domain. The current release of 
the DHS contains 1459 CATH homologous superfamily domains which have been 
annotated with 495,611 UniProt sequence relatives.
The HOMSTRAD and CAMPASS databases, constructed by Blundell and co­
workers (Mizuguchi et al. 1998; Sowdhamini et al. 1998), are not hierarchical but focus 
on using SCOP, PFAM and other resources to cluster together families of evolutionary 
relatives. HOMSTRAD (HOMologous STRucture Alignment Database) groups 
proteins into families on the basis of sequence and structural similarity. HOMSTRAD 
combines SCOP, Pfam, PROSITE and SMART classifications with PSI-BLAST 
sequence similarities and sequence-structure profiles to define protein families. 
Currently the PDB is grouped into 1032 families representing 3454 structures. Each 
family is represented by manually curated structure-based alignments. The CAMPASS 
database groups more distant structural homologues than HOMSTRAD by using the 
structural comparison algorithms COMPARER and SEA to generate multiple 
alignments of SCOP superfamilies. Both these resources contain validated multiple 
structural alignments for families and superfamilies that can be used to identify further 
relatives using derived substitution matrices or conserved structural features.
2.1.6 Structural Annotation of Genomes
More than two thousand high throughput complete genome sequencing 
initiatives have produced over a million protein sequences. These protein sequences 
require annotation. Such annotation must be assigned using methods that are fast and 
reliable and the large amount of resulting data must be processed and stored efficiently. 
The assignment of structure to newly sequenced proteins using fast automated 
assignment methods, notably PSI-BLAST and the HMM’s described previously, has 
resulted in development of genome annotation databases that contain sequence-based 
and structure-based annotation of complete genomes. There are four main genome 
annotation databases that contain structurally annotated genomes. These are 
SUPERFAMILY, the Genomic Threading Database, 3D-GENOMICS database and 
Gene3D. The processes used for constructing each database are described below.
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The SUPERFAMILY database (Madera et al., 2004) uses SAMT generated 
profile hidden Markov models to predict SCOP structural domains in 220 complete 
genomes. The Genomic Threading Database (McGuffin et al., 2004) applies the 
GenThreader algorithm (described previously, see section 1.2.2.2) to assign structural 
domains to 218 complete genomes. The 3D-GENOMICS database (Fleming et al., 
2004), as of January 2005, contains 173 complete genomes. These genomes are 
annotated with SCOP structural domains (using PSI-BLAST derived IMPALA profiles) 
and Pfam sequence domains (using HMMER) as well as PROSITE and COG functional 
annotation. In addition, protein sequences are annotated with coiled-coil, low 
complexity, signal peptide, secondary structure, repeated regions and transmembrane 
regions.
Gene3D was originally set up by Buchan et al. in 2002 (Buchan et al., 2002;
2003) and contained 66 complete genomes (53 bacteria, 11 archaea and 2 eukaryota) 
and consisted of domain assignments from CATH (version 2.4) and Pfam (release 6.2) 
mapped onto protein sequences using PSI-BLAST derived IMPALA profiles.
The recent increase in the number of completed genomes, especially those of 
eukaryotes, necessitated further development of Gene3D to increase the number of 
genomes and to provide protein family information. This chapter describes 
development of a novel protocol (PFscape) for identification of both protein and domain 
families in complete genomes and the implementation of this protocol in building 
release 3 of Gene3D.
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2.2 Objectives
This chapter reviews methods for clustering sequences into families of relatives 
using sequence and structure-based methods and the use of these clusters to annotate 
complete genome sequences. The design and use of a novel protocol called PFscape, 
for assigning protein family, domain annotation and functional annotation to complete 
genomes is described in the construction of Gene3D, a resource containing protein 
sequences from 120 complete genomes, clustered into protein families and annotated 
with structural and sequence domain family information, together with metabolic 
pathway and functional data from GO, KEGG and COG. Finally, the user interface and 
web services are briefly outlined.
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2.3 Results
Gene3D was completely re-structured to include information on both protein 
families and domain families. Protein families are themselves sub-divided into 
sequence identity clusters of more closely related protein sequences. Within each 
protein family, sequence and structural domain assignments to each protein sequence 
reveal domain context and assign domain architectures to proteins. Gene3D differs 
from other structural genomics resources (described previously, see section 2.1.6) in 
that, in addition to domain assignments, proteins are clustered into protein families. 
The advantage of this clustering approach is that within a protein family, domain and 
functional assignments to annotated protein members can be inherited to un-annotated 
protein members. The use of subclusters within each protein family permits such 
inheritance to be restricted to protein relatives with varying degrees of sequence 
identity.
2.3.1 Genome Sources in Gene3D
Gene3D version 3.0 contains 120 complete genomes (90 bacteria, 14 archaea 
and 16 eukaryota) comprising 854,897 protein sequences. The majority of genomes 
were downloaded from the NCBI. However, seven eukaryotic genomes (Takifugu 
rub ripe s, Arabidopsis thaliana, Homo sapiens, Drosophila melanogaster, Anopholes 
gambiae, Mus musculus, and Rattus norvegicus) were downloaded from ENSEMBL, 
where the sequence collections were more recent. Subsequent version updates in 
Gene3D have added over 100 additional genomes.
2.3.2 Domain Sources in Gene3D
Each protein is annotated separately with CATH (release 2.5) and Pfam (release 
10) protein domains. These two domain annotation schema can be combined into a 
Domain Architecture for each protein, where gaps in the CATH domain assignment are 
filled with non-overlapping Pfam domain assignments. Remaining unassigned regions 
of 50 residues or more are denoted as NewFam regions. CATH and Pfam assignments
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are achieved using an HMM library containing 4036 models representing 1467 CATH 
structural domains and 6190 models representing 6190 Pfam sequence domains. 
Subsequent version updates in Gene3D have added CATH release 2.6 and Pfam release 
17 domain assignments.
2.3.3 Family Clusters in Gene3D
Protein sequences in Gene3D are clustered into protein families using 
TribeMCL, a clustering program written by Enright et al. (Enright et al., 2002). Each 
protein family is further clustered into sequence identity subclusters of 35, 60, 95 and 
100 percent sequence identity using Homolseqs, in-house single linkage clustering 
software (Orengo et al., 1997).
Domain assignments in Gene3D are clustered into domain families on the basis 
of their CATH or Pfam domain family classification. Each domain family is further 
clustered into sequence identity subclusters of 30, 35,40, 50, 60,70, 80, 90, 95 and 100 
percent sequence identity using TCluster, in-house directed multi-linkage clustering 
software written by Tony Lewis.
2.3.4 Database Tables in Gene3D
In order to facilitate complex queries a Gene3D relational database was designed 
to store both domain assignment data and protein family data. The core database 
consists of four MySQL (open source database, www.mysql.com) tables, illustrated in 
figure 2.3. The central PROTEIN table stores data for all the 854,897 protein sequences 
in the database. This table links to DOMAIN ASSIGNMENT and PROTEIN FAMILY 
tables to show domain assignments and protein family classifications respectively for 
each protein. Lastly, the ORGANISM table designates the genomic context of each 
protein in the PROTEINS table.
62
PROTEIN FAMILY
PROTEIN
DOMAIN ASSIGNMENT
iquenci
Linked Value
ta Value
ORGANISM
Taxor  ^Number
Or janism
Ge nome
Submission
Full Taxonomy
Figure 2.3 Gene3D Database Table Structure. Note that red linked values allow data 
in different tables to be connected (arrows).
Table links occur between Cid and Taxon Number data fields. Organisms in 
Gene3D are designated using NCBI Taxonomy (Benson et al., 2000) taxon numbers. 
The taxon number field provides a unique identifier for each organism. Genomes 
downloaded from the NCBI (Wheeler et al., 2005) were directly assigned a taxon 
number from the NCBI Taxonomy resource. Where genomes were downloaded from 
ENSEMBL (Hubbard et al., 2005), the taxon number was added manually.
Proteins in Gene3D have many different formats of protein identifiers. To 
facilitate manipulation of the data an internal protein identifier was used. A Cid is an 
internal identifier that is kept within the Gene3D database. Each protein sequence in the 
database is assigned a unique 8-digit Cid (for example: 00000001). Identical proteins 
that occur in different organisms or in different locations within the same organism are 
distinguished by different Cids.
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2.4 Protein Family Landscape Protocol
A Protein Family Landscape (Lee et al., 2005) protocol was developed in 
collaboration with David Lee to assign protein family, domain annotation and 
functional annotation to complete genomes in a fast and efficient manner (shown in 
figure 2.4 below). Following protein family clustering, sequences within each family 
are annotated with protein domain information from CATH and Pfam to determine 
domain architectures. Validation of protein family clusters is undertaken by comparing 
consistency of domain architectures within protein families.
The efficiency of the PFscape protocol is achieved through the use of new 
technologies, most notably TribeMCL (Enright et al., 2002) clustering and hidden 
Markov model (HMM, Karplus et al., 1998) domain libraries for domain assignment to 
whole protein sequences.
PFscape protocol generation of Gene3D is only possible due to the recent 
acquisition of computers with very large amounts of memory and a 150 processor 
computer farm where tasks can be massively parallelised. The PFscape protocol has 
three stages: protein family clustering, protein domain assignment and functional 
annotation. These are described below.
Update ProtocolWeb Query Interface
120 Genomes Protein Seauences
Amalgamate Data into Relational Database
STAGE 2 -  Domain Assignment
STAGE 3 -  Functional Annotation
STAGE 1 -  Protein Family Clustering
Figure 2.4 PFscape Protocol Structure. Note that protein clustering and domain 
assignment are simultaneous independent processes.
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2.4.1 Stage 1: Protein Family Clustering
TribeMCL (Enright et a l , 2002) was chosen for protein family clustering as this 
method is fast, automated, and successfully overcomes the clustering problems of 
protein domains, fragmented peptides and sequence similarity errors (as discussed 
previously). TribeMCL is based upon the Markov clustering algorithm (van Dongen,
2000) and represents proteins as nodes in a graph; connections between these nodes 
represent sequence similarity between proteins. A matrix consisting of sequence 
similarities in the graph, transformed into probabilities associated with transitions from 
one protein to another within the graph, is passed through iterative cycles of matrix 
multiplication and matrix inflation to simulate random walks on the graph. Protein 
clusters in the graph can be identified since random walks on the graph are less likely to 
go between clusters than remain within a single cluster, since within protein clusters 
there is a higher probability of transitioning between cluster members than between 
members of different clusters. Matrix multiplication (i.e. matric squaring) computes 
longer random walks on the graph and associates new probabilities with all pairs of 
nodes in the graph, thus acting to dissipate clusters. Matrix inflation augments the 
probabilities of intra-cluster walks and diminishes the probabilities of inter-cluster 
walks, eliminating connections between clusters. Iterative rounds of expansion and 
inflation act to separate the graph into clusters. The granularity of these clusters can be 
altered by changing the matrix inflation parameter, to produce tighter or broader 
clusters.
TribeMCL has been tested previously by Enright et al., (Enright et a l , 2002) 
and shown to be robust and reliable, with at least 87% accuracy. The authors report that 
in TribeMCL clustering of SwissProt, of the 1,821 clusters containing four or more 
members with corresponding InterPro annotations, 1,583 (87%) of these clusters 
contain fully corresponding domain structures across all annotated members. In 
addition, Enright et a l  show that in TribeMCL clustering of the PDB, the total number 
of proteins in clusters with SCOP classifications that are consistent with the most 
common SCOP annotation in the cluster ranges from 79-87% depending on the inflation 
value used.
TribeMCL can cluster proteins at granularity levels between 1 (broadest 
clusters) to 3 (tightest clusters). Protein family clusters in Gene3D should contain
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members where all proteins have the same domain architecture. In order to further 
validate TribeMCL, structural data was used as remote homologues are more reliably 
detected using structural data. The optimal granularity level for TribeMCL clustering 
was determined by validating clusters made at all three granularity levels against a 
dataset of structurally characterised proteins that had been manually validated in the 
CATH database.
2.4.1.1 Benchmarking TribeMCL using Structural Data
Multi-domain protein structures from the PDB (having their individual domains 
previously classified in CATH) were clustered using TribeMCL at three levels of 
granularity. The resulting clusters were assessed by comparing the total percentage of 
proteins that contained the most common domain architecture (same CATH domain 
assignments in the same order) in each cluster. As can be seen in figure 2.5, a 
granularity level of 3 produces clusters where 94.8% of all proteins contain the most 
common domain architecture CATH classification in their cluster. Clustering at 
granularity level 3 is therefore the most appropriate to cluster proteins in Gene3D to 
obtain protein families with consistent domain architectures.
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Figure 2.5 TribeMCL Granularity Benchmarking. TribeMCL clustering o f 
multidomain proteins in the PDB performed at different granularity levels. At 
granularity level 3, the broadest clustering level, 94.8% o f all the proteins in the 
TribeMCL clusters contain the most common domain architecture in their cluster.
Ideally the protein families identified by the PFscape protocol should consist of 
unique domain architectures, indicating that all identifiable evolutionary relatives in the 
PDB are present in the protein family. Half of all domain architectures are found to 
occur in a single cluster, see figure 2.6 below. This demonstrates that half of all domain 
architectures identified in the PDB are unique to a single cluster and are not found to 
occur in any other cluster. This effect is seen at all three inflation values, indicating that 
these clusters are quite robust and are formed early in the TribeMCL clustering process 
by distinct, closely related groups of proteins.
Figure 2.6 shows that TribeMCL clustering is quite conservative, 50% of 
domain architectures occur in two or more clusters and that therefore half of protein 
family clusters may need to be merged subsequently. However, this was considered 
preferable to protein families containing inconsistent domain architectures. Information 
on domain architecture from CATH, Pfam and NewFam domain family assignments 
will be exploited to merge protein families at some stage in the future (see section
3.3.4.2 and 6.2).
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Figure 2.6 TribeMCL Granularity Benchmarking. TribeMCL clustering o f the 
Protein Data Bank performed at three different granularity levels. Note that half o f 
CATH domain architectures are found in a single cluster irrespective o f cluster 
granularity.
2.4.2 Stage 2: Domain Assignment
Mapping protein domains onto protein sequences allows the conservative 
protein families produced from Stage 1 to be validated and confirm that protein families 
are, as the benchmarking would indicate, families containing evolutionary related 
proteins sharing common domain architecture. Additionally, domain assignment 
permits related protein family clusters to be more safely merged, where appropriate.
Protein domain regions are often more reliably identified by using structural data 
as the structures of proteins are much more highly conserved during evolution than the 
sequences of proteins. Whilst a number of comprehensive domain structure 
classifications exist, the CATH protein structure classification was chosen as the 
primary protein domain assignment classification in Gene3D. In addition to structural
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domains classified in CATH, sequence domain families from Pfam were also used to 
annotate proteins.
2.4.2.1 Building HMM Libraries
In order to map CATH domains onto protein sequences in each protein family 
individual CATH structural domains were represented by sequence profiles called 
hidden Markov models. HMM libraries representing CATH and Pfam domains were 
generated using the SAMT program suite (Karplus et al., 1998) running default 
recommended settings searching the non-redundant GenBank database (nr, released 
February 2003).
Hidden Markov models were produced to model each homologous superfamily 
in CATH according to the schema shown in figure 2.7.
CATH Homologous Superfamily
s35 Familys35 Family s35 Family s35 Family
Build
HMM
Build
HMM
Build
HMM
Build
HMM
Figure 2.7 HMM Representation of a CATH Homologous Superfamily. A
representative domain sequence from each CATH s35 sequence family for every 
homologous superfamily in CATH is used to build an HMM. Multiple HMMs can 
therefore represent a single homologous superfamily.
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In order to capture all the protein sequence diversity present in a given CATH 
homologous superfamily, HMMs were built from representative sequences for each s35 
family within a homologous superfamily (see section 2.1.5.4). A single homologous 
superfamily can therefore be represented using several HMMs, one for each s35 family. 
In total 4036 HMMs were produced representing 1467 homologous superfamilies in 
CATH.
Previous analyses have shown that on average, 35-45% of proteins within a 
genome contain structural domain assignments (Buchan et al., 2003; Gough et al.,
2001). Therefore an additional source of protein domains for assignment is needed to 
increase genome coverage. Sequence/functional domains sometimes comprise just a 
fragment of a structural domain or in some cases correspond to multiple structural 
domains. There are several resources dedicated to sequence/functional domains in 
proteins which could be used for annotating genomes. Pfam provides a comprehensive 
and high quality set of profiles for protein domain families and now attempts, where 
structures are known, to ensure that sequence domain boundaries correspond with 
structural domain boundaries.
SAMT was used to build HMMs from Pfam alignments. The Pfam database 
supplies protein sequence alignment files for each Pfam sequence domain family, and 
these were used to produce an HMM that represents each Pfam domain. Whilst Pfam 
provides HMMER HMMs, these models were not used in order to preserve continuity 
in Gene3D, since SAMT is used in-house. Pfam version 10 was used, which contains 
6190 sequence families, producing an additional 6190 HMMs. The final HMM library 
used in Gene3D for domain assignment contains a total of 10,226 HMMs representing 
CATH and Pfam domains.
2.4.2.2 Benchmarking HMM Libraries
HMMs generated using the SAMT technology developed by Karplus et al.t are capable 
of identifying significantly more distant homologues than other profile methods, for 
example PSI-BLAST (Park et al.t 1998; Madera and Gough, 2002; see section 1.2.1.5). 
SAMT was benchmarked in-house by Sillitoe et a l (Sillitoe et al., 2005). Figure 2.8
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shows the accuracy of HMMs in detecting remote homologues in the CATH database at 
various error rates. This error rate was measured as the percentage of false positives.
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Figure 2.8 HMM Coverage of CATH Homologous Superfamilies. The percentage 
of targets identified using HMM profiles. The dataset consists o f CATH remote 
homologous superfamily members (<35% sequence identity). Taken from Sillitoe et al, 
2005.
Scanning a remote homologue benchmark dataset against the CATH SAMT 
HMM model library identified 76% of homologues with an error rate of 0.1%.
2.4.2.3 Domain Assignment by DomainFinderll
The 854,897 protein sequences from 120 genomes in Gene3D were scanned 
against the HMM library using the SAMT program suite. SAMT output was filtered 
according to several criteria by DomainFinderll, an updated version of DomainFinder 
(Pearl et al., 2002) in-house software written and updated by David Lee, and CATH and 
Pfam domain assignments were then made to protein sequences. DomainFinderll filters 
SAMT output using three criteria: (i) the percentage of the HMM model sequence that 
was identified in the protein sequence (Percent Model Matched (PMM)), (ii) the
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percentage of the domain assignment that overlaps with other domain assignments in 
the protein sequence (Acceptable overlap (AO)) and finally (iii) the SAMT E-value for 
the domain assignment (E-value). These selection criteria are described below.
2A.2.4 Percent Model Matched Domain Assignment Threshold
PMM measures the percentage of the HMM that was identified in the protein 
sequence. A high PPM cut-off would exclude valid HMM hits, since domain family 
members can vary in length by 2 fold or more in some domain families. A low cut-off 
would allow erroneous hits to motifs and sub-domain secondary structures. The number 
of CATH domain assignments at each E-value is plotted for a range of different PPM 
cut-offs in figure 2.9 below. As figure 2.9 shows, a PPM cut-off of 90% or more 
(black, pink lines) severely limits the number of domain assignments made, even at very 
low E-values. With a PPM cut-off below 90%, there is little difference in the number of 
domain assignments made at E-values lower than 1.0e-10. Above E-values of 1.0e-10, 
the PPM cut-off has a marked effect on the number of assignments (see figure 2.9 
(bottom)). Whilst a lower PPM cut-off allows many more domain assignments to be 
made (for example at an E-value of 1.0e-05, a PPM of 50% (orange line) allows 5000 
more domain assignments to be made than a PPM of 80% (yellow line)), a PPM cut-off 
of 50% was chosen to ensure that at least half the domain defined by the HMM is 
identified in the sequence. This cut-off avoids domain families with members of 
variable length being penalised.
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Figure 2.9 Percent Model Matched Cut-off. The number o f CATH domain 
assignments permitted by DomainFinderll at different percent model matched cut-offs 
is shown for all E-values (top) and expanded for E-values above 1.0e-14 (bottom).
2A2.5  Acceptable Overlap Domain Assignment Threshold
Domain structures in the same CATH fold group with no evidence of an 
evolutionary relationship at the time of classification are placed into different 
homologous superfamilies. HMMs from different CATH homologous superfamilies in
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the same fold group sometimes cross-hit related sequences, suggesting these 
superfamilies comprise distant homologues not yet recognised in CATH. Conflicting 
domain assignments in Gene3D therefore can sometimes occur between HMMs 
representing different homologous superfamilies in the same fold group. The degree of 
acceptable overlap between different HMM model assignments and what to do with 
significantly overlapping domain assignments must be considered.
As with other domain assignment protocols (DRange, Buchan et al., 2002; 
SCOP, Andreeva et a l , 2004), assignments overlapping less than 30% of the length of 
the shorter domain assignment are considered acceptable and both assignments are 
retained. This approach allows for variability in domain boundaries and domain linker 
regions. This is illustrated in figure 2.10. DomainFinderll permits the overlapping 
domain assignment with the lowest E-value to be retained, whilst noting conflicting 
rejected domain assignments. Conflicting domain assignments may provide useful 
insight into possible evolutionary relationships between different CATH homologous 
superfamilies.
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Figure 2.10 Acceptable Overlap in DomainFinderll Domain Assignment.
Normalised SAMT assignments (top box) are processed in order o f lowest to highest E- 
value to produce DomainFinderll domain assignments (lower box). The non­
overlapping red domain is permitted, whilst the blue domain is discarded due to 
unacceptable overlap with the green domain, leaving the purple domain acceptable.
2.4.2.6 E-value Domain Assignment Cut-Off
From benchmarking of the HMM library, (Sillitoe et al., 2005), it was 
determined that an E-value cut-off of 0.01 was appropriate for the HMM library, 
producing accurate domain assignments with a 0.1 % error rate.
2A.2.1 Resolving Multiple Overlapping Assignments
Normalised SAMT assignments comprise hits of HMMs representing Pfam 
domain families and CATH s35 sequence families. Some of the CATH s35 sequence 
families are members of the same CATH homologous superfamilies. These HMMs are 
likely to assign domains to the same protein region. The vast majority of significantly
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overlapping assignments are from HMMs representing different s35 sequence families 
but identical homologous superfamilies. This is illustrated in figure 2.11 below, where 
of the total assignments made (yellow line), the majority are overlapping domain 
assignments from different s35 sequence families but identical homologous 
superfamilies (pink line). Whilst the number of raw SAMT assignments increases 
dramatically (yellow line) with increasing E-value, a similar increase in the number of 
DomainFinderll assignments is not seen (red line), indicating that DomainFinderll can 
resolve multiple overlapping matches to give a single domain assignment. The number 
of domain assignments removed completely due to overlapping with another domain 
assignment from a different homologous superfamily (green) is rather small when 
compared to the number of domain assignments made (red). This is an encouraging 
indication of the effectiveness not only of the HMM technology itself, but also of the 
domain boundaries defined in the CATH database.
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Figure 2.11 DomainFinderll Effect. The number o f CATH domain assignments: 
From the total number o f SAMT assignments (yellow), assignments are discarded due 
to: overlapping hit to same homologous superfamily (pink), PPM cut-off (blue), 
overlapping hit to different homologous superfamily (green). The final assignment by 
DomainFinderll is shown in red.
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The domain assignment process described above was undertaken independently 
for CATH and Pfam HMM scan results using DomainFinderll. Domain assignments 
were then stored in the Gene3D database. The CATH and Pfam domain assignment 
tables were then used to construct domain architectures for protein sequences.
2.4.2.8 Domain Architectures
Domain architecture indicates the order of domains in the protein sequence to 
which they have been assigned. Priority is given to CATH domain assignments, Pfam 
domain assignments were added where they do not overlap significantly (less than 30% 
of the length of the shorter domain assignment). Unassigned regions were labelled as 
Newfam (unassigned putative domain) regions (discussed in more detail in section 
3.3.2.1). Figure 2.12 illustrates the DomainFinderll domain assignment process and the 
identification of domain architectures.
DomainFinderll Domain Architecture
DomainFinderll CATH Assignm ents
DomainFinderll Pfam Assignm ents
Raw SAMT99 CATH Assignm ents
Raw SAMT99 Pfam Assignm ents
Figure 2.12 Domain Architecture Assignment Protocol. Raw SAMT CATH and 
Pfam domain assignments to a protein sequence (black line) are filtered by 
DomainFinderll. Hits are discarded due to higher E-value same homologous family hit 
(pink), higher E-value different homologous superfamily hit (orange), and hit below 
PPM cut-off (green). Note that the red domain is discontinuous. Domain architecture 
assigned with priority to CATH domains (red, pink) before Pfam domains (purple). 
Finally, unassigned regions are labelled as Newfam domains (yellow).
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2.4.3 Stage 3: Functional Annotation
Gene3D is primarily intended for the study of protein and proteome evolution, 
by analysis of protein domain and protein family distributions across complete 
genomes. Functional assignment to protein sequences in Gene3D is sourced from 
resources that describe whole protein function, not only in molecular terms but also in 
biological process functions. Functional resources (described previously, see section 
1.3) such as GO, KEGG and COG assign function via inheritance from sequence similar 
proteins whilst STRINGS and Affymetrix allow functional inheritance from proteins 
that may not be expected to have detectable sequence similarity. All five resources are 
used to assign functional information to protein sequences in Gene3D.
2.4.3.1 Functional Assignment in Gene3D
Functional assignment from annotated proteins in functional resources to 
proteins in Gene3D is achieved by sequence comparison and protein identifier 
comparison between protein sequences. As described previously (see section 1.1.9) the 
level of sequence identity between proteins where function is being inherited can 
determine the confidence of inheriting correct functional annotations between proteins. 
Following consideration of the analysis by Todd et al., (2001), and the observations by 
Devos and Valencia (2000), and Rost (2002) that even 50% sequence identity may not 
be reliable in inheriting functional annotation, a level of 60% sequence identity was 
chosen as the minimum sequence identity at which functional annotations could be 
assigned to Gene3D protein sequences, to ensure that functional annotations to proteins 
in Gene3D are confidently assigned.
2.4.3.2 Function Assignment to Gene3D Proteins
STRINGS protein identifiers were mapped to KEGG and NCBI protein 
identifiers associated directly with proteins in Gene3D. GO, KEGG, COG and 
Affymetrix protein sequences were BLASTed against Gene3D protein sequences and 
functional assignments made where significant sequence similarities were identified (at 
least 80% of the longer sequence overlapped and there was 60, 95 or 100% sequence
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identity). The level of sequence identity allows three different confidence levels to be 
assigned to the annotation.
A single Affymetrix microarray (RG_U34A, Rat Genome U34 Set) was used to 
give an indication of the percentage of microarray sequences that are represented in 
Gene3D. As figure 2.13 shows, almost three-quarters of the sequences represented on 
the microarray are found in Gene3D. This indicates that Gene3D is a resource that can 
be used to analyse microarray data, and also, that microarray data can be used to form 
functional associations between Gene3D proteins.
73%
23%
Figure 2.13 Gene3D Coverage of Affymetrix Microarray. Percentage o f genes 
represented on array that have a near identical sequence relative (BLAST E-value <1.0 
e-10, blue), a close sequence relative (BLAST E-value < 1.0 e-02, red) or no 
identifiable close sequence relative (BLAST E-value > 1.0 e-02, yellow) in Gene3D.
Functional coverage of Gene3D is shown in figure 2.14. As the sequence 
identity cut-off at which functional annotation is inherited decreases from 100 percent 
(identical protein sequences) to 60 percent, there is a 9.1% (GO), 1.2% (KEGG) and 
7.0% (Annotated) increase in the percentage of proteins in Gene3D that inherit 
functional annotation. These functional annotations were used to assign protein family 
names and functions and provide functional annotation for CATH domain families, 
described later.
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Figure 2.14 Functional Annotation of Proteins in Gene3D. Percentage o f proteins 
receiving functional annotation at sequence identities o f 100% (blue), 95% (red) and 
60% (yellow) for GO, KEGG, COG, EC and the total Annotated with any functional 
annotation. Note that COG and EC annotations are only inherited at 100% sequence 
identity since functional inheritance occurs through identical sequence identifiers (see 
section 2.4.3).
2.4.3.3 Functional Coverage of Genomes
Whilst only 53% of total proteins in Gene3D have functional annotation, 
genome coverage of some individual genomes is more comprehensive. The percentage 
of proteins within a genome which have an associated function is shown in figure 2.15. 
Prokaryotic genomes are much better annotated than eukaryotic genomes. In addition, 
there is a much smaller increase in the number of additional proteins inheriting 
functional annotation at less stringent sequence identities in prokaryotic genomes than 
in eukaryotic genomes. This is due to a high degree of common prokaryotic sequences 
in Gene3D, GO and KEGG. All three resources use prokaryotic genome sources which 
are relatively stable, well curated sequence collections with many related organisms and 
are generally much better functionally characterised than eukaryotic genomes.
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Figure 2.15 Functional Annotation of Genomes in Gene3D. Percentage o f proteins 
receiving functional annotation at sequence identities o f 100% (line) and 60% (dotted 
line) for GO (green), KEGG (pink), COG (blue), EC (brown) and the total Annotated 
(red) with any functional annotation. Note that COG and EC annotations are only 
inherited at 100% sequence identity.
Functional coverage of individual Kingdoms of life is shown in table 2.2. 
Higher eukaryotes are generally poorly annotated with the exception of GO annotations. 
Table 2.2 highlights the importance of functional annotation inheritance and shows that 
this has a marked effect on genome functional coverage in poorly annotated eukaryotic 
genomes where genome functional coverage increases by nearly 10% as functional 
annotations are inherited from 60% sequence identity relatives.
Table 2.2 Functional Annotation by Kingdom in Gene3D. Functional annotation 
coverage at si 00 and s60 inheritance.
Kingdom %GO %KEGG %COG %EC % Annotated
Archaea (si00) 50.9 20.9 59.8 13.7 73.8
Bacteria (si00) 54.5 24.7 40.5 16.6 70.7
Eukaryota (si 00) 28.7 5.7 10.8 2.8 32.0
Archaea (s60) 53.6 21.4 - - 73.9
Bacteria (s60) 59.7 25.1 - - 71.8
Eukaryota (s60) 39.1 7.8 - - 41.8
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2.5 User Interface
The interface is designed to allow a user to query the database in real time via 
the internet. Specific database tables were created to permit fast data queries by users. 
The interface is designed to run from web browsers such as Internet Explorer and 
Netscape.
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O Affymetrix ID 
O Other
Home > Top > Gene3D 
G en e3 D : v e r s io n  3.0
G ene30 is supplem entary to the CATH database . This protein sequence  d a ta b ase  con 
clustered into protein families and annotated with CATH dom ains, Pfam dom ains and funr 
STRINGS (more details).
QUERY G«n«3D
You can look within a genom e (option 1), or look within a protein family (option 2), or searc 
CATH or Pfam domain (option 4) Finally you can  u se  Gene3D to ass ign  predicted fund
browsing Gene3D.
E ach query type (1 -4) can be se lec ted  at the sam e  time (you can  query a genom e and a pn 
selec t multiple item s at the sam e  tim e (you can  se lec t several genom es to query at once) 
remove them  from your query To d e - se le d  all your item s p re ss  the R eset button To en ter yi
The left hand box m enu (Query Gene3D) allows additional sea rch e s  Here you can  look 
Gene3D cid or Affymetrix identifier. You can  also sea rch  for any other identifier type (gene sy
1. View gcnom e(s) from list below.
(hold Ctrl to select multiple genomes)
Aeropyrum pemix
Agrobacterium tum efaciens str. C58 (Cereon) 
Agrobacterium tum efaciens str. C58 (U.W ash) 
A nopheles gam biae 
Amiifox aonlicus
Figure 2.16 Gene3D Website. Screenshot o f user interface start page for Gene3D 
(www.biochem.ucl.ac.uk/bsm/cath/Gene3D_v3.0/gene3d.html). The interface for  
release 3 has since been further improved with the latest release 4 o f Gene3D 
(bsmmacl. biochem. ucl. ac. uk:8080/Gene3D/).
The user interface web pages run live database queries, the results of which are 
returned to the user as web page displays. The Gene3D website (shown in figure 2.16) 
has had over 11,000 web accesses, up to 868 visitors per month, the majority of which 
enter via the CATH or InterPro websites. The user interface consists of seven main 
queries, summarised in table 2.3.
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Table 23  User Interface Queries in Gene3D. For each user query the data returned 
is shown.
Query Type Data
1 Genome Genome coverage, residue coverage
2 Protein Family Number, kingdom distribution, domain architectures of family members
3 Protein
Protein sequence, description, family and subcluster, domain assignments, 
domain architecture, functional annotation
4 Domain
Domain family size, family subclusters, kingdom distribution, number of 
discontinuous domain assignments, number of domain partners, domain 
architectures, functional annotation
5 BLAST BLAST search with protein query sequence to find Gene3D relatives
6
Specific
Term
(Database
Identifier)
Search for Gene3D protein with 23 different types of protein identifiers 
(NCBI gi number, NCBI protein accession, ENSEMBL gene identifier, 
ENDEMBL protein identifier, Affymetrix identifier, KEGG entry, 
LocusLink id, FlyBase, Gadfly, RatMap, KEGG name, KEGG definition, 
KEGG position, COG id, SWISSPROT-TrEMBL id, NCBI description, 
OMIM, Genome DataBase id, Rat Genome Database id, Mouse Genome 
Database id, EC number, GenScan id, ENSEMBL description)
7
Functional
Prediction
BLAST search with protein query sequence to find nearest relative with a 
domain architecture in Gene3D
Where possible, all returned pages allow the user to browse related data. For 
example, genome queries return genome coverage and residue coverage statistics in 
Gene3D, and also provide links to lists of all protein families and proteins occurring in 
the genome. These in turn provide links to domain assignment and domain architecture 
assignments, which are displayed as diagrams (shown in figure 2.17). Domain 
architecture diagrams are clickable, allowing the user to link to individual CATH and 
Pfam domain pages by clicking on each domain box.
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Domain A rch i tec tu re :
( m o u s e  o v e r  t o  s e e  a s s i g n m e n t  d e t a i l s )
D o m a i n  A r c h i t e c t u r e k t  100 150 200 250
C A T H  A s s i g n m e n t s 50 100 150 200 250
P f a m  A s s i g n m e n t s
PF 00126 I— I PF 03466 j-
50 100 150 200 250
Follow links to view domain family data
Figure 2.17 Gene3D Domain Assignment Diagram. Screenshot of domain 
assignments (for Gene3 protein cid 00772590). Clickable domains (coloured boxes) 
link to source database websites.
In addition to searching for specific identifiers from 23 different databases 
whose identifiers have been mapped to Gene3D proteins (for list of identifiers see table 
2.3), the search facility and the functional prediction facility run a live BLAST 
comparison between the users input query protein sequence and all proteins in Gene3D 
to identify protein relatives in Gene3D. Users run -150 BLAST searches per month.
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2.6 Summary
In this chapter, a novel protocol was described and benchmarked for clustering 
proteins into families and assigning domain annotations and functional annotations to 
proteins. This protocol was used in the construction of a completely new design and 
build of the Gene3D database, containing 120 complete genomes. The functional 
coverage of protein sequences, genomes and Kingdoms in Gene3D was described. The 
user interface for Gene3D was briefly outlined. The number and populations of protein 
and domain families in Gene3D will be described in the next chapter.
85
CHAPTER THREE
Analysis of Protein Families and Domain Families in 120 
Complete Genomes 
3.1 Introduction
3.1.1 Power Laws in Protein Family Data
There are a number of resources that cluster large numbers of protein sequences 
into families. Recent analyses reveal that TRIBES clusters 83 complete genomes 
(311,257 protein sequences) into between 60,934 and 82,692 protein families, 
depending on the clustering granularity used. SYSTERS clusters 1,168,542 proteins 
from SWISSPROT, TrEMBL and 11 complete genomes into 158,153 protein families 
of which 110,322 are singleton families containing only a single protein sequence.
Comparison between different protein family resources that use different 
methodologies to cluster proteins can be difficult. However, some general 
characteristics of large scale protein family clustering can be observed, notably the 
observation of power law distributions in family cluster data. A power law describes 
the domination of a population by a selected few. Power law relationships were 
described in economic theory in the 19th century by Vilfredo Pareto illustrating the 
relationship whereby 20% of the total population earns 80% of the total income. A 
Pareto or power law distribution is a probability distribution where the density is 
proportional to a power function P(x) = 1/Zxalpha for any real value alpha and 
normalisation factor Z. In biological data there are many established examples of power 
law distributions (Luscombe et al., 2002). In terms of protein families, the frequency of 
protein families of a particular size (protein families containing a certain number of 
members) has been reported to follow a power law relationship where most families are 
very small containing few protein relatives, while a few families are very large having 
many protein relatives, in both clustering of completely sequenced genomes and in 
clustering SWISSPROT-TrEMBL protein sequences (Enright et a l 2003; Kunin et al., 
2005; Meinel et al., 2003). Whilst Luscombe et al., report that two other functions 
(triple-exponential and lognormal) also describe these distributions quite well, they
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conclude that the power law distribution is a better descriptor of genomic data, since 
power law functions fit many different biological distributions with a more simple 
function compared to triple-exponential and lognormal functions.
In a genomic context, the protein families within an individual genome also 
adopt power law behaviour whereby a small number of protein families are large and 
have many relatives throughout the genome, but the vast majority of protein families are 
small having few relatives within a genome (Harrison & Gerstein, 2002).
3.1.2 N ovel Protein Families
Kunin et a l, (Kunin et al., 2003) have investigated the rate of discovery of novel 
protein families as successive completed genome sequences are released. Interestingly 
they calculate that the number of novel protein families identified over time has 
remained constant, indicating that our coverage of protein family sequence space is not 
yet saturating.
Whilst the phylogenetic position of a newly completed genome determines the 
number of novel protein families identified (for example a closely related strain of a 
previously sequenced genome contains less novel protein families than a newly 
sequenced genome with no previously sequenced closely related genome), the recent 
addition of several eukaryotic genomes does not account for the observed trend. 
Excluding eukaryotes, Kunin et a l , find that protein family sequence space occupied by 
prokaryotic genomes is still being expanded at a constant rate, that is novel protein 
families are just as likely to be identified in the average newly sequenced prokaryotic 
genome today. Indeed, these novel families are not only genome specific but are likely 
to remain very small until closely related genomes are sequenced to identify close 
relatives. This contrasts with large protein families with relatives in many different 
genomes, where each newly sequenced genome adds more relatives to the protein 
family.
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3.1.3 Domain Assignment to Genomes
Genome coverage in genomic domain assignment resources can be defined as 
the average percentage of genes in a genome that have at least one domain assignment. 
There are two resources that assign domains to genomic sequences where genome 
coverage information is available, the SUPERFAMILY database and the Genomic 
Threading Database; both assign SCOP domains to complete genome sequences.
Amongst the 220 genomes in SUPERFAMILY (described previously, see 
section 2.1.6), as of February 2005, the genome coverage (residue coverage in 
parenthesis) ranges from 19% (15%) to 81% (71%), with an average coverage of 57.4% 
(49.5%).
In the Genomic Threading Database (described previously, see section 2.1.6), as 
of February 2005, the genome coverage (residue coverage in parenthesis) ranges from 
46.9% (37.7%) to 97.2% (79.1%), with an average coverage of 81.6% (61.6%) in the 
218 genomes within the database.
Both these databases are able to achieve impressive genome coverage with 
domain assignments in over half the proteins within an average genome.
3.1.3.1 Un-assienable Redons
When considering how much of a genome is described by domain assignments 
to proteins, and the limits of this characterisation, domain assignment coverage by 
percentage of total protein residues is found to be lower than coverage by percentage of 
total proteins with at least one domain assignment, since a significant proportion of 
residues cannot be assigned a domain. These un-assignable residues include signal 
peptides (SP), transmembrane helix (TM), disordered regions with no regular secondary 
structure (NORS), coiled-coil (CC) or low-complexity (LC) regions.
Liu and Rost (Liu and Rost, 2002) described the percentage of genes in 30 
genomes (6 archaea, 20 bacteria, 4 eukaryota) that have been identified as belonging to 
some of these groups, and therefore cannot be assigned a domain. Liu and Rost
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reported the percentage of total proteins containing transmembrane regions (22% of 
proteins had at least one TM region, and that half of these contained more than five TM 
regions), coiled-coils (8%) and NORS regions (16%). The distribution across 
individual genomes differed by Kingdom: twice as many eukaryotic proteins than 
prokaryotic contained coiled-coil regions and almost eight times as many eukaryotic 
proteins contained NORS regions than prokaryotic proteins, although the percentage of 
proteins with a transmembrane region was similar across all Kingdoms. The total 
percentage of proteins that contained regions that cannot be assigned a domain ranged 
from 30-40%. Recent analyses of 203 completely sequenced genomes has shown that, 
on average, the percentage of residues in a genome that are un-assignable is 7.5%, 
contrasting with the percentage of genes in a genome containing these un-assignable 
regions of 16.6% (Russell Marsden, personal communication).
3.1.4 Domain Architecture
Vogel et al. (Vogel et al., 2004) introduced the term domain architecture* to 
describe the complete domain makeup of a protein as the string of known SCOP 
domains and un-assigned regions assigned to a protein. In 261,344 multi-domain 
proteins from 131 genomes they identify 28,387 different domain architectures. They 
show that proteins sharing identical domain architectures tend to have similar functions 
and that this relationship is domain order dependent since this is not the case if domain 
order is swapped. Domain architectures found in different proteins are likely to come 
about by duplication from a common ancestor. Thus proteins with the same domain 
architecture can be regarded as belonging to a single protein family and sharing a 
common evolutionary ancestor.
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3.2 Objectives
In this chapter the distribution of protein and domain families in different 
Kingdoms is explored and the consistency and characterisation of domain architectures 
in Gene3D is examined. Domain family assignments and protein family information is 
used to investigate the Kingdom distribution of protein families and domain families in 
120 genomes. Finally, the sequence diversity of protein families is described, and 
functional annotation in Gene3D is used to characterise sequence diverse and sequence 
invariant protein families.
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3.3 Results
3.3.1 Analysis of Protein Family Populations in Gene3D
A total of 854,897 proteins from 120 completely sequenced genomes in Gene3D 
were clustered into protein families and subclusters according to the PFscape protocol. 
The number of protein families and subclusters can be seen in table 3.0 below.
Table 3.0 Number of Protein Families and Subclusters in Gene3D. Clustering 
levels o f protein family and subclusters of 35%, 60%, 95% and 100% sequence identity 
are shown for all clusters and for non-singleton clusters.
Cluster Level Number of Clusters
Total Clusters Non-Singleton Clusters
Protein Family 112,464 50,219
S35 subcluster 228,253 166,008
S60 subcluster 356,392 294,147
S95 subcluster 459,675 397,430
slOO subcluster 501,135 438,890
Using a threshold BLAST E-value for matches below 0.0001 (the default 
threshold used in granularity benchmarking and TRIBES, described previously, see 
section 2.4.1) resulted in 417,160,739 significant similarities between all the proteins. 
A small fraction of proteins did not produce any significant BLAST E-values when 
compared to all other proteins. These protein sequences, mostly less than 25 residues in 
length, are highly unlikely to produce a significant BLAST E-value, even when 
compared to themselves since these sequence are not long enough to produce significant 
BLAST alignments. Such sequences were left as singleton clusters consisting only of 
themselves. This does not necessarily indicate that the protein has no relatives, but 
merely that a relative could not be identified by BLAST similarity.
3.3.1.1 Size Distribution of Protein Families
After the clustering process was completed 112,464 protein families had been 
identified. 62,245 of these gene families are singleton gene families containing only a
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single member, leaving 50,219 non-singleton gene families. The size of these non­
singleton protein families exhibits power law like behaviour whereby 20% of protein 
families contain 70% of protein sequences. This distribution appears as a linear 
relationship when plotted on double-logarithmic axes. This observation is in agreement 
with several previous analyses (Enright et al., 2002; Luscombe et al., 2003; Kunin et 
al., 2005). A small percentage (1%) of protein families (823 families) are very large, 
containing more than 100 relatives and accounting for a large percentage (25%) of 
protein sequences. Conversely, a large percentage of protein families (79%) are very 
small, containing less than ten relatives and accounting for only 27% of total proteins. 
As figure 3.0 shows no obvious deviation from a power law distribution, it can be 
concluded that the protein family clustering process employed by Gene3D does not 
artificially over-represent protein families of any particular size.
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Figure 3.0 Power Law Distribution of Protein Families. Number o f protein families 
of a given size (plotted as a percentage) against protein family size on double log axes 
approaches power-low behaviour. A power-law is o f the form y = ax'b and appears as a 
straight line when plotted on double log axes.
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The largest protein families are shown in table 3.1 below. The largest protein 
family comprises zinc finger containing transcription regulators with 4,842 members. 
These large families have been identified by previous analyses (SYSTERS, Meinel et 
al., 2005; TRIBES, Enright et al.t 2003) and contain proteins that are performing 
important generic functions, such as regulation of transcription, signal transduction and 
DNA replication exploited by organisms in all kingdoms. When divided into 
prokaryotic and eukaryotic protein families, the largest protein families in prokaryotes 
are involved in metabolism and transcription regulation, whereas in eukaryotes the 
largest families are involved in regulation of transcription, G-protein coupled receptor 
signal transduction pathways and cell adhesion.
Table 3.1 Largest Protein Families in Gene3D. Top ten largest protein families with 
the number o f members shown for each family. Protein family names are derived from 
the most common GO term assigned to family members.
Protein Family Name Size (# Relatives)
Nucleic Acid Binding (Zinc Finger) 4,842
ATP Binding (ABC Transporter) 3,969
Rhodopsin-like Receptor Activity 2,638
Oxidoreductase Activity (NAD(P)-Binding) 1,741
Protein Serine/Threonine Kinase Activity 1,732
Trypsin Activity 1,309
DNA Binding 1,074
Protein-tyrosine Kinase Activity 1,030
Kinase Activity 1,029
ATP Binding 968
3.3.1.2 Diversity of Protein Families in Gene3D
The number of s35 subclusters within a protein family can be used as a measure 
of the sequence diversity within the protein family. Family diversity can be measured 
by dividing number of s35 subclusters by the protein family size (the number of 
relatives in the family). The distribution of protein family diversity can be plotted as 
shown in figure 3.1. This distribution shows that the average diversity for a protein 
family is 0.225. Protein families with a diversity less than 0.05 can be defined as 
sequence invariant, whilst those with a diversity greater than 0.5 can be defined as 
sequence diverse. Functional classification of diverse and invariant protein families was
determined by protein family GO, KEGG, COG functional assignments and Pfam 
domain assignments. These are discussed below.
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Figure 3.1 Frequency Distribution of Protein Family Diversity. Number of protein 
families with a given diversity for protein families with at least 20 members.
3.3.1.2.1 Function of Invariant Protein Families
The function of invariant protein families is shown in figure 3.2. The majority 
of sequence invariant protein families comprise proteins involved in two specific core 
processes: nucleic acid binding proteins involved in nucleotide excision/repair 
processes; and metabolism and biosynthesis enzymes involved in the tricarboxylic acid 
cycle, purine/pyrimidine biosynthesis and amino acid biosynthesis. Many of the largest 
invariant protein families are transposases, proteins necessary for efficient DNA 
transposition, many of which bind metal ions required for catalysis of DNA cleavage at 
specific sites. The next largest group of sequence invariant protein families are 
ribosomal proteins, large ribonucleoprotein particles required for translation of mRNA 
into protein in both prokaryotes and eukaryotes.
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Figure 3.2 Functions of Invariant Protein Families in Gene3D.
3.3.1.2.2 Function of Diverse Protein Families
The vast majority of diverse protein families are poorly functionally annotated, 
as shown in figure 3.3. Those protein families that have been assigned a function 
perform many different functional roles. Functional classification of these protein 
families reveals only a few large functional groups. The largest group of diverse protein 
families is the two component sensor histidine kinases. These bacterial proteins 
combine signal recognition, signal transduction and gene activation in a two protein 
system. The sensor histidine kinase interacts directly with a signal ligand, or a receptor 
that binds the signal ligand. Variability in signal ligand, or with specific response 
regulator proteins that bind DNA, thus activating transcription, provide a wide range of 
virulence factors and antimicrobial resistance responses in pathogenic bacteria and 
fungi, as well as regulation of essential cellular functions. Diversity in sensor histidine 
kinases is required to detect an immense diversity of possible signal ligands.
The next largest groups of diverse protein families comprise methyl-accepting 
chemotaxis proteins and glycosyltransferases. Bacterial chemotactic signal transducer 
proteins respond to changes in the environmental concentration of a wide range of 
attractants and repellents and transduce a signal from the outside to the inside of the cell
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in response, via deamidation and reversible methylation. Attractants increase the level 
of methylation, whilst repellents decrease it. Glycosyltransferases are proteins that 
catalyse the transfer of glycosyl groups from donor to acceptor molecules by forming 
glycosidic bonds. These proteins are involved in the degradation and biosynthesis of 
polysaccharides, glycoproteins and glycolipids and are usually very specific for both 
donor and acceptor substrates (Campbell et al., 1998). Other proteins involved in 
degradation are found in diverse protein families, notably cytochrome P450 enzymes. 
This large and diverse family of enzymes are principally responsible for the degradation 
of a practically unlimited variety of chemicals. The remaining diverse protein families 
have a wide variety of different functions and include known diverse protein families, 
for example the subtilisin serine protease family of endopeptidases that share a common 
catalytic triad but possess highly diverse N and C terminal extensions.
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Figure 3.3 Functions of Diverse Protein Families in Gene3D.
Both highly diverse and highly invariant protein families perform functions 
critical to an organism’s survival. The diversity of these protein families is dictated by 
their biological function. Highly invariant protein families perform very specific 
functions and interact with only a few ligands associated with core metabolic and 
nuclear processes. Highly diverse protein families perform a myriad of functions,
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interacting with a huge variety of ligands regulating complex cellular responses, often to 
environmental stresses.
3 3.2 Analysis of Domain Family Populations in Gene3D
Scanning all protein sequences in Gene3D against a library of HMMs 
representing CATH structural domains and Pfam sequence domains was undertaken 
according to the PFscape protocol. Using a threshold HMM E-value for matches of 
0.01, an HMM percentage model matched cut-off of 50% and a domain overlap cut-off 
of 30% resulted in 417,132 significant CATH domain assignments and 508,348 
significant Pfam domain assignments.
3.3.2.1 Size Distribution of Domain Families
The size of domain families in Gene3D follows a power law like behaviour, 
where a few large domain families have a large number of domain assignments whilst 
most domain families are small and have a small number of domain assignments. The 
size distribution of CATH domain families closely follows Pareto’s 80/20 Law, the 
largest 20% of domain families accounting for 80% of all domain assignments. The ten 
largest CATH domain families, representing only 0.8% of all CATH domain families) 
account for 104,689 CATH domain assignments (25% of total CATH domain 
assignments). The vast majority of domain families are small, only 11% of CATH 
domain assignments are found in the smallest 70% of CATH domain families.
The sizes of CATH and Pfam domain families are shown in figure 3.4 below. 
There are 91,216 more Pfam domain assignments than CATH domain assignments in 
total. These additional Pfam domain assignments are mainly from medium sized Pfam 
domain families containing between 10 and 200 domain family members, which are not 
related to domain families represented in CATH.
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Figure 3.4 Sizes of Domain Families. Domain family size (log scale) against domain 
families ranked by size (number of domains assigned to family) for CATH homologous 
superfamilies (red) and Pfam domain families (blue).
The s35 sequence family size distribution of CATH, Pfam and uncharacterised 
(Newfam) domain families also shows power law like behaviour. This is illustrated in 
the power law plots in figure 3.5 below for CATH, Pfam and Newfam families and 
show that most of the uncharacterised families (Newfam) tend to be much smaller than 
the CATH and Pfam families.
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Figure 3.5 Log-log Plots of (a) CATH, (b) Pfam and (c) Newfam Families. Graphs 
show power-law like behaviour. Fitted power law functions and their exponents are 
shown for comparison (d). Note that most Newfam families are small with relatively 
few members.
Although the Newfam families are much smaller families, with less members 
than CATH and Pfam families, it is encouraging to note that the length distribution of 
Newfam sequences is close to the length distribution of domains classified in the CATH 
(see figure 3.6 below). This is indicative that many Newfam families, whilst sparsely 
populated, are likely to represent protein domains. A small percentage of Newfam 
domains are very long and are thus more likely to represent multiple domains.
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Figure 3.6 Length Distribution of Newfam Sequences compared to CATH 
Domains.
The number of domain assignments for the largest CATH and Pfam domain 
families are shown in table 3.2 below. These largest families identified in Gene3D have 
also been identified by previous analyses (Buchan et al., 2002; Bateman et al., 2004).
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Table 3.2 Largest Domain Families in Gene3D. The top ten domain families with the
most members are shown for CATH and Pfam domain families.
CATH Domain 
Family
CATH Domain 
Name
Size 
(# Relatives)
3.40.50.300 P-loop Containing Nucleotide Triphosphate Hydrolase 28,417
3.30.160.60 Classic Zinc Finger 19,118
2.60.40.10 Immunoglobulins 11,386
3.40.50.720 NAD(P)-Binding Rossmann-Like 9,451
1.10.10.10 Winged Helix Repressor DNA Binding Domain 7,519
1.10.10.60 Homoedomain-Like 6,403
1.10.510.10 Transferase (Phosphotransferase) Domain 1 6,088
3.30.200.20 Phosphorylase Kinase Domain 1 5,526
3.40.190.10 Periplasmic Binding Protein-Like II 5,454
2.10.25.10 Laminin 5,327
Pfam Domain 
Family
Pfam Domain 
Name
Size 
(# Relatives)
PF00096 Zinc Finger, C2H2 Type 15,012
PF00005 ABC Transporter 8,352
PF00069 Protein Kinase Domain 6,085
PF00028 Cadherin Domain 5,601
PF00041 Fibronectin Type HI Domain 5,389
PF00400 WD Domain, G-Beta Repeat 5,278
PF00001 Seven Transmembrane Receptor (Rhodopsin Family) 4,709
PF00023 Ankyrin Repeat 4,679
PF00083 Sugar (and Other) Transporter 4,252
PF00076 RNA Recognition Motif (RRM, RBD, RNP Domain) 4,079
3.3.3 Domain Assignments to Protein Families in Gene3D
By combining protein family and domain assignment data in Gene3D, the 
domain coverage of protein families can be characterised. The figures below illustrate 
the extent of CATH (figure 3.7) and Pfam (figure 3.8) domain assignments to protein 
families in Gene3D.
The graphs show that for most protein families with more than 5 members, at 
least half of the protein families have a Pfam domain assignment. The coverage of
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protein families is slightly less comprehensive for CATH domains, where for protein 
families with at least 20 members, at least half of the protein families have a CATH 
domain assignment. Coverage of protein families by CATH is lower than that of Pfam. 
Additionally, families annotated with CATH are, on average, much larger than families 
annotated with Pfam, this is because small families are under-represented in CATH, 
whilst Pfam annotates many more smaller families. Structural data allows detection of 
very distant relatives, so that Pfam families are often merged once representative 
structures are solved. This can be clearly seen in Figure 3.7 and 3.8 below.
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Figure 3.7 CATH Domain Coverage of Protein Families. Crosses indicate where 
50% of protein families of this size have a CATH domain assignment (blue) or do not 
have a CATH domain assignment (red).
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Figure 3.8 Pfam Domain Coverage of Protein Families. Crosses indicate where 50% 
of protein families of this size have a Pfam domain assignment (blue) or do not have a 
Pfam domain assignment (red).
3.3.3.1 CATH and Pfam Domain Assignment Overlap
Since some domain families are classified in both CATH and Pfam, it is 
expected that some CATH and Pfam domain assignments will be made to the same 
regions within protein sequences and result in overlapping CATH and Pfam domain 
assignments. Figure 3.9, below, shows the extent of the overlap between CATH and 
Pfam domain assignments. As figure 3.9 shows, 21% of Pfam domain families have a 
significant overlap (where, on average, greater than 80% of the Pfam domain 
assignment is overlapped by a CATH domain assignment) with CATH domain families, 
suggesting that these Pfam and CATH families may be regarded as equivalent domain 
families. Whilst 68% of the 5,179 Pfam domain families assigned in Gene3D have no 
significant overlap (i.e. overlap less than or equal to 20%) with any CATH domain 
families, 11% of Pfam domain families have an intermediate level of overlap, 
suggesting that these Pfam domain families may comprise additional structurally 
uncharacterised domains. This is in agreement with an earlier study by Elofsson and 
Sonnhammer (Elofsson and Sonnhammer, 1999), which compared Pfam and SCOP
103
classifications (a structural domain classification similar to CATH). Whilst this earlier 
study compared a much smaller version of Pfam (containing only 1407 domain 
families), of these, 802 domain families (or 57%) were found to exist in SCOP, which is 
close to the 1087 Pfam domain families (21% of Pfam domain families with a 
significant CATH overlap) identified in Gene3D, which uses a more recent release 
containing significantly more Pfam domain families. Pfam built up their database by 
using the largest families and these were more likely to contain at least one structural 
representative, hence the initial high overlap with SCOP.
3500
I 3000
1 2500
a
1 2000
o
s 1500
£
© 1000U
2a 500c3Z 0
0-20 21-40 41-60 61-80 81-100
Average percent of Pfam domain assignment overlapped by CATH
Figure 3.9 Overlap of CATH and Pfam Domain Assignments. Most Pfam families 
show negligible overlap with CATH (0-20% sequence overlap) but 1,085 Pfam families 
show substantial overlap (81-100% sequence overlap). There are relatively few Pfam 
families with an intermediate level of overlap.
3.3.4 Domain Architectures in Gene3D
CATH and Pfam domain assignments were combined into domain architectures 
using the DomainFinderll protocol described previously (see section 2.4.2.8). When 
combining CATH and Pfam domain assignments into domain architectures, 63% of all 
Pfam domain assignments are excluded by an overlapping CATH assignment. As
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figure 3.9 shows, there are 1,085 Pfam domain families that overlap significantly 
(greater than 80%) with CATH. Since these 1,085 families represent 63% of all Pfam 
assignments, they are large domain families, where the domain family is also 
represented in the CATH classification.
Domain architectures were assigned to a total of 386,340 proteins in Gene3D. 
59% of these domain architectures contain only CATH domain assignments, 32% 
contain only Pfam domain assignments, leaving 9% of domain architectures containing 
both CATH and Pfam domain assignments. This is consistent with the level of 
observed overlap between CATH and Pfam domain classifications.
3.3.4.1 Domain Architecture Consistency in Protein Families
From the structural benchmarking of TribeMCL clustering (see section 2.4.1.1), 
protein families in Gene3D might be expected to show highly consistent domain family 
architectures across the members of each protein family. However, the domain 
architecture consistency in protein families from clustered completed genome sequences 
could be different from that seen clustering a far smaller and less sequence diverse 
benchmarking dataset. The consistency of domain architectures in Gene3D protein 
families was therefore examined.
Figure 3.10 shows domain architecture consistency in 7,453 protein families 
which contain at least 3 relatives, in which the domain architecture covers on average at 
least 80% of the protein’s residues. 77% (5,719) of these protein families have >90% of 
annotated members with the same domain architecture, whilst 87% of the protein 
families have more than 70% of members sharing a common domain architecture. 
Although these 7,453 protein families represent only -11% of non-singleton protein 
families in Gene3D, comprising 17% of non-singleton sequences, they give some 
indication of consistency in domain architecture achieved by the TribeMCL clustering.
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Figure 3.10 Consistency of Domain Architecture in Protein Families. More than 
three-quarters of protein families have more than 90% of their members annotated with 
the same domain architecture.
3.3.4.2 Domain Architecture Superfamilies in Gene3D
For protein families that are completely annotated, domain architecture 
information can be used to resolve subgroups of dissimilar relatives into separate 
families sharing common architectures. It also allows mapping between protein 
families with common domain architectures. Figure 3.11 shows the distribution of 
2,212 domain architectures that are found in 5,719 protein families, which contain at 
least 3 relatives and in which the domain architecture covers on average at least 80% of 
protein residues, and where >90% of annotated protein family members have the same 
domain architecture. 60% of these domain architectures are unique to a single protein 
family, a further 20% only occur in two protein families, whilst the remaining 20% 
occur in 3 or more protein families.
This suggests that TribeMCL is rather conservative at clustering sequences, but 
this is desirable since it preserves the consistency of the domain architecture within a 
protein family. Sequences sharing common domain architectures but placed in separate 
protein families can be merged into the same domain architecture superfamily. For 
example, the 5,719 protein families described above can be collapsed into 2,212 domain
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architecture superfamilies. The number of families which can be merged in this way 
will increase following expansion in the HMM domain libraries of CATH and Pfam; 
and the inclusion of novel domain-like sequence families (NewFam domain families, 
see section 3.3.2.1) which will extend domain mapping of the gene sequences. Future 
HMM libraries could be constructed to include HMMs built from large domain 
architecture superfamilies to improve the detection of evolutionary relationships 
between protein families.
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Figure 3.11 Domain Architecture Distribution across Protein Families. The
percentage of domain architectures against the number of different protein families in 
which they are identified. Note that 60% of complete domain architectures are found in 
only a single protein family.
3.3.5 Using Gene3D Families to Validate Genscan Predictions
Genscan protein sequences are in-silico translations of open reading frames 
identified in eukaryotic genomic DNA sequences using the Genscan (Burge and Karlin, 
1997) prediction program. These predicted protein sequences are not included in 
analysis in Gene3D since their validation as biologically active entities cannot be
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verified from existing sources, but have been included in the PFscape process to expand 
the information for Tribe-MCL clustering. The distribution of these genscan predicted 
proteins within the protein families and domain families identified in Gene3D is of 
interest because it can indicate the biological relevance of these protein predictions and 
allow an estimation of the proportion of predicted proteins that are likely to have a 
biological function.
Of the 854,897 proteins in Gene3D, 270,846 proteins are genscan predicted 
sequences. These proteins are assigned to 127,804 protein families of which 29,765 are 
non-singleton. Of these, 22,332 protein families contain both genscan predicted 
proteins and known proteins. The 154,965 genscan predicted proteins in these protein 
families are most likely to be biologically active proteins that have yet to be 
characterised experimentally.
107,524 CATH domain assignments and 125,277 Pfam domain assignments are 
made to genscan predicted proteins. Whilst 62% of eukaryotic known proteins have a 
domain assignment, only 30% of genscan predicted proteins have a domain assignment.
To summarise, 57% of genscan predicted proteins occur in protein families with 
known characterised proteins and 30% genscan predicted proteins have a CATH or 
Pfam domain assignment. These genscan predicted proteins would make the most 
promising targets for expression studies in eukaryotes to determine whether they are 
expressed, as suggested by Gene3D, and should therefore be studied further.
3.3.6 Genome Coverage in Gene3D
Genome coverage can be assessed in two ways: Gene Coverage - the percentage 
of protein sequences in a genome that have at least one domain assignment; and 
Residue Coverage - the percentage of protein residues in a genome that are covered by 
one or more domain assignments. The first of these measures simply describes the 
percentage of proteins in a genome for which some domain information can be 
assigned, and does not necessarily provide an accurate measure of how completely such 
information describes these proteins as a whole. The percentage of residues within a
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genome with domain assignments gives a much clearer indication of the completeness 
of protein annotation by domain assignment.
The following figures show gene coverage (figure 3.12) and residue coverage 
(figure 3.13) in all the 120 genomes in Gene3D, data for individual genomes can be 
seen in appendix I.
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Figure 3.12 Gene Coverage of Genomes in Gene3D. Percent of genes in each 
genome with a CATH domain assignment (red), Pfam domain assignment (blue), a 
CATH and a Pfam domain assignments (orange) and genes with no domain assignment 
(green) for all genomes grouped into Archaea, Bacteria and Eukaryota.
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Figure 3.13 Residue Coverage of Genomes in Gene3D. Percent of residues in each 
genome with a CATH domain assignment (red), Pfam domain assignment (blue), a 
CATH and a Pfam domain assignments (yellow) and residues with no domain 
assignment (green) for all genomes grouped into Archaea, Bacteria and Eukaryota.
Table 3.3 summarises the average coverage for all genomes in Gene3D, and for 
each kingdom in Gene3D.
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Table 3 3  Average Domain Coverage in Gene3D. Average percentage o f proteins 
and residues for Archaea, Bacteria, Eukaryota and all genomes that have been 
annotated with a CATH, Pfam, a CATH & a Pfam domain assignment Total un­
annotated and total annotated with domain assignments for all genomes are indicated 
in bold. Numbers in parentheses indicate the number o f genomes in each dataset.
Archaea (16) Bacteria (90) Eukaryota (14) All (120)
Annotation:
%
Protein
%
Residue
%
Protein
%
Residue
%
Protein
%
Residue
%
Protein
%
Residue
CATH only 38.81 33.42 41.88 35.49 38.15 26.04 41.04 34.11
Pfam only 22.17 16.30 24.33 19.37 19.72 13.80 23.50 18.31
CATH & non- 
overlapping 
Pfam
2.8 0.03 4.41 0.05 5.81 0.03 4.36 0.04
Total
Unannotated
36.22 49.44 29.38 45.09 36.32 60.14 31.10 47.42
Total
Annotated
63.78 50.56 70.62 54.91 63.68 39.86 68.90 52.58
Combination of CATH and Pfam annotations gives an average overall coverage 
of 68.9% of proteins within a genome having at least one domain assignment. In some 
small bacterial genomes (for example Buchnera) the total coverage is as high as 97%. 
On average 45.4% of proteins in a genome can be assigned at least one CATH structural 
domain. In addition, Pfam domain assignments can be made to a further 23.5% of 
proteins. An average of 4.36% of proteins in a genome comprises non-overlapping 
domains from both CATH and Pfam. It should be noted that genome coverage by 
proteins with an assignment is on average 16% higher than genome coverage by 
residues, indicating that whilst many proteins have a domain assignment, these domain 
assignments do not characterise all the residues in these proteins and so do not fully 
describe their domain architecture.
Genome coverage in Gene3D is comparable to the coverage in related databases, 
see table 3.4.
i l l
Table 3.4 Genome Coverage in Gene3D. Gene coverage and residue coverage for
Gene 3D and comparable databases.
Database Release
Gene Coverage 
(%)
Residue Coverage
(%)
Gene3D (CATH) Aug 2003 45.4 34.2
Gene3D (CATH & Pfam) Aug 2003 68.9 52.6
SUPERFAMILY Feb 2005 57.4 49.5
Genomic Threading Database Feb 2005 81.6 61.6
A lower Gene3D CATH coverage compared to SUPERFAMILY and the 
Genomic Threading Database is because the CATH fold library is smaller than the 
SCOP fold library used to provide SUPERFAMILY and The Genomic Threading 
Database domain assignments and more stringent criteria are used in the match/query 
overlap between the HMM and the protein sequence during domain assignment.
3.3.7 Increasing Genome Coverage in Gene3D
3.3.7.1 HMM Library Expansion
Gene3D CATH domain assignment HMM libraries are built using CATH s35 
sequence family seed sequences provided from the CATH database. However, seed 
sequences from additional sequence families in CATH may provide a mechanism to 
capture more sequence diversity within CATH domain families. HMMs were built as 
described previously, but using seed sequences from CATH s95 sequence families to 
produce an s95 CATH HMM library. This library was used to scan the Escherichia coli 
K12 genome in order to compare genome coverage with that previously achieved using 
the s35 CATH HMM library, shown in table 3.5 below.
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Table 3.5 Escherichia coli Genome Coverage using s35 and s95 HMM Libraries.
Gene coverage (% ofE.coli K12 genes with a CATH domain assignment).
HMM Library Scan Library Size Gene Coverage (%)
s35 CATH HMMs E.coli K12 4023 models 52.36
s95 CATH HMMs E.coUK12 7913 models 54.04
As can be seen from the table, an increase in genome coverage of 1.68% was 
achieved using the s95 CATH HMM library. However, this slight increase in genome 
coverage required a doubling in the size of the HMM library. The computational time 
required for scanning the genome is also doubled. This small increase in genome 
coverage is simply not worth the huge increase in computational resources which it 
takes to achieve. Similar results were obtained by Sillitoe et a l (Sillitoe et a l, 2005) 
where the authors used s35 and s95 CATH HMM libraries to scan a dataset of 4,036 
sequence homologues, none of which had more than 35% or 95% sequence identity 
respectively to the HMM being scanned against. The authors concluded that coverage 
of their dataset was not increased significantly by using an s95 CATH HMM library 
over an s35 CATH HMM library.
3.3Z7.2 Updated Versions of CATH and Pfam
Updated releases of both the CATH and Pfam databases contain more domains 
in established domain families as well as novel domains in novel domain families, and 
thus cover a larger amount of sequence and structure space. In addition, HMMs built 
using more recent and larger non-redundant protein sequence databases (see methods) 
are more sensitive (Sillitoe et a l, 2005). Successive releases should therefore provide 
an increase in genome coverage. All the sequences in Gene3D were scanned with 
CATH version 2.4 and CATH version 2.5 s35 HMMs, as well as Pfam version 10 and 
Pfam version 13 HMMs. In addition, SAMOS A HMMs (models built by Ian Sillitoe) 
were scanned against all sequences in Gene3D. SAMOSA models are built from 
multiple structural alignments of large CATH domain families and have previously 
been shown to increase coverage in specific datasets (Sillitoe et a l, 2005). An increase 
in genome coverage of 6-7% was achieved using these expanded HMM libraries (see 
table 3.6).
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Table 3.6 Genome Coverage In Gene3D using various HMM Libraries. Gene 
coverage (average % o f genes with a domain assignment) for all genomes in Gene3D.
HMM Library Release Date Library Size Gene Coverage (%)
CATH 2.4 02/02 3,285 38.1
CATH 2.5 08/03 4,036 45.4
Pfam 10 07/03 6,190 61.2
Pfam 13 04/04 7,426 67.8
CATH + SAMOSA 2.5 - 4,725 45.5
CATH + Pfam 2.5 /10 - 10,226 68.9
CATH + Pfam 2.5 /13 - 11,462 72.9
The insignificant increase in genome coverage found when using SAMOSA 
HMMs underlines the difference between genomic datasets and those previously used to 
benchmark SAMOSA models which showed an increased coverage of -10% (Sillitoe et 
al., 2005).
The trends seen above in genomic datasets are supported by the observations of 
Sillitoe et al., who illustrate how the increase in the size of Genbank sequence 
repository and the increased number of CATH structural families is responsible for the 
increased rate of detection of remote homologues from the CATH structural database 
over time. The author's note that as Genbank increased in size from 907,000 sequences 
used for CATH version 2.4 HMM building to 1,399,000 sequences used for CATH 
version 2.5.1 HMM building, an increased coverage of 6% was observed in their dataset 
consisting of 4,036 remote homologues with less than 35% sequence identity to the 
models being matched. Future releases of both CATH and Pfam are likely to provide 
increased coverage not only due to an increase in the domains described by these 
resources but also as future Genbank sequence databases will be significantly larger and 
produce more sensitive HMM libraries.
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3-3-8 Kingdom Distribution of Protein Families and Domain Families in
Gene3D
It is interesting to consider the proportion of domain or protein families common 
to all the genomes in Gene3D and the percentage of genome sequences belonging to 
these families. For a domain to be considered universal it should be detected in a 
significant proportion of organisms within a kingdom, in order to reduce the likelihood 
of its presence being due to recent horizontal transfer between organisms as opposed to 
vertical transfer from a common ancestor.
However, universal domains will not necessarily be present or detected in all 
120 genomes in Gene3D for several reasons. Some of the organisms are obligate 
intracellular parasites (e.g. Chlamydia trachomatis) and symbionts (e.g. Wigglesworthia 
brevipalpis) and cannot independently perform some of the functions that are essential 
to life (Zomorodipour and Andersson, 1999). The domain assignments in these 
genomes are unlikely to reflect their evolutionary heritage since protein functions and 
their associated domains may no longer be present in these genomes. Furthermore, 
HMMs used for domain mapping are not expected to identify all remote homologues. 
Indeed, as previously described, the level of domain assignment in genomic datasets has 
not saturated, and as sequence databases and domain classifications become larger more 
domain assignments will be made to genomes. Currently 76-80% of remote 
homologues are detected using the CATH HMM library (see Chapter 2, section 2.4.2.2).
Taking these factors into account we decided that domain families found in at 
least 70% of the organisms could be considered universal. Using this 70% universality 
measure the percentage of CATH and Pfam domain assignments in each genome that 
are probably universal to each Kingdom can be calculated. Figure 3.14 shows the 
percentage of CATH and Pfam domain assignments within a genome where the domain 
is universal in one, two or three kingdoms. Domain assignments unique to the genome 
are also indicated. Where a domain occurs in more than one genome but does not occur 
in 70% of genomes within any Kingdom and cannot therefore be considered universal 
to any Kingdom, the domain is indicated as not specific to a Kingdom (i.e. it is specific 
to only a subset of a Kingdom).
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Figure 3.14 Kingdom Distribution of Domains in Gene3D. Percent o f proteins in 
each genome belonging to a domain family that is universal to one (K1 - yellow), two 
(K2 - blue), three (K3 - red) Kingdoms, unique to the genome (Ku - green) or specific to 
a subset o f a Kingdom (KO - black).
It can be seen from figure 3.14 that -16% of domain assignments within a 
genome belong to domain families which are not universal to any kingdom, while 
almost 50% of all domain assignments are universal to all three kingdoms of life. There 
are 212 CATH and Pfam domain families that are found in at least 70% of the genomes 
from each of the three kingdoms of life and these domains may correspond to universal 
families with essential functions (listed in appendix II). In contrast, figure 3.15 shows 
that less than 10% of protein sequences (mostly comprising multidomain architectures) 
are assigned to protein families universal to all three kingdoms of life while -63% do 
not appear to be universal to any kingdom, as they occur in less than 70% of the 
organisms in any of the kingdoms.
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Figure 3.15 Kingdom Distribution of Protein Families in Gene3D. Percent of 
proteins in each genome belonging to a protein family that has members from one (K1 - 
yellow), two (K2 - blue), three (K3 - red) Kingdoms, unique to the genome (Ku - green) 
or specific to a subset of a Kingdom (KO - black).
Interestingly, 50% of the domain structure annotations arise from families that 
are common to all the genomes. By contrast less than 10% of genome sequences are 
assigned to protein families common to all kingdoms. This is in agreement with 
previous findings (Chothia et al. 2003; Hegyi et al. 2002) suggesting that common 
domains have been combined in different ways to generate kingdom specific domain 
architectures. Since modification in domain architecture is frequently associated with 
change in protein function (Todd et al., 2001), changes in domain architecture provide a 
mechanism for expanding the functional repertoire of the organism. These findings will 
be discussed and expanded later, but show that Gene3D protein families and domain 
assignments can be used to gain insight into the evolutionary relationships between 
genomes, protein families and protein domains.
3.4 Summary
The family size distribution of protein families in Gene3D was found to closely 
follow Pareto’s 80/20 Law, where 20% of non-singleton protein families contain 70% 
of non-singleton protein sequences. Power law family size distributions were also 
observed in domain assignment data, where 20% of CATH domain families account for 
80% of CATH domain assignments. The size distributions of Newfam regions indicate 
these families are mostly extremely small. Length distributions of Newfam regions 
were shown to be similar to those of individual CATH domains, indicating that many of 
these novel domain-like regions may be single domains.
The largest protein families and domain families in Gene3D are shown to be 
similar to those previously reported in similar protein clustering and domain family 
classifications. In addition, the most sequence diverse and sequence invariant protein 
families were functionally characterised, revealing that highly invariant protein families 
perform very specific functions, interacting with few ligands, whilst highly diverse 
protein families perform many more functions and interact with a huge variety of 
different ligands.
The domain architectures identified in Gene3D protein families were shown to 
be highly conserved within protein families, 87% of the protein families were found to 
have more than 70% of members sharing a common domain architecture. The power 
law distribution of domain architecture superfamilies across protein families was 
described, highlighting the potential for development of HMMs representing specific 
domain architectures in fast assignment of newly completed genomes.
Analysis of Genscan predicted protein sequences in Gene3D, showed that up to 
57% of eukaryotic Genscan predictions are likely to be correct protein sequence 
predictions.
The distribution of domain families and protein families across the genomes in 
Gene3D revealed that whilst 50% of domain assignments in a genome are common to 
all three Kingdoms of life, less than 10% of proteins in a genome are assigned to protein 
families common to all three Kingdoms, indicating that common domain families are 
reused in different contexts providing diverse protein functions across the genomes.
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CHAPTER FOUR
Application of Gene3D to Structural Genomics
4.1 Introduction
Many structural genomics initiatives are currently in progress and although the 
aims vary between consortia, many groups are selectively targeting protein families for 
which the fold is unknown in order to increase our knowledge of fold space.
In order to attempt predictions on fold space we need to know how many protein 
families there are in nature and how many of these are likely to possess a novel fold. 
Genome sequencing still considerably outpaces the structure genomics initiatives with 
more than 260 completely sequenced genomes, yielding over a million protein 
sequences at the start of 2005 (GOLD database, Bernal et a l, 2001). This contrasts 
with 30,041 PDB entries (Deshpande et a l , 2005), some 1000 of which were 
determined by structure genomics consortia over the last five years. Encouragingly, and 
in parallel with the expansions in the structure and sequence databanks over the last 
decade, HMM based sequence homology detection methods allow the granularity of 
protein family space to be more accurately charted by allowing recognition of extremely 
distant homologues.
Although analyses of completed genomes suggest that there are tens of 
thousands of domain families (Lee et a l , 2005; Liu and Rost, 2002), currently only 5% 
of newly determined structures are observed to have a novel fold (Todd et a l , 2005), 
suggesting the there are a much smaller number of folds in nature. The Protein 
Structure Initiative (PSI; www.nigms.nih.gov/Initiatives/PSI/) is a large-scale, high- 
throughput structural genomics project with groups from the United States, European 
Union, Japan, China, Canada and Israel. The PSI entered a production phase, with the 
aim of solving structures for all the large structurally uncharacterised domain families, 
to increase the number of known folds in the PDB. Around 2% of structures deposited 
in the PDB by conventional structural biology contain novel folds. In contrast, 11% of 
structures deposited in the PDB during the initial phase of the PSI (September 2000
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until June 2005) were novel folds, and 67% were structures for new sequence families, 
compared to 21% from conventional structural biology (Todd et al., 2005).
Thus it is clear from this initiative that even when sequence families are targeted 
because they are predicted to have a novel fold, a relatively small percent (-11%) are 
found to possess a novel fold once their structures are solved. These observations 
support earlier hypotheses (Chothia, 1992; Orengo, 1994) derived from analyses of 
sequence data that there are a limited number of folds in nature.
Over the last decade there have been several attempts to predict the number of 
folds. Whilst Wolf et al. (2000) predict the number of folds in individual genomes; 
most estimates consider the total number of folds in nature. Current estimates of the 
number of folds range from 1000 to 10,000 depending on the models and 
approximations applied (Leonov et al., 2003; Coulson and Moult, 2002; Koonin et al., 
2002).
One of the earliest estimates of fold numbers was a simple approximation by 
Chothia (1992). This assumed that there are a limited number of folds in nature that 
sequences could adopt due to physical constraints. If these are randomly sampled then 
the probability that a new sequence has a novel fold can be estimated by determining 
the proportion of unrelated sequences e.g. in the structure classification SCOP that are 
found to share the same fold. This approach predicted 1000 structural families based on 
the proportion of sequences of known structure in SCOP that had unique folds, the 
fraction of the SWISSPROT sequence database these sequences comprised and the 
fraction of new sequences found to be related to sequences in SWISSPROT. A similar 
model applied by Orengo and co-workers (1994) also took account of the number of 
protein families in SWISSPROT. Using the CATH structure database they predicted a 
higher estimate of -8000 folds. Both these calculations were undertaken when 
sequence and structure databases were relatively sparse, and under-represent the bias in 
the distribution of certain folds, often referred to as superfolds (Orengo et al., 1994), 
which are more highly reused by different protein families in nature than expected by 
chance.
Since Chothia* s early estimates, several groups have applied approaches that 
model this uneven distribution of fold usage (Zhang and DeLisi, 1998; Govindarajan
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and Goldstein, 1996). Random sampling of known sequence families assigning equal 
likelihood to each fold gives rise to a non-uniform fold distribution which, when further 
modified to account for the extreme bias of the superfolds and the fact that many folds 
are only rarely seen in nature, gives an estimate of 4000 folds (Govindarajan et al., 
1999).
Coulson and Moult (2002) assume three types of folds -  superfolds which are 
adopted by very many protein families and are highly recurrent in the genomes, 
mesofolds which have an intermediate number of protein families associated with them 
and unifolds adopted by a single narrow sequence family. They simulated the 
expansion of new folds classified in the SCOP structure database over the last two 
years, as a fraction of new sequence families added. Assuming a maximum of 50,000 
protein families in nature, this approach predicts up to 400 mesofolds and some 10,000 
unifolds in addition to 9 superfolds. Perhaps more importantly, the majority of 
sequence families belong to superfold and mesofold groups and for 80% of these 
families we probably know the fold already.
Several groups attempt to model the uneven fold/family distribution using power 
laws. Power laws appear to be ubiquitous in nature and society and seem to explain 
many of the biological trends recently revealed by genome data e.g. protein family 
distributions, domain associations, protein-protein interactions (Koonin et al., 2002; 
Qian et a l, 2001; Luscombe et al., 2002).
Karev et al. (2003) model protein family distributions by simulating the birth 
(gene duplication), death (gene loss) and innovation (new protein) of different domains 
in individual genomes (Karev et al., 2002). Although this entirely stochastic model 
fails to account completely for the observed distribution, it shows that a close fit is 
possible using a model with only three independent parameters. Implicit in the model is 
the notion that the ‘fit’ get ‘fitter’ and domains randomly duplicated early in evolution 
increasingly dominate the population. None of these models incorporate selection 
pressures that might operate to favour the retention of duplicated domains performing 
important biochemical activities. However, many highly recurrent domains appear to 
have important biochemical functions; for example in providing energy or redox 
equivalents for enzyme reactions or in responding to cellular signals and binding to 
DNA (Pawlowski et al., 2001).
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These models still ignore possible bias in the structure and sequence databases. 
However, it is likely that proteins sampled for structure determination have been 
relatively easy to purify and crystallise - witnessed by the small numbers of 
transmembrane structures known. Perhaps more worrying are recent analyses 
suggesting that we have barely sampled sequence and family space as each new genome 
adds more families and there is no sign of saturation in this expansion (Kunin et a l , 
2003). Even with the huge advances in genome sequencing, there are still at least ten 
million more organisms uncharacterised (Koonin et al., 2002).
4.1.1 How many Domain Fam ilies are Currently Recognised and how  
many N ovel Folds can we predict using this data?
One of the first steps in calculating how many new folds remain to be 
discovered is the determination of the number of sequence families in nature. Once we 
have a reasonable prediction for this number we can estimate the number of new folds 
based on the proportion of structurally characterised families that have unique folds. 
Perhaps the hardest problem in clustering sequences into protein families is handling the 
similarities between multi-domain proteins and the fact that many different multi­
domain proteins share common domains but in different contexts. This recurrence of 
domains suggests their importance as primary evolutionary units and although some 
researchers hypothesise that smaller super-secondary structural motifs may be the 
building blocks of evolution (Soding and Lupas, 2003), the majority of globular 
compact folds characterised to date comprise whole domains.
However, domain boundary recognition is a non-trivial algorithmic challenge 
particularly if no structural data are available. Even methods based on structures 
disagree in their assignments 20-40% of the time (Jones et al., 1998). The problem is 
compounded by discontinuities in some domain sequences whereby the insertion of a 
second domain disrupts an existing domain region within a multidomain protein. 
Structural data in CATH suggests these discontinuities exist in about 23% of domains 
occurring in multi-domain proteins (Pearl et al., 2002). In Gene3D, there are 341,726 
domain assignments made to multi-domain proteins, of which 31,090 or 10.0% are 
discontinuous domain assignments.
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Some of the most successful approaches to boundary prediction combine 
multiple sequence data and residue propensities using neural networks (Liu and Rost, 
2003; Yona and Levitt, 2000). Other methods exploit the recurrence of domains in 
different contexts to identify boundaries from multiple alignments (Servant et al., 2002; 
Park and Teichmann, 1998; Heger and Holm, 2003). The elegant approach of Holm 
and co-workers (ADDA) exploits graph theory to build networks of domain links in 
multidomain proteins from which multiple alignments can be extracted and recursively 
analysed and chopped to yield their single domain components.
Estimates of the numbers of domain families identified vary substantially 
depending on the sequence datasets clustered and thresholds employed. The ADDA 
algorithm of Holm and co-workers which firsts chops sequences into domains and then 
clusters, identifies some 34,000 domain families in a combined sequence dataset of 
SWISSPROT, TrEMBL, PIR, PDB, WORMPEP and ENSEMBL which after removing 
redundancy at 40% sequence identity, contained almost 250,000 protein sequences. 
Almost 170,000 sequences remain as singleton sequences that are not clustered into any 
family.
Similarly, a recent analysis by Liu and Rost (2002), chopping and clustering 
sequences from 5 eukaryotic genomes suggested 22,000 domain-like clusters in 
eukaryotes. Again these represent low estimates as only a tiny percentage of species 
have been completely sequenced. Additional analysis by Liu and Rost (2002), 
chopping and clustering sequences from 62 complete genomes identified 118,108 
singleton and 63,300 non-singleton domain-like clusters.
Although, similarity in the structures adopted by different families may reflect 
folding preferences and Convergence to energetically stable folds it is possible that 
many of the families adopting the superfolds are in fact very distantly related, beyond 
the sensitivity of current algorithms to detect homology. Families adopting TIM barrel 
folds are a case in point with recent analysis suggesting that many families may have 
evolutionary links supported by unusual sequence signatures and functional properties 
(Copley and Bork, 2000; Nagano et al., 2002).
Recent calculations of the number of folds using new estimates of sequence 
families, suggest about 400-6000 well populated folds in nature (Grant et a l , 2004; see
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also section 4.3.3 below). The PSI proposes to solve 3000 structures within the next 
five years (Chandonia and Brenner, 2005). Thus, provided families are targeted 
carefully, we may know a significant proportion of all highly populated folds in nature 
by the end of the initiative. However, due to the very high attrition rates, target 
selection is important for increasing the efficiency of future structural genomics 
initiatives. In the first phase of the PSI, which ran from September 2000 until June 
2005, only 2-10% of the proteins selected by PSI structural genomics centres resulted in 
a solved structure. For example the Midwest Center for Structural Genomics Center 
targets around 5000 proteins a year from which only 100-200 are solved 
(www.mcsg.anl.gov/). The loss of targets at each stage in the process of structural 
determination is shown in figure 4.0 below.
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Figure 4.0 The Number of Targets at each stage of the Structural Genomics 
Pipeline. From over 30,000 elected targets, 314 structures were deposited in the PDB 
in 2003. Adapted from Bourne et al., 2003.
We now know the fold for many of the largest domain families, particularly 
those which dominate the genome annotations, for example 813 CATH folds can be 
assigned to 45.4% of protein sequences in the genomes, and an additional 4,440 Pfam 
families can be assigned to approximately 23.5% of protein sequences (see figure 3.3.6 
and table 3.4). Once a fold has been identified for one member of these domain
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families, it can be confidently predicted that all other domain family members will 
adopt a similar fold. However, it may not be possible to model every member of the 
domain family to give accurate models, since many relatives are likely to have a 
prohibitively low sequence identity to the relative with solved structure. Vitkup et al. 
(2001) suggest that 30-35% sequence identity is sufficient to achieve accurate 
comparative modelling, and recent analysis of CATH supports this view (Reeves et al., 
in preparation). Therefore in addition to targeting structurally uncharacterised 
sequences that have been predicted to have a novel fold, it is clear that in some families 
multiple targets must be solved to increase the number of accurate models available for 
the family.
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4.2 Objectives
This chapter describes using Gene3D for selection and prioritisation of targets 
for structural genomics initiatives. The largest structurally uncharacterised domain 
families occurring in the genomes are identified as primary targets, solving at least one 
structure for these families will increase the proportion of genome sequences with a 
known fold. This has been referred to as 'coarse grained* structural coverage of 
genome sequences. Additional targets are then identified in large families which are 
already structurally characterised but are under-represented in the PDB. Solving these 
structures increases the number of sequences in these families for which accurate 
homology models can be built, so called 'fine grained’ structural coverage of genome 
sequences. A protocol for prioritising these structural genomics targets will be shown, 
that allows rational target selection.
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4.3 Results
4.3.1 Calculating the Number o f Dom ain Fam ilies in Gene3D
The following section details the identification of sequence families in Gene3D 
data, including CATH domain sequence families of known structure, Pfam domain 
sequence families, and Newfam domain sequence families. Newfams are novel domain 
families identified in Gene3D (described previously, see section 2.4.2.8). Analysis of 
the distribution of these sequence families can suggest the total number of fold groups 
present in the 120 genomes in Gene3D and can be used to identify families suitable for 
coarse grained target selection i.e. to increase the number of known folds and structural 
families.
Sequence families for CATH domains (CATH-fams), non-overlapping Pfam 
domains (Pfam-fams) and novel domains containing neither CATH nor Pfam 
assignments (Newfams) were characterised from s35 protein family subclusters in 
Gene3D (see section 2.3.3).
50% of Gene3D domain assignments to genomes can be assigned to 93,571 
CATH-fams representing 1277 CATH homologous superfamilies from 813 folds. A 
further 33% of domain assignments can be assigned to 61,722 Pfam-fams representing 
1832 Pfam domain families (Pfam release 9). The remaining 17% of domain 
assignments are assigned to 52,973 Newfams. The number of sequence families of each 
family type (CATH-fam, Pfam-fam, Newfam) is shown in table 4.0 below. As can be 
seen from table 4.0, there are a total of 208,266 sequence families in Gene3D.
Table 4.0 Domain Family Characterisation in Gene3D. This table excludes 148,578 
singleton sequence families not considered in this analysis.
Family Type
Percentage of 
Total 
Domains
Number of 
s35 Sequence 
Families
Number of 
Superfamilies
Number of 
Folds
CATH-fam 50 93,571 1277 813
Pfam-fam 33 61,722 1832 -
Newfam 17 52,973 - -
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The uneven fold/family distribution, revealed by several previous analyses 
(Zhang and DeLisi, 1998; Govindarajan and Goldstein, 1996) can be clearly seen in 
figure 4.1 below, which shows that a small percentage of fold groups in the CATH 
domain structure database - 54 ‘superfolds’, (defined as CATH folds with three or more 
homologous superfamilies), representing only 6.6% of the number of fold groups in 
CATH, are very highly populated, accounting for 76% of s35 sequence families, whilst 
there are many folds adopted by a single family.
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Figure 4.1 Percentage of CATH Folds Accounting for Percentage of CATH s35 
Sequence Families in Gene3D. The percentage of CATH folds against the cumulative 
percentage of CATH sequence families shows marked sequence family size distribution 
bias where a small number of folds account for a large proportion of sequence families.
Although, similarity in the folds adopted by different families may reflect 
folding preferences and convergence to energetically stable folds it is possible that 
many of the families adopting the superfolds are in fact very distantly related, beyond 
the sensitivity of current algorithms to detect homology. Families adopting TIM barrel 
folds are a case in point with recent analysis suggesting that many families may have 
evolutionary links supported by unusual sequence signatures and functional properties 
(Copley and Bork, 2000; Nagano et al., 2002).
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4.3.2 Should Structural Genomics be Targeting Singletons?
Are the singleton sequence families (almost 150,000 in Gene3D) distant 
relatives of existing families unrecognised by current algorithms or are they genuinely 
unique sequences having novel folds, and therefore good targets for structural 
genomics? Kunin and co-workers (2003) showed that as newly sequenced genomes are 
completed, there is a constant gain in the number of singleton families. This may 
change as the databases expand and recognition methods improve. Original estimates 
of the proportion of singletons in bacterial genomes lay at about 50% (Zhang and 
DeLisi, 1998) but this number has steadily fallen with average values of 30% for the 
first release of Gene3D (Buchan et al., 2002) and 18% for the current release of 
Gene3D. However, some proportion of these proteins may represent genuinely new 
families and folds.
The length distribution of singletons is lower than the average structural domain 
(Rost and Liu, 2003; Marsden et al., 2006 in press) and many of the very small 
sequences containing disordered regions may correspond to unstructured proteins 
existing only as complexes and/or peptides involved in regulation and binding to DNA. 
As such, these proteins may not fold independently and will therefore lie outside the 
range of targets amenable to structural genomics.
4.3.3 How many folds remain to be discovered bv Structural Genomics?
Using the numbers of s35 sequence families identified by Gene3D we can make 
an approximation of the total numbers of folds in completed genomes by assuming the 
following: (1) We have sampled all the superfolds -  defined as folds with 3 or more 
homologous superfamilies in CATH (i.e. 71,080 CATH-fams from the 54 highly 
populated CATH folds); (2) We have been able to map these folds onto all their 
relatives in the genome sequences and so we can remove these folds from the estimates 
of the remaining numbers of folds; (3) Singletons can also be removed from the 
estimate as they are probably very distant relatives belonging to these or other folds, 
that have diverged beyond the sensitivity of current recognition methods or because 
they are short sequences unlikely to fold independently but associated with functional 
complexes. Although singletons could be novel folds and as such could skew any
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estimate of total number of protein folds, they do not represent a significant proportion 
of domains; and finally (4) We assume that non-superfolds and non-singletons have 
been sampled randomly by families in nature and that there are no biases in the current 
sequence and structure databases.
Removing the 54 superfolds from the Gene3D dataset leaves (93,571 -  71,080) 
22,491 CATH-fams of known structure which adopt (813-54) 759 folds in CATH. 
Therefore, we can expect the 114,695 remaining s35 sequence families in Gene3D of 
unknown structure (61,722 Pfam-fams + 52,973 Newfams) to adopt
((114,695/22,491)*759) 3871 new folds. We must also take into account the fact that 
about 25% of the sequences of newly sequenced genomes can not be assigned to any 
protein family in Gene3D (Marsden et al., 2006 in press), increasing the number of 
novel folds by 4/3 to 5161. Adding together the superfolds, known folds, and estimated 
number of new folds (54 superfolds + 759 known folds + 5161 estimated folds) we get 
an estimate of the number of folds in the 120 genomes in Gene3D of 5974. Although 
all fold estimates are unsatisfying in that they necessitate simplified models of fold 
usage and optimism regarding lack of bias in the databases and our sparse sampling of 
species space, the values predicted by current data suggest that provided families are 
targeted rationally in the next phase of the PSI, we may know a large proportion of the 
major fold groups by the end of the initiative.
4.3.4 Structural Genomics Target Selection Using Gene3D
4.3.4.1 Coarse Grained Target Selection to Identify Novel Folds
There are 4,365 Pfam domain families (Pfam release 10) identified in Gene3D 
that are non-overlapping with CATH domain assignments, including singleton Pfams. 
Pfam families would make good targets for structural genomics initiatives since Pfam is 
a well validated and curated resource and these families represent some of the largest, 
structurally uncharacterised families in the genomes. Figure 3.5 (see section 3.3.2.1) 
iUustrates the fact that Pfam families are much larger than Newfam families. In 
addition, they have been manually validated to improve domain boundary identification, 
an important consideration for structure determination. Of these targets, 1,876 Pfam 
families contain more than 20 members identified in the genomes, representing 89.3%
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of total Pfam domain sequences; and 447 Pfam families contain more than 100 
members identified in the genomes, representing 56.3% of total Pfam domain 
sequences.
Since protein structure initiatives propose to solve 3000 structures over the next 
five years, these Pfam families would be good targets for structural genomics initiatives 
that aim to identify novel folds, since these larger Pfam families would have a 
significant impact on genome coverage for each solved structure (shown in figure 4.2 
below). Alternatively, these Pfam family targets could be prioritised according to 
Kingdom distribution, or individual genome occurrence, using Gene3D information, 
according to any specific aims of individual structural genomics efforts. For example, 
the Midwest Center for Structure Genomics consortium (MCSG) is particularly 
interested in targeting pathogens.
This approach is similar to the Pfam5000 strategy reported by Chandonia and 
Brenner (2005), in which the authors propose targeting the 5000 largest Pfam families. 
As the authors note, solving a single structure for each Pfam family could significantly 
increase coarse grained structural coverage of sequence space. However, if 
representative structures for the largest 1,876 Pfam families are solved this would then 
give structural assignments for, on average 66.4.0% of genome sequences (45.4% 
previously characterised by CATH domain assignments, and an additional 21.0% 
characterised by the 1,876 newly determined Pfam families; see genome coverage 
section 3.3.6 and table 3.4). Although aiming to solve 5000 or more structures may be 
outside the scope of the PSI initiative, 1,876 new structures may be achievable, and if 
the largest uncharacterised Pfam families are targeted, this will cover nearly 90% of 
Pfam domain sequences (see figure 4.2 below) and ensure that a significant proportion 
of domain sequences have a known structure (see figure 4.3).
Of these 1,876 Pfam families identified above, 1,369 families have been selected 
for structural determination by the PSI over the next two years. These were chosen 
because they had low probabilities of containing transmembrane regions, or other 
features which might make these targets harder to solve. To improve the probability of 
obtaining a structure for a selected family, each consortium typically identifies 5-10 
relatives per family. Over the remaining three years of the PSI initiative, further 
sampling from these families may be needed and targeting of the next largest Pfam
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families will be undertaken. Once all the Pfam families have been targeted, large 
Newfam families will be sampled.
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Figure 4.2 Running Total of the Percentage of Pfam Domain Sequences in the 
largest Pfam families in the Genomes. Pfam families are ordered by number of 
relatives in the family. Note that the largest 1,876 Pfam families account for 89.3% of 
Pfam domain sequences in the genomes (red dotted lines).
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Figure 4.3 Running Total of the Percentage of Domain Sequences in CATH, Pfam 
and Newfam families in the Genomes. CATH domain families of known structure 
(red), Pfam domain families of unknown structure targeted by the PSI (blue) and 
remaining families (untargeted Pfam families and novel Newfam families, of which 
-20% are membrane associated; green), ordered by decreasing number of members 
plotted against the percentage of domain sequences in the genomes.
Although solving the structures of the largest structurally uncharacterised Pfam 
families will increase the proportion of genome sequences for which we know the fold, 
as discussed above many of the sequences in families of known structure will not be 
closely enough related to the solved structure to build accurate homology models from 
this structure. Therefore to increase the number of sequences for which an accurate 
homology model can be built, it is necessary to select additional targets from families of 
known structure. This has been described as fine grained sampling.
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4 3.4.2 Fine Grained Target Selection to Increase the Number of Homology Models 
for Genome Sequences
Below, a strategy is described for identifying multiple representatives from 
domain families of known structure, where the structure has already been solved and 
classified in CATH. Multiple sampling from CATH rather than the uncharacterised 
Pfam families was undertaken initially as these domain families tend to be much larger 
than the Pfam families (see section 3.3.2.1) and because these families are much more 
under-represented in the PDB (see figure 4.5). Furthermore, knowing the structure of 
one or more relatives already can help in structure determination of other relatives by 
isomorphous replacement. In the future a similar strategy can be applied for multiple 
sampling of uncharacterised Pfam and Newfam families.
Since sequence identities above 30-35% ensure that good homology models can 
be built (Vitkup et al., 2001), structural genomics initiatives aiming to provide accurate 
homology models for all members of a structural family require domain family 
subclusters to be identified. Clustering was performed as described previously in 
Chapter 2 (see section 2.3.3).
Sequence identities between domain sequences from each CATH homologous 
superfamily were calculated from an all against all BLAST (where at least 80% of the 
longer sequence is overlapped) and TCluster was then used to cluster each CATH 
domain family in Gene3D at 35 sequence identity (see section 2.3.3). CATH domain 
assignments made to genscan predicted protein sequences are included in this analysis 
as these genscan predictions are likely to represent translated reading frames.
Clustering of CATH domain family sequences in the 120 genomes of Gene3D 
produced more than 93,000 s35 subclusters. However, since this represents a very large 
number of targets and may be outside the scope of what is possible in current structural 
genomics initiatives, further analysis using Gene3D has been used to prioritise these 
targets and is discussed below.
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4.3.5 Prioritising Sequence Diverse Domain Families
The most sequence diverse CATH domain families identified in the genomes, as 
measured by the number of distinct s35 subclusters, are shown in table 4.1 below. 
These comprise a total of 20,763 s35 subclusters representing 20.4% of the genome 
sequences. Many of these families are already observed to be structurally very diverse 
(Reeves et al., in preparation), and solving additional structures in these families will 
give further insights into the manner by which structures and functions have evolved in 
diverse relatives.
Table 4.1 Most Diverse CATH Domain Families in Gene3D. The CATH domain 
family name o f the top ten most diverse CATH domain families is shown, with the total
number o f family members and the number ofs35 subclusters identified in Gene3D.
Domain Family
Number of family 
members in Gene3D
Number of s35 subclusters 
in Gene3D
P-loop containing nucleotide 
triphosphate hydrolases
31,908 4881
Immunoglobulins 19,290 2571
DNA binding domain, 
transcription factor
4456 2385
NAD(P)-binding Rossmann- 
like Domain
10697 2069
"winged helix" repressor 
DNA binding domain
8270 1710
Hydrolase activity, aromatic 
compound metabolism
4738 1633
Periplasmic binding protein­
like H
5637 1439
S-adenosylmethionine- 
dependent methyltransferase 
activity
5674 1432
YVTN repeat- 
like/Quinoprotein amine 
dehydrogenase
5162 1369
Ribonuclease Inhibitor 4566 1274
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Since known structures in CATH only represent a small proportion of CATH 
domain sequences in Gene3D, and since these may not have been sampled to reflect the 
true sequence diversity of these families in nature, the difference between the sequence 
diversity of these families in CATH was compared to the predicted diversity of families 
in the genomes. The relative diversity was calculated by dividing the percentage of 
total s35 subclusters in the genomes by the percentage of total s35 subclusters in CATH 
for each domain family. To enable this comparison, the CATH classification of domain 
families with known structure was clustered to identify s35 subclusters using the same 
protocol described previously for identification of s35 subclusters in Gene3D (see 
section 2.3.3). 193 domain families in CATH are from Kingdoms (i.e. viruses) or
genomes not represented in Gene3D and are therefore excluded from this analysis. The 
relative diversity of domain families is shown in figure 4.5 below. There are 21-fold 
more s35 subclusters in total in the genomes than in CATH.
Figure 4.4 below shows the most diverse domain families in the genomes are 
comparatively more diverse than indicated by their CATH classification. Clearly it 
would be beneficial to have more structural representatives for these highly expanded 
domain families.
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Figure 4.4 Size/Diversity of CATH and Gene3D Domain Families. Domain families 
ranked by number of s35 subclusters (diversity) against percentage of total s35 
subclusters (total diversity) for CATH (pink) and Gene3D (blue).
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As can be seen in figure 4.5 below, some domain families are much more 
sequence diverse in the genomes than in the CATH classification. 132 domain families 
with a relative diversity greater than 2 were considered significantly structurally under­
represented, representing 37,214 s35 subcluster targets. Taking into account the current 
attrition rates of 2-10%, multiple targeting of these families could provide structures for 
a further 700-3000 relatives from these families.
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Figure 4.5 Relative Diversity of CATH Domain Families. Relative diversity (% of 
total s35 subclusters in Gene3D /  % total s35 subclusters in CATH, for each domain 
family) between CATH domain families of known structure classified in CATH and 
predicted in the genomes. Domain families are ranked by CATH Class (1-4) and 
descending relative diversity.
The sequence and structural diversity of CATH domain families has been shown 
to correlate with their functional diversity (Ranea et al., submitted; Reeves et al., in 
preparation). Targeting family relatives from expanded domain families identified in 
Gene3D may therefore aid in understanding how function evolves in these structurally 
diverse domain families. The top most under-represented domain families (in terms of 
predicted structural diversity) are shown in table 4.2 below. There are 5,966 s35
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subclusters altogether in these families with no structural representative, that could be 
targeted for structure determination.
Table 4.2 Most Structurally Under-represented CATH Domain Families. The
relative diversity (% o f total s35 subclusters identified in Gene3D divided by the % o f 
total s35 subclusters identified in CATH) is shown for the ten most under-represented
domain families.
Domain Family
No.
Subcl
CATH
)fs35
lusters
Gene3D
% o f l
Subc
CATH
'otals35
lusters
Gene3D
Relative
Diversity
Cadherins, calcium 
dependent cell adhesion
2 601 0.05 0.62 13.5
Galactose oxidase, radical 
copper oxidase family
1 268 0.02 0.28 12.0
Tachycitin domain 1 247 0.02 0.25 11.1
Two-component signal 
transduction protein
1 242 0.02 0.25 10.9
DNA binding, transcription 
regulation
10 2385 0.23 2.46 10.7
"winged helix" repressor 
DNA binding domain
1 193 0.02 0.20 8.7
Two-component signal 
transduction protein
1 186 0.02 0.19 8.3
Two-component signal 
transduction protein
5 906 0.11 0.93 8.1
AMP binding domain, 
peptide synthase proteins
4 642 0.09 0.66 7.2
Complement Protease Cls, 
immune response
2 296 0.05 0.31 6.6
Some of these domain families are found in proteins performing important 
biological functions. Three of the domain families are involved in the two-component 
signal transduction pathway, an extremely functionally diverse protein family
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(described previously, see section 3.3.1.2.2). Of particular interest is the galactose 
oxidase domain family, from a copper oxidase family of enzymes. These enzymes have 
a distinct active site, containing a novel Tyr-Cys modified amino acid dimer, formed 
spontaneously during the maturation of the protein. Interestingly, the metal ion ligands 
in the active site of these proteins have been shown to perform essential proton transfers 
and redox functions. This family of oxidases has a wide phylogenetic distribution, and 
may play a fundamental role in the biology of oxygen (Whittaker, 2002). The diversity 
across the family may reflect different interaction partners and solving the structures of 
multiple relatives from this family may provide insights into these interactions.
Also of functional interest is the tachycitin domain, a chitin-binding domain 
found in a variety of proteins. Tachycitin has been shown to have antimicrobial 
properties in many organisms, and in mammals in particular is thought to participate in 
immune defence response against nematodes and other pathogens (Tjoelker et al.,
2000). Finally, the complement protease C ls, the first protein of the classical 
component cascade system consisting of about 30 serum proteins, has a well 
documented biological function. Solving the structure of additional representatives may 
allow a greater understanding of the structural mechanisms underlying the activation, 
mechanism of action and substrates of relatives in this important protease family.
4.3.6 Prioritising Functionally Diverse o f Domain Fam ilies
Another approach is to preferentially target functionally diverse and highly 
expanded families in the genomes, whose functional diversity is currently under­
represented by known structures in CATH. To compare the functional diversity of 
domain families of known structure in CATH and Gene3D, the functional diversity of 
each domain family was characterised by four criteria: (i) Annotation -  this indicates 
whether there is one or more functional annotations for the family; (ii) Coverage -  the 
percentage of members within a domain family with a functional annotation; (iii) Scope 
-  the number of different functional annotations in the domain family; and (iv) 
Agreement -  this indicates whether at least 80% of annotated family members have the 
same functional annotation. Average values for (ii) and (iii) are calculated for all 
families in Gene3D and CATH. In addition, the percentage of families classified as (i)
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Annotated and (iv) in Agreement in Gene3D and CATH was also calculated. Figure 4.6 
below illustrates these criteria.
G 0 1 .G 0 2  
G 0 1 .G 0 2 . G 03  
G 02. G 03  
G 0 1 .G 0 2 . G 03  
GQ1.GQ3
ANNOTATION
COVERAGE
SCOPE
AGREEMENT
= YES 
= 100% 
= 4 
= NO
G04
G 03. G 04  
G 03. G 04  
G 03
G 03. G 04
ANNOTATION
COVERAGE
SCOPE
AGREEMENT
= YES 
= 100% 
= 3 
= NO
G01
G01
G01
G01
ANNOTATION
COVERAGE
SCOPE
AGREEMENT
= YES 
= 80%
= YES
Family Members Annotation Functional Criteria
Annotation 
(YE9+YES+YES)/3 
= 100% YES
TOTAL
S cope 
<4+3*1)13 
= 2.7
A greem ent 
(NO+NO+YES)/3 
= 334%  YES
Figure 4.6 Functional Characterisation of Domain Families. Characterisation of 
functional annotation in three domain families is illustrated. Note that scope is defined 
by the number of distinct, ordered, concatenated GO functional terms per family (i.e. in 
Family B “G03, G 04 '\ “G 0 3 ” and “G 0 4 ” gives a scope of 3).
The functional characteristics of Gene3D domain families and CATH domain 
families are shown in table 4.3. Functional characteristics for the CATH classification 
were taken from the Dictionary of Homologous Superfamilies (DHS version 2.5.1, 
released January 2005, downloaded July 2005), which functionally annotates CATH 
(described earlier, see section 2.1.5.4). It can be seen that because Gene3D domain 
families have many additional sequence relatives from the genomes, there is a much 
clearer picture of the functional diversity than currently observed in CATH, with 
increased Annotation, Coverage and Scope.
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Table 43  Scope of Functional Annotation In Gene3D Families. Functional 
annotations in Gene3D and CATH domain families, assessed by Annotation, Coverage, 
Scope and Agreement.
Family Resource
Annotation
(%)
Coverage
(%)
Scope
Agreement
(%)
Gene3D
Domain
Family
GO 97.8 45.5 191.9 1.5
KEGG 68.3 63.5 73.6 0
COG 69.7 1.2 82.2 0.2
CATH
Domain
Family
GO 70.9 15.1 20.8 2.6
KEGG 62.8 7.3 6.7 2.1
COG 66.0 7.4 6.9 1.9
The functional diversity of domain families in CATH and the genomes was 
compared by reference to GO functional annotations, since these have the highest 
coverage of the three resources (GO, KEGG, and COG). Functionally under­
represented families were identified by the relative scope of the family between Gene3D 
and CATH. Relative scope was calculated by dividing the scope in Gene3D by the 
scope in CATH for each domain family. 380 domain families with a relative scope 
greater than 2 were considered functionally under-represented, representing 27,191 s35 
subclusters.
Not all structurally under-represented domain families are also functionally 
under-represented. Of the 132 structurally under-represented domain families identified 
previously, 60 of these domain families are also functionally under-represented and thus 
can be selectively targeted as likely to be more informative for investigating the 
structural mechanisms for the evolution of function within a domain family.
The relationship between the sequence diversity and functional diversity of 
domain families in the genomes is shown in figure 4.7 below, revealing a general trend 
where sequence diverse domain families are also functionally diverse, supporting the 
observations of Reeves et al. and Ranea et al. (Reeves et al., in preparation; Ranea et 
al., submitted).
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Figure 4.7 Log-iog plot showing Functional Diversity versus Sequence Diversity of 
CATH Domain Families in Gene3D. Functionally diverse families (greater than 2000 
scope) and sequence diverse families (greater than 1% of total s35 subclusters) are 
indicated by red dotted lines.
Ten domain families dominate the sequence diverse and functionally diverse 
CATH domain families in the genomes. Each of these families represents 1% or more 
of total s35 subclusters and has a functional scope of 2000 or more, shown in table 4.4 
below. Collectively these ten domain families represent 20.1% of total s35 subclusters, 
and comprise 19,000 potential targets for structural genomics. Solving the additional 
structures from these families would enable greater understanding of the relationship 
between the structural variation and the evolution of functional diversity in these 
domain families. However, some of these families already dominate the PDB (for 
example the P-loop containing nucleotide triphosphate hydrolases). For these families 
we may want to use additional information in Gene3D to target those s35 subclusters 
which have particular GO functions for which we currently have no structural 
representative, or which have novel domain contexts for which we have no structural 
representative. Targeting novel domain contexts has been suggested previously by 
Vogel et a l, (Vogel et a l, 2004), target selection of novel domain contexts using 
Gene3D is currently ongoing.
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Table 4.4 Ten Structurally and Functionally Diverse CATH Domain Families
Dominate Gene3D.
Domain Family
% of total s35 
Subclusters
Scope # Targets
P-loop containing nucleotide 
triphosphate hydrolases,
5.2 20,464 4,881
NAD(P)-binding Rossmann-like 
domain
2.2 7,134 2,069
"winged helix" DNA binding domain, 
transcription factor
1.8 5,780 1,710
S -adenosy lmethionine-dependent 
methyltransferase activity
1.5 3,987 1,432
Homeodomain-like transcription 
regulation
1.2 3,859 1,127
Periplasmic binding protein-like n, 
transporter activity
1.5 3,409 1,439
Hydrolase activity, aromatic 
compound metabolism
1.7 3,136 1,633
Electron transport, Oxidoreductase 
activity, metabolism
1.2 2,494 1,088
Electron transport, Thioredoxin-like 1.1 2,448 1,050
Immunoglobulins 2.7 2,388 2,571
TOTAL 20.1 - 19,000
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4.4 Summary
Analysis using Gene3D can identify suitable targets for structural genomics 
initiatives. Of the 4,365 Pfam families identified in the genomes, that are structurally 
uncharacterised, selection of the largest 1,876 of these families permits a greater 
proportion of genome sequences to be structurally annotated. All these families contain 
more than 20 relatives, 447 contain more than 100 relatives, allowing multiple targets to 
be selected from these families to increase the probability that a substantial proportion 
of structures will be solved, given the high attrition rates.
The identification of 93,571 target subclusters from structurally characterised 
families in CATH would be required to accurately homology model all the relatives of 
domain families in the genomes from known fold groups. This is a prohibitively large 
number and underscores the need for rational prioritisation of structural genomics 
targets. Analysis using Gene3D has identified the most sequence diverse domain 
families, representing 20,763 target subclusters. Comparison of the distribution of 
sequence diversity between known structures classified in CATH and those predicted in 
the genomes has shown that many domain families are more sequence diverse than 
suggested by their current classification, with a 21-fold increase in the number of target 
clusters identified in Gene3D. 132 domain families have been identified that are 
significantly structurally under-represented, some of the most under-represented of 
these families perform diverse and biologically important functions, and greater insight 
into the structural mechanisms behind these functions may be gained from targeting the 
5,966 homology modelling targets identified in these domain families. Analysis of the 
structural and functional diversity of domain families shows that ten domain families 
dominate the genomes - these families comprise 19,000 target subclusters.
In summary, Gene3D data allows sampling of all apparently diverse families to 
select targets for functions and domain contexts that have not yet been structurally 
characterised. By considering Kingdom distribution, the number of domain family 
relatives represented in each target subcluster, and the domain context of the domains 
represented in each target subcluster, further prioritisation of these targets can be 
accomplished.
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CHAPTER FIVE
Phylogenetic Occurrence Profiles to Analyse the Function and 
Evolution of Domain Families
5.1 Introduction
Phylogenetic profiles have been exploited to detect functionally related proteins, 
and proteins that interact (see section 1.2.3.4 for a description and review of methods). 
Traditional phylogenetic profiles are based upon a presence/absence profile, whereby 
the presence of an orthologue in a genome is designated 1, and the absence 0. The 
resulting binary string represents the presence/absence profile of a protein across several 
genomes. These profiles can be compared and clustered into groups of profiles that are 
statistically significantly similar and may indicate that the proteins interact or are 
functionally related.
Bacterial genomes provide a good dataset for analysing protein domain and 
family evolution. The size of bacterial genomes has long been hypothesised to be under 
natural selection. The gene repertoire of bacterial genomes results from a balance 
between opposing mechanisms of gene increase, via horizontal transfer and gene 
duplication, and gene loss, via gene inactivation and deletion. The evolutionary 
mechanisms that maintain a small bacterial genome size, in order to maintain a 
competitive rapid rate of replication have been analysed by several researchers. Mira et 
al. (2001) describe a ‘deletional bias’ in bacterial genomes that acts to eliminate non­
functional genes with decreased functional selection. The loss of genes that are no 
longer functionally selected for acts to maintain small bacterial genomes that lack non­
functional sequences. Evolution by reduction, whereby the smallest genomes are 
derived from bacteria with larger genomes (Dobrindt and Hacker, 2001; Moran, 2002) 
has been described in many obligate intracellular bacterial pathogens. Massive gene 
loss significantly reducing genome size to an optimal genome size is an adaptive 
response to intracellular environmental selection pressures.
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The gene repertoire of these genomes is far from static. As noted by Ochman et 
al. (2000) bacteria obtain a significant proportion of their genetic diversity through the 
acquisition of sequences from distantly related organisms. Horizontal transfer 
introduces substantial amounts of genetic material into bacterial genomes, combined 
with a high level of deletion of genetic material, bacterial gene repertoires are dynamic, 
maintaining a small efficient genome that can adapt to and exploit changing selective 
pressures. Bacterial genome size is not simply related to phenotype or lineage. Bacteria 
with a wide range of different phenotypes and lifestyles can have similar genome size; 
conversely, bacteria from narrow phylogenetic groups can have considerable diversity 
in genome size (Ochman et al., 2000).
Gene duplication (Koonin et al., 2002) and lineage-specific gene loss (Dobrindt 
and Hacker, 2001; Moran, 2002) are the primary mechanisms determining bacterial 
genome size. The influence of horizontal transfer in determining bacterial genome size 
is less apparent (Chothia et al., 2003; Kurland et al., 2003). Jordan et al. (2001), 
describe a positive correlation between the fraction of genes within lineage specific 
expansions (gene duplications occurring within specific prokaryotic lineages) and the 
total number of genes in a genome.
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5.2 Objectives
The first section of this chapter describes using Gene3D to analyse bacterial 
evolution. In particular the identification of universal domains and the analysis of their 
genome frequency with regard to genome size. The following sections describe 
identification of genome size-dependent and universal domain families in bacteria using 
phylogenetic profiles, and the relationship between these domain families and bacterial 
genome size. Later sections of this chapter exploit domain family subclustering to 
generate more highly resolved phylogenetic profiles. A novel method of fine tuning 
these phylogenetic profiles to identify functionally related domain family subclusters is 
described, along with preliminary results describing some novel functional relationships 
identified using this method.
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5.3 Results
There is a large complement of completely sequenced bacterial genomes in 
Gene3D. In collaboration with Juan Ranea, the distribution and occurrence of CATH 
homologous superfamilies in 100 bacterial genomes was investigated to explore the 
genetic and functional determinants involved in bacterial size distribution. We decided 
to study the distribution of CATH homologous superfamilies in bacteria, as there was a 
large dataset of bacterial genomes available. These genomes are less complex than 
those of eukaryotes (for example more accurate gene identification and annotation), 
which consisted of only 16 completed genomes existed at the time of this study. In 
bacterial genomes the absence of introns and long intergenic non-coding regions make 
open reading frame identification more accurate. Bacterial genome size will therefore 
be more likely to reflect the size of the bacterial proteome. Evolutionary selection on 
bacterial genome size, to promote small, reproductively efficient genomes, allows 
genome complexity and size to be estimated from the number of ORFs (Mira et a/.,
2001), which is the measurement of genome size used in this chapter.
5.3.1 Analysis of the Genome Size Dependence of CATH Superfamilies
For each of the 940 CATH domains assigned to at least one gene in the bacterial 
genome dataset, an occurrence profile was derived (see figure 5.0). These occurrence 
profiles were used to explore the distribution of the CATH homologous superfamilies in 
the bacterial dataset.
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Domain Occurrence Profiles
Domain Bacteria Bacteria Bacteria Bacteria
Superfamily: 1: 2: 3: 4:
A 12 13 14 11
B 35 0 0 60
C 16 0 0 0
Figure 5.0 Domain Occurrence Profiles. The number of open reading frames 
containing domain family relatives in each bacterial genome is converted into an 
occurrence profile for each CATH homologous superfamily.
The occurrence of a CATH domain within each bacterial genome was calculated 
by counting the total number of different proteins in which the CATH domain had been 
assigned. Proteins that contained more than one CATH domain assignment of the same 
homologous superfamily were only counted once. This avoids redundancy and gives 
equal weight to domains occurring in different multi-domain contexts so more 
accurately reflecting a domains contribution to bacterial complexity. To explore the 
correlation between genome size and the number of domain relatives in a particular 
organism, correlation coefficients between genome size variation and CATH domain 
occurrence profiles were obtained by Spearman’s rank correlation method (Kendall and 
Gibbons, Rank Correlation Methods (5th edition), 1990). 116 CATH domains with a 
Spearman’s coefficient greater than or equal to 0.7 were considered significantly 
correlated with genome size and are termed size-dependent CATH homologous 
superfamilies (shown in figure 5.1). A Spearman’s coefficient of 0.7 corresponds to a 
statistical probability of less than 0.0005 that the correlation occurs in the dataset by 
chance. These 116 size-dependent CATH homologous superfamilies represent only 
12% of the total number of superfamilies occurring in the bacterial dataset, but account 
for 60% of domain assignments.
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Figure 5.1 Size-Dependent CATH Homologous Superfamilies. Spearman's Rank 
Correlation values for all CATH homologous superfamilies in the bacterial dataset. 
Correlation values greater then 0.7 indicate size-dependent superfamilies.
5.3.2 Identification of Universal CATH Homologous Superfamilies
Within the set of size-dependent CATH homologous superfamilies identified in 
the bacterial dataset, a sub-set of universal CATH homologous superfamilies was 
identified. Size-dependent CATH homologous superfamilies with a wide representation 
in bacterial genomes (identified in at least 70% of genomes in the bacterial dataset) 
were considered universal to bacteria. A cut-off of 70% was considered an acceptable 
threshold since the sensitivity of the HMM method used to identify the CATH domains 
in the genomes is 76% using a structural dataset (see section 2.4.2.2). As can be seen 
from figure 5.2 below, 73% (85/116) of size-dependent CATH homologous 
superfamilies are universal to bacterial genomes. These size-dependent universal 
CATH homologous superfamilies represent only 9% of the total number of CATH 
homologous superfamilies, but account for 56% of domain assignments. This indicates 
that a few, highly recurring superfamilies are primarily responsible for genome 
complexity in bacteria, and suggests there are ancestral, homologous genetic 
mechanisms that narrowly specify genome complexity. Only 28% of non-size- 
dependent CATH homologous superfamilies are found to be universal, suggesting that
150
most superfamilies with low size correlation are likely to be associated with functions 
specific to a few organisms.
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Figure 5.2 Universal Size-Dependent Superfamilies. The universality value 
(percentage o f total genomes containing domain family members) for all size dependent 
superfamilies in the bacterial dataset. Universal superfamilies are present in at least 
70% of bacteria.
5.3.3 Distribution of Size-Dependent Universal CATH Superfamilies
The distribution of 85 CATH homologous superfamilies that are both size- 
dependent and universal was analysed by plotting domain occurrence against genome 
size for each CATH domain in order to determine the type of relationship between 
domain occurrence and genome size. Linear regression model validation was 
performed by standardised residual analysis plotted against their respective y fitted 
values calculated from the linear regression model (Anscombe 1973; Atkinson 1985). 
Linear regression assumption was validated independently for all the universal and size- 
dependent superfamilies distributions. Three different types of distributions were 
identified: linear, power-law and logarithmic which characterised a total of 66 
superfamilies. The type of distribution for the remaining 19 superfamilies was not 
clear. See appendix III for a complete list.
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Figure 5.3 below shows the residual pattern analysis of the linear regression 
validation for the three main types of behaviour observed; linear, power-low and 
logarithmic. For each type of behaviour, the pattern of the error distribution around the 
linear model gives an indication of the most appropriate model.
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Figure 53  Distribution of Size-Dependent Universal Superfamilies Plotting domain 
occurrences against genome size for each size-dependent universal superfamily reveals three 
types of distribution. Left hand plots show the best linear regression fitting for the three main 
types of domain superfamilies distributions: (a) linear, (c) power-law and (e) logarithmic. The 
equations for the regression lines and the R2 values are indicated. The plots on the right show 
the standardised residual (r) (y-axis) calculated for each of the three linear regression models 
plotted against y* fitted values (x-axis): (b) plot shows a residual distribution pattern 
confirming linearity, and (d) and (f) plots show curvatures characteristic of nonlinearity.
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5.3.4 Analysis of the Function of Size-Dependent Universal CATH
Superfamilies
Functional analysis was undertaken for all superfamilies from each distribution 
set (linear, power law, logarithmic) using annotations from the COG database, as well 
as additional annotations from Pfam, SWISSPROT, CATH, SCOP and the literature 
where required. Functional classifications of each superfamily can be seen in appendix
m.
The 38 linearly distributed, size-dependent universal superfamilies were found 
to be primarily involved with metabolism. 87% of domains and 82% of superfamilies 
in this category are involved in cellular metabolism. For example, the two most 
frequently occurring superfamilies in bacteria occur in this category: the nucleotide 
triphosphate hydrolase domain (CATH code 3.40.50.300) supplies reaction energy in 
both prokaryotes and eukaryotes; whilst the NADP-binding domain (CATH code 
3.40.50.720) performs reducing or oxidising chemistry for a wide range of different 
reactions (Apic et a l, 2001; Hegyi et al, 2002).
The 20 power law distributed, size-dependent universal superfamilies were 
found to be primarily involved in gene regulation mechanisms. 80% of domains and 
60% of superfamilies in this category perform gene regulatory roles in bacteria. Major 
transcription factors occur in this category: winged-helix (CATH code 1.10.10.10); 
homeodomain-like (CATH code 1.10.10.60); and 1-repressor DNA-binding domain 
(CATH code 1.10.160.10) (Babu and Teichmann, 2003). In addition to transcription 
factors, domains of the two-component signal transduction system (CheY response 
regulator domain (CATH code 3.40.50.2600), high-affinity periplasmic solute-binding 
protein (CATH code 3.40.190.10), and histidine kinase domain (CATH code 
3.30.565.10)) are found in this category (Goudreau and Stock, 1998). Since regulatory 
domains show a high degree of modularity and usually combine with enzymatic or 
small molecule binding domains responsible for regulatory specificity (Apic et a l , 
2001; Babu and Teichmann, 2003), it is perhaps not surprising that this category also 
contains some metabolic superfamilies.
The 8 logarithmically distributed, size dependent universal superfamilies do not 
show any common functional tendency. These superfamilies are involved in diverse
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functions such as metabolism, RNA binding and DNA repair, which makes it difficult 
to define a single functional term for this category. However, since these superfamilies 
represent only 10% of all size dependent universal domains and 9% of all size 
dependent universal superfamilies they represent only a small proportion of 
superfamilies and are not considered for further analysis.
5.3.5 Identifying the Bacterial Genome Size Determinants o f Size  
Dependent Universal Superfamilies
When considering the influence of size dependent universal superfamilies upon 
bacterial genome size, the balance between metabolic and regulatory functions and their 
respective costs can be considered. As hypothesised by Bird (1995), increasing 
complexity is limited by the increase in logistical problems of distinguishing signal 
from noise. In terms of bacterial complexity, the benefits of environmental exploitation 
and adaptation gained from an increase in genome size come with combinatorial 
increases in protein network complexity to fully integrate and apply the functions of 
additional genes. As each additional gene is added to a genome, the combination of 
possible gene interactions and protein interactions increases by an increasing amount. 
Thus the benefits derived from expansion of the metabolic repertoire are accompanied 
by an increase in the regulatory repertoire necessary to control interactions between 
these proteins and so distinguish signal from noise.
5.3.5.1 Economies of Scale
The relationship between a linear increase in one factor (i.e. metabolic 
repertoire) requiring a non-linear increase in another (i.e. regulatory repertoire), is 
analogous to the factory optimisation model exploited in economic analyses (Mankiw, 
Principles of Microeconomics (2nd edition), 1998). The factory optimisation model is 
used to describe microeconomics -  a single factory which produces a single product 
which is always in demand. In the factory optimisation model illustrated in figure 5.4, a 
linear increase in unit production produces a non-linear increase in production 
overheads. At low levels of unit production there is little restraint on production unit 
increases as the required increases in production overheads are low. However, at high
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levels of unit production there is a large restraint on production unit increases as the 
required increases in production overhead cost more than the benefit of increased unit 
production. A major factor influencing optimum size in productive systems is the effect 
where any linear increase in production complexity is usually associated with a larger 
increase in the associated logistic cost (Frizelle, The Management of Complexity in 
Manufacturing, 1998; Orr, 2000).
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Figure 5.4 Economies of Scale: Optimum Factory Size Factory production revenue 
(straight line) and factory production overhead costs (curve) values show maximum 
economic factory size (red arrow) where any further increase in production revenue 
results in a larger increase in production overhead costs, making an increase in factory 
size unprofitable; and optimal factory size (blue arrow) where production revenue is 
offset by an equivalent production overhead cost, maximising profit.
53.5.2 Predicting Optimal Bacterial Genome Size
This model can be applied to an analysis of bacterial genome size, shown in 
figure 5.5. An analogy between unit production and metabolic capacity can be made 
since an increase in metabolic capacity provides bacteria with new ways to exploit the 
environment and hence increase survivability. The regulatory processes required to
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integrate and control metabolic systems is analogous to the cost of production 
overheads, since an increase in the number of regulatory genes can be considered a cost 
because bacteria have to keep their genome size to a minimum in order to replicate most 
efficiently, which is important for their survival. The cellular cost of regulatory systems 
can be seen in bacteria with stable substrate sources (for example endosymbiotic 
bacteria) where the strategy of constant expression of metabolic enzymes and loss of 
regulatory genes is observed. In contrast, in free living bacteria, efficient exploitation 
and response to diverse environmental pressures provides a survivability advantage that 
offsets the cost of maintaining regulatory systems.
Fitting the distributions of metabolic (linearly distributed size-dependent 
universal superfamilies) and regulatory (power law distributed size-dependent universal 
superfamilies) superfamilies to regression lines shows two interesting effects of these 
superfamilies on bacterial genome size.
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Figure 5.5 Economies of Scale: Optimum Bacterial Genome Size. Plotting the 
distribution curves of metabolic size-dependent universal superfamilies and regulatory 
size-dependent universal superfamilies indicates maximum bacterial genome size (red 
arrow) and optimal bacterial genome size (blue arrow).
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The two functions cross at 10,500 open reading frames. This suggests that 
above a genome size of 10,500 ORFs the cost of additional regulation exceeds the 
benefit of increased metabolic complexity. The optimal bacterial genome size occurs 
when the incremental costs of metabolic increase and regulatory increase are equal, this 
level of metabolic complexity is of maximal efficiency, since it is achieved at minimal 
relative regulatory cost, i.e. where the regulatory superfamilies distribution gradient is 
equal to the metabolic superfamilies distribution gradient. This optimum bacterial 
genome size occurs at 4,805 open reading frames. Deviation away from this optimum 
incurs a cost of reduced reproductive efficiency. Above optimal genome size an 
increase in metabolic complexity demands a comparatively higher increase in regulatory 
complexity. For example, as can be seen from the gradient of the regulatory 
superfamilies distribution curve, the regulatory increment required to add one gene 
when the genome size is 8000 is almost triple that required when the genome size is 
2000.
The size distribution given by the metabolic and regulatory superfamily 
distribution curves is shown in figure 5.6 (blue bars). This shows the percentage benefit 
at particular genome sizes, obtained by subtracting the regulatory cost from the 
metabolic revenue (i.e. the shaded area in figure 5.5). Interestingly this distribution is 
similar to the size distribution of generalist species of bacteria (black line, de Bruijn et 
al., 1998), that can use multiple carbon and energy sources with few organic growth 
requirements in culture. The average number of genes in a generalist bacteria, 4,900 (de 
Bruijn et a l , 1998), is very close to the optimal bacterial genome size of 4,805 
calculated above.
The distribution of genome sizes in the 100 bacterial genomes in the dataset 
used in this analysis (yellow bars) is actually closer to the distribution of genome size of 
specialist bacteria (intracellular bacteria incapable of reproducing by themselves; dotted 
line, de Bruijn et al., 1998) than generalist bacteria (free living bacteria). The fact that 
the calculated optimal genome size derived from metabolic and regulatory superfamily 
distribution curves is in good agreement with the average genome size of generalist 
bacteria, indicates that the size dependent universal superfamilies represent universal 
molecular technology shared by all prokaryotes to perform their metabolic and 
regulatory processes, and that all bacteria have used similar molecular technology to 
optimise their reproductive efficiency. This efficiency has been achieved by maintaining
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a metabolic complexity and associated regulatory complexity that balance the capacity 
for environmental exploitation with reproductive efficiency.
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Figure 5.6 Distribution of Bacterial Genome Size. The size distribution curve for  
bacterial genomes predicted from metabolic/regulatory size-dependent universal 
superfamilies (figure 5.5 hashed area) shown by blue bars is similar in range and shape 
to the size distribution of generalist bacteria (black line). The size distribution of the 
100 bacteria in the dataset (white bars) is similar to the size distribution of specialist 
bacteria (dotted line).
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5.4 Using Gene3D Phylogenetic Occurrence Profiles for 
Predicting Protein Functional Relationships
A novel method of phylogenetic profiling using Gene3D domain family data 
was developed in collaboration with Juan Ranea. This approach was based on three 
considerations. Firstly, phylogenetic profiles consisting of a range of values, rather than 
presence/absence profiles are able to discern more subtle profile relationships (Date and 
Marcotte, 2003). Whilst presence/absence profiles are effective in bacterial genomes, 
which maintain low gene copy numbers, presence/absence profiles are less effective in 
eukaryotic genomes, since they do not account for the wide variation in gene copy 
number. Gene3D phylogenetic occurrence profiles were therefore developed to use 
occurrence profiles rather than presence/absence profiles in order to detect more subtle 
relationships in bacterial and eukaryotic genomes.
Secondly, the use of phylogenetic profiles based upon occurrences of conserved 
protein domains across complete genomes, rather than whole protein sequences, can 
detect functional relationships and protein interactions that are not detectable using 
phylogenetic profiles of whole proteins (Pagel et al., 2004). Gene3D phylogenetic 
profiles use the occurrence of CATH homologous superfamilies across complete 
genomes. At present, only CATH domain assignments are used to generate 
phylogenetic occurrence profiles, an obvious future expansion of this method would be 
to incorporate Pfam, Newfam and other domain assignments (via InterPro).
Thirdly, and perhaps most importantly, Gene3D phylogenetic occurrence 
profiles are derived not only from the occurrence of CATH homologous superfamilies 
across complete genomes, but since CATH homologous superfamily assignments have 
been clustered into domain family subclusters at several different levels of sequence 
identity (for example s30, s35, s40, s50, s60, s70, s80, s90, s95 and s i00 subclusters, 
described previously, see section 4.3.1.2), phylogenetic profiles are also constructed 
from each domain family subcluster level. This unique approach allows individual 
domain family subcluster profiles to be compared and clustered into statistically 
significant groups of profiles, thus identifying functional relationships and protein 
interactions between specific domain family subclusters. The building of Gene3D 
phylogenetic profiles is illustrated in figure 5.7 below.
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Figure 5.7 Building Gene3D Phylogenetic Profiles. An occurrence profile is derived 
from the number o f relatives identified in each genome from each CATH domain family 
and from each CATH domain family subcluster level within the domain family. Thus 
multiple profiles are generated from a single domain family that represent the 
occurrence o f domain family relatives and the occurrence of domain family subcluster 
relatives across complete genomes in Gene3D.
5.4.1 Pair Comparison of Profiles
Once phylogenetic profiles have been built for all CATH domain families and 
domain family subclusters in Gene3D, the similarity between each profile and all other 
profiles is calculated by an all versus all pairwise profile comparison, which uses two 
similarity criteria.
Firstly, for each profile pair, the Pearson correlation coefficient (Weisstein, 
1999) is calculated, pairs with a Pearson correlation coefficient of 0.8 or higher are
160
retained since this indicates significant similarity between these profiles. The Euclidean 
distance between each occurrence value in each genome of both profiles is also 
calculated. Profiles pairs are retained where the total Euclidean distance divided by the 
mean occurrence value across all genomes is less than or equal to 10. Although this is 
an arbitrary cut-off, in practice it was found to ensure that profiles which contain similar 
occurrence values across the genomes are retained, and that profiles representing 
domains present in similar species but with very different numbers of relatives in those 
species are eliminated, as they would have a prohibitively greater average Euclidean 
distance. This is illustrated in figure 5.8 below, where profiles with low Pearson 
correlation coefficients and high Euclidean distance are excluded from further analysis.
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Figure 5.8 Profile Pair Comparison. An all versus all pairwise profile comparison 
selects profile pairs that have a Pearson correlation coefficient o f 0.8 or higher (for 
example profile pair 1 and 4 (A) is rejected (Pi <0.8) whilst profile pair 1 and 5 (B) is 
retained (P2 > 0.8)), and a Euclidean distance/mean occurrence value less than or 
equal to 10 (for example profile pair 1 and 3 (C) is now rejected (Ei> 10) whilst profile 
pair 1 and 2 (D) is retained (E2 < 10)).
■  Profile 1 □  Profile 2D
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5.4.2 Degenerate Domain Family Subcluster Profiles
Gene3D profiles pairs that are retained (according to the selection criteria 
described above, see section 5.4.1) are further filtered to remove profile pairs that are 
degenerate, that is where a profile pair between profiles from a deeper subcluster level 
has already been retained. This reduces the number of profiles without reducing the 
correlation information they represent, and thus enables faster profile clustering 
(discussed below). For example, in a profile pair consisting of profile A (representing a 
domain family 1.10.10.10 s40 subcluster) and profile B (representing a domain family 
3.40.50.300 homologous superfamily); this profile pair is degenerate and can be 
removed if another profile pair has been retained containing profiles from 'deeper* 
subcluster levels. For example a pair consisting of the same profile A but a deeper 
profile subcluster than profile B (for example representing a domain family 3.40.50.300 
s35 subcluster profile, instead of the homologous superfamily). This filtering does not 
remove any informative pairwise relationships, but permits ‘fine tuning* of any 
identified correlated profile pairs to the deepest domain family subcluster level, and so 
may reveal correlations between different domain family members that may not be 
apparent when only comparing profiles of less depth.
5.4.3 Information Content of Profiles
In addition to removing degenerate profiles, profiles with low information 
content were also removed. Low information content profiles are those profiles 
containing domain occurrences in either very few or very many genomes. Profiles 
where domain relatives are only found in few genomes (less than 10 genomes) are more 
likely to be due to random occurrence, or horizontal transfer. Profiles where domain 
relatives are found in nearly all genomes are also of low information content, since 
these profiles do not show any distinctive phylogenetic pattern. Removal of these low 
information content profiles reduces the number of false-positive profile relationships 
(Pagel et al., 2004).
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5.4.4 Comparison of Gene3D Profiles to Randomised Null Models
The functional relevance of related profiles derived from Gene3D data could be 
obscured by correlations due to non-functional factors in our dataset such as correlations 
between profiles resulting from variations in the size of genomes in Gene3D or 
variations in the size of domain families in Gene3D. To account for these factors, 
Gene3D data was randomised in two different ways to generate two different null model 
datasets: genome shuffling and profile shuffling.
The genome shuffling null model dataset is used to estimate the effect that 
genome size has on profile correlations. This dataset is generated by randomly 
shuffling domain assignments between genomes, each genome receives the same 
number of domain assignments it had before, but because these assignments are made 
randomly, any correlations due to genome size are eliminated.
The profile shuffling null model dataset is used to estimate the effect of domain 
family size on profile correlations. This dataset was generated by shuffling each 
domain family s i00 subcluster profile, in effect assigning domain occurrences to 
random domain families. All other lower level profiles were then regenerated from this 
shuffled data. The resulting null model dataset effectively contains genomes with a 
generic set of domain assignments where any correlations due to domain family size are 
eliminated.
Pairwise Pearson correlation coefficients for each null model dataset were 
calculated, and the resulting distribution of Pearson correlation coefficients compared to 
Gene3D profile data. As can be seen in figure 5.9 below, neither of the null model 
datasets produced pairwise comparisons with significant Pearson correlation 
coefficients of 0.8 or higher, indicating that Gene3D profile pairs with Pearson 
correlation coefficients above 0.8 are likely to be due to the correlated evolution of 
functionally related or interacting protein domains, rather than effects of genome size or 
domain family size.
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Figure 5.9 Comparison of Gene3D Profile Correlations to Randomised Null Model 
Datasets. The distribution o f Pearson correlation coefficients in all versus all pairwise 
profile comparison for each o f three datasets: Gene3D profiles (red), genome shuffled 
null model profiles (blue) and profile shuffled null model profiles (green) is shown.
5.4.5 Gene3D Phylogenetic Occurrence Profile Clustering
Gene3D profiles are clustered into single linkage and multilinkage clusters on 
the basis of their Pearson correlation coefficients, using TCluster (described previously, 
see section 2.3.3). Multilinkage clustering produces tight clusters where all the member 
profiles in a cluster have a significant relationship to one another. This produces quite 
restrictive clusters, often containing less than ten member profiles (see figure 5.10 
below). Single linkage clustering produces much less restrictive clusters, since a 
member profile within a cluster only requires one significant relationship to an existing 
cluster member to be included in the cluster. As can be seen in figure 5.10 below, this 
can result in a giant cluster containing the vast majority of profiles. This giant cluster 
effect is typical of small world networks which have been observed in other biological 
data including protein domain co-occurrence, protein-protein interactions, and 
metabolic pathways (Wuchty and Almaas, 2005).
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Figure 5.10 Gene3D Profile Clustering. Representation of the network o f profile 
clusters seen using single linkage. The figure shows clustering o f eukaryotic profiles 
from Gene3D produced using the BioLayout program (Goldovsky et al., 2005). 
Labelled clusters indicate profiles representing proteins involved in 1: Actin and VCP- 
like ATPases, 2: Chaperones and Cytoskeleton, 3: DNA Replication and Repair, and 4: 
DNA Topoisomerase and Elongation Factor G.
5.4.6 Functional Clusters revealed by Gene3D Phylogenetic Occurrence 
Profile Clustering
The 1277 CATH homologous superfamilies assigned in Gene3D produced 2.1 
million individual domain family and domain family subcluster profiles, providing 2.2 
billion possible pairwise profile comparisons. These profiles were analysed in three 
analysis groups: eukaryotic profiles, prokaryotic profiles and eukaryotic/prokaryotic 
profiles. After the filtering process, the number of profiles with significant pairwise 
relationships is significantly reduced. For example, the eukaryote/prokaryote analysis 
group contains 1,255 profiles found in 4,029 profile pairs.
5.4.6.1 Profile Clusters Representing known Functional Groups
The functional significance of clusters was analysed using GO functional 
information from Gene3D. For each profile in a cluster, the GO functional terms
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associated with the proteins containing the domain assignments that built the profile 
were used to identify the functions represented by the profile. Profile clusters that 
represent proteins already known to be functionally related were identified in all three 
analysis groups. These clusters contained either profiles representing different protein 
domains from the same protein, or profiles representing protein domains from different 
proteins.
The eukaryote/prokaryote dataset consists of 1,255 profiles that are found in 
4,029 profile pairs. These profiles are clustered into 80 single linkage and 214 
multilinkage clusters. An example identified in eukaryotic/prokaryote multilinkage 
clustering is the urea amidohydrolase multilinkage cluster, which contains four profiles, 
all of which represent domains occurring in urea amidohydrolase. Urea amidohydrolase 
catalyses the hydrolysis of urea to ammonia and carbamate. The enzyme consists of 
three protein subunits: alpha, beta and gamma (Mobley et al., 1995). Profiles 
representing both the urease alpha domain (CATH code 2.30.40.10) and the metal- 
dependent hydrolase domain (CATH code 3.20.20.140) in the urease alpha protein 
cluster with profiles representing the urease beta domain (CATH code 2.10.150.10) in 
the urease beta protein and the urease gamma domain (CATH code 3.30.280.10) in the 
urease gamma protein. Profiles in this cluster represent domain family relatives in 36 
genomes, of which 2 are eukaryotic (A. thaliana and S. pombe) and 34 are prokaryotic. 
Interestingly, whilst the domain profiles from urease beta and gamma subunits are 
homologous superfamily level profiles, the profiles representing the two domains in the 
urease alpha subunit are both domain family s30 subcluster profiles, implying that these 
specific domain family s30 subclusters are functionally and evolutionarily more closely 
linked, as might be expected from domains occurring in the same protein.
Initial analysis of the eukaryotic dataset, single linkage clustering produced a 
giant cluster, as can be seen from figure 5.10 above. In addition, several interesting 
clusters were identified, containing profiles representing Actin/VCP-like ATPases; 
Chaperones/Cytoskeleton; DNA Replication/Repair; and DNA Topoisomerase 
/Elongation Factor G. These clusters can be seen in figure 5.10 above. The DNA 
topoisomerase/elongation factor G cluster contains three profiles, shown in figure 5.11 
below.
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Figure 5.11 Eukaryotic Cluster Domain Occurrence Profiles. Domain occurrence 
in each species represented in the eukaryotic dataset for the three profiles in the DNA 
Topoisomerase/Elongation Factor G cluster.
Two of these profiles represent domains found in the same protein, elongation 
factor G (CATH codes 3.40.50.670 and 3.90.199.10), whilst the remaining profile 
represents a domain found in DNA topoisomerase (CATH code 3.30.970.10). The 
domain occurrences for each profile in the cluster are shown in figure 5.11 below. Both 
proteins represented by profiles in this cluster are involved in protein synthesis, whilst 
elongation factor G catalyses the translation reaction in the ribosome, DNA 
topoisomerase unpackages/repackages the DNA. Experimental evidence suggests that 
there may be a functional association between DNA topoisomerase and protein 
translation regulation. Rapisarda et al., (2004), describe the repression of hypoxia- 
inducible factor 1 (HIF-1) protein accumulation by the topoisomerase poison topotecan 
(TPT). The authors show that TPT inhibits HIF-1 translation, and that topoisomerase is 
required for this inhibition. The authors conclude that a novel pathway connects 
topoisomerase-dependent signalling events and the regulation of HIF-1 protein 
expression and function. The identification of a cluster containing domains from 
topoisomerase and elongation factor G provides potential insight into the mechanisms in 
this novel pathway.
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5.4.6.2 Deep Domain Family Subcluster Profiles
The depth of the profiles in a cluster is indicative of the closeness of the 
evolutionary and functional relationships between the domain families and subfamilies 
represented in the cluster. The deeper a profile, the higher the sequence identity 
between the relatives, indicating a higher level of sequence conservation across the 
domain subcluster represented in the profile. A cluster containing an s70 profile, for 
example, represents domains with an extremely high degree of sequence conservation 
across the genomes. This is indicative of domains that are intimately evolutionarily or 
functionally linked. The number of profiles at different depths in the 
eukaryote/prokaryote dataset is shown in table 5.0 below. As the table shows, there are 
six profiles that represent domain family s70 subclusters.
Table 5.0 Depth of Profiles in Eukaryote/Prokaryote Dataset. The number of 
profiles o f each depth (subcluster level) is indicated. Note that there are no profiles 
that represent domain family subclusters levels deeper than s70.
Profile Depth Frequency
Homologous Superfamily 39
s30 193
s35 109
s40 78
s50 45
s60 14
s70 6
This section describes one of the clusters containing a domain family s70 
subcluster profile in the eukaryote/prokaryote dataset, which can be used to predict 
probable functional relationships of profiles representing domains in proteins that have 
no known function. The cluster contained two profiles. One profile represented a 
domain family s70 subcluster of the CATH homologous superfamily 2.20.29.10, 
functionally annotated as 'translocation elongation factor G’ (a G protein factor that 
catalyses the translocation of peptidyl-tRNA from the A site to the P site of the 
ribosome during protein synthesis). The other profile in the cluster represented a 
domain family s30 subcluster of CATH homologous superfamily 3.40.50.610, 
functionally annotated as 'conserved hypothetical protein*. Both these profiles have 
identical species distributions across 32 genomes, and represent 37 domain assignments
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to 37 different proteins across the 32 genomes, and 34 domain assignments to 34 
different proteins across the 32 genomes respectively. These domain assignments 
occurred in different proteins in each genome, indicating that within each of the 32 
genomes, these proteins were functionally associated and in addition, that the 34 
conserved hypothetical proteins were likely to be specifically functionally associated 
with a highly conserved 2.20.29.10 domain family s70 subcluster found only in 
elongation factor G. Although the proteins containing domains represented in the 
domain family s30 subcluster have no known function, and are simply annotated as 
‘conserved hypothetical proteins’, Gene3D phylogenetic profile clustering provides 
compelling evidence that predicts these proteins are intimately associated with 
elongation factor G, an essential protein involved in the elongation process during 
protein synthesis.
5.4.7 User Defined Query Profiles
Gene3D profile clusters can also be searched to identify proteins that have a 
functional relationship to user-defined data. In a test example, Gene3D profiles were 
searched to find proteins that may have a significant functional relationship to ras (a 
well studied protein with an established role in eukaryotic signalling cascades). Query 
phylogenetic profiles were generated using ras occurrences across eight eukaryotic 
genomes. In these profiles the user defined the subset of, in this case, eight species 
which made up the occurrence profile, and manually assigned ras occurrences to these 
genomes. However, the user could have chosen any subset of species from which to 
generate the query profile, and any method of defining protein or domain occurrence in 
their chosen genomes. Gene3D profiles were searched to identify significantly similar 
Gene3D profiles to the query profile, by calculating Pearson correlation coefficients and 
Euclidian distances between the ras query profiles and Gene3D profiles. Single linkage 
clustering of eukaryotic profiles and the user-defined ras query profiles produced a ras 
cluster containing the ras query profile and 17 additional profiles, these are shown in 
table 5.1 below.
From table 5.1 it can be seen that three profiles in the ras cluster represent 
proteins directly involved in signal transduction and the activation of transcription. Six 
profiles represent proteins involved in transcriptional regulation, including 
developmental transcription regulators with Homeobox domains and Polycomb
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domains. Proteins with these domains are already known to be involved in embryonic 
development and regulation of cell cycle control acting through ras-mediated signalling 
pathways (Maclean et al., 2005; Jacobs et a l, 1999).
The presence of profiles representing proteasome 20S subunit proteins in this 
cluster indicates a link between ras and the proteasome. /tas-activated kinases are 
known to regulate levels of other proteins (for example c-Myc (Sears, 2004) and 
retinoic acid receptors (Srinivas et a l, 2005)) via phosphorylation and induction of 
ubiquitin-proteasome protein degradation. Ras has also been shown to inhibit 
proteasome mediated degradation by promoting the stabilisation of otherwise degraded 
proteins, for example ras-induced stabilisation of p21 cyclin-dependent kinase inhibitor 
(Coleman et a l , 2003), however these effects are not thought to involve direct 
interaction between ras and the proteasome.
Recently, solute carrier family 4, member 11 has been shown to function as an 
Na/borate co-transporter involved in cell cycle control (Romero, 2005), raising the 
possibility that solute carrier family 4, member 1 represented in the ras profile cluster 
may also be involved in cell cycle control, possibly mediated by ras.
Interestingly, three profiles in the ras profile cluster represent a total of 60 
eukaryotic proteins that have no known function. The domain families that generated 
these three profiles (shown in table 5.1) are the protein tyrosine phosphatase domain (26 
proteins), fibronectin type 3 domain (9 proteins), and the NAD(P)-binding Rossmann- 
like domain (25 proteins). Since protein tyrosine phosphatase domains may be 
regulated by, or themselves regulate, ras (Zhang et a l, 2004), and cellular attachment to 
extracellular fibronectin type 3 domains has been shown be abolished by ras (Fang et 
a l, 1994), the 60 proteins of unknown function represented by these three profiles make 
intriguing targets for experimental study to determine the nature of any functional 
association to ras.
Table 5.1 Profiles in the Ras Query Cluster. The 17 profiles that clustered with the 
user-defined Ras query profiles.
CATH
Depth of # Relatives
Domain Functional Description
Profile
Code
in Profile
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Homologous
Superfamily
1.20.1050.20 109
Signal transduction/transcription 
activation
Homologous
Superfamily
2.60.40.630 104
Signal transduction/transcription 
activation
Homologous
Superfamily
1.10.532.10 93
Signal transduction/transcription 
activation
s30 1.20.58.30 47 Solute carrier family 4, member 1
s30 1.20.920.10 60 Bromodomain: transcription regulation
s30 3.40.50.2020 23 Uridine kinase
s30 3.40.50.720 25 NAD(P)-binding Rossmann-like domain
s30 3.90.190.10 26 Protein tyrosine phosphatase domain
s30 3.90.830.10 20 Vesicle transport related
s30 1.10.10.60 25 Homeobox: transcriptional regulation
s30 1.10.183.10 60 Myosin heavy chain
s35 2.60.40.30 9 Fibronectin type 3 domain
s35 3.60.20.0 25 Proteasome 20S subunit
s50 3.90.490.0 16 p33 ING1 tumour suppressor-like
s50 3.30.40.10 19 Polycomb: transcription regulation
s70 1.10.10.60 37 Homeobox: transcription regulation
s70 1.10.10.60 88 Homeobox, transcription regulation
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5.5 Sum m ary
Phylogenetic profiles built from Gene3D data have been shown to identify size 
dependent and universal CATH homologous superfamilies in prokaryotic genomes. A 
subset of universal size-dependent CATH homologous superfamilies (just 9% of CATH 
homologous superfamilies in prokaryotes) has been shown to account for 56% of 
prokaryotic genome domain assignments. The relationship between genome size and 
domain occurrence of metabolic domain families and regulatory domain families within 
these universal size-dependent CATH homologous superfamilies appears to follow 
microeconomic principles that may underlie determination of the size of prokaryotic 
genomes.
A novel protocol using Gene3D domain family subcluster phylogenetic 
occurrence profiles has been designed and shown to identify novel functionally 
associated domain clusters across complete genomes. The use of domain family 
subcluster occurrence profiles allows functional associations between specific domain 
family subclusters to be identified. Initial analysis of these clusters shows encouraging 
results. The method has been shown to identify known functionally associated proteins, 
as well as novel functionally associated proteins. These profile clusters can also be 
searched for significant matches to user-defined occurrence profiles, in which the user 
can specify the species distribution and genome occurrence in their own query profile. 
Initial analysis using user-defined ras (a well established signalling cascade protein) 
occurrence profiles identifies known ras-associated signal transduction and 
transcription regulators. In addition, three novel profiles representing a total of 60 
functionally uncharacterised eukaryotic proteins have been identified as functionally 
associated with ras, and would make good experimental targets for further analysis.
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CHAPTER SIX
Discussion and Future Work
6.1 Discussion
Gene3D is the first domain architecture database which characterises completely 
sequenced genomes by clustering into protein families and then assigning structural and 
sequence domain families from well characterised resources (CATH, Pfam). 
Throughout this thesis this resource is extensively described and used for genomic 
analysis to identify evolutionary relationships between individual components of 
completely sequenced genomes.
The identification of power law like behaviour in the size distributions of protein 
families, domain families and domain architecture families underlines the evolutionary 
relationships of proteins and protein domains in genomes, where few families dominate 
genome-space. The re-use of protein domains to form novel domain architectures in 
different protein families provides an illustration of the evolutionary strategy applied by 
Nature in genome evolution, whereby 50% of domain family assignments are common 
to all three Kingdoms of life, whilst only 16% of protein families are common to all 
three Kingdoms of life.
The power law distributions described in Gene3D can be exploited in several 
ways. Analysis of domain family distribution across multiple genomes has been used to 
estimate the number of folds in Nature. Structural genomics initiatives have already 
exploited Gene3D to identify novel domain families and prioritise structural genomics 
targets. Novel fold groups and structural families identified by analysing Gene3D data 
can be prioritised by several criteria including species distribution and fold group size, 
according to the strategic requirements of the different structural genomics consortia. 
Given the limited resources of structural genomics initiatives, it is vital to provide the 
best possible strategy for mapping fold space. The expansion of certain domain 
families in the genomes illustrates the bias in current protein structure classifications, 
where some domain families appear to be highly under-represented. Identification of
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these expanded domain families can be used to select further targets to allow homology 
modelling of a greater proportion of the genome sequences.
The expansion of CATH domain families with sequences from completed 
genomes significantly increases the amount of functional data associated with these 
families. This data revealed those families in which multiple functions had evolved and 
highlighted the importance of considering domain context when inheriting functional 
properties between domain relatives. Analysis using Gene3D therefore allows domains 
in different contexts having different functional properties to be targeted for structure 
determination to reveal the structural mechanisms by which function evolves.
Analysis also identified 154,965 genscan sequences belonging to protein 
families containing known proteins, indicating that at least 57% of these genscan 
predictions are likely to be real protein sequences, thus warranting further study. This 
shows that gene predictions in eukaryotic genomes can be assessed for their reliability 
using protein family and domain assignment data.
The relationship between domain family frequency and genome size in bacteria 
was analysed. The identification of 85 universal, size-dependent domain families that 
are strongly correlated with bacterial genome size, representing just 9% of domain 
families but accounting for 56% of domain assignments in bacterial genomes highlights 
the dominance of a small number of domain families in bacterial genome evolution. 
This data adheres to microeconomics principles that can provide an explanation of the 
correlation between domain family usage and genome size in prokaryotes. The balance 
between the selection pressures of reproductive efficiency promoting small genomes, 
and environmental response and exploitation capacity promoting larger genomes, acts to 
enforce a balance between metabolic and regulatory genes a highly competitive system.
To attempt to understand the complex relationships between domain distribution 
across genomes and protein functional networks, a novel phylogenetic profile method 
for identifying functionally associated clusters of proteins, based upon domain family 
subcluster occurrence profiles was developed. This protocol enables identification of 
protein clusters sharing discrete domain distributions across genomes, which are 
indicative of functional and evolutionary associations. In addition to identification of 
clusters containing proteins with previously reported functional associations, novel
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clusters containing proteins with no previously reported functional association were also 
identified. User-defined occurrence profiles have been used to search Gene3D profiles 
for proteins with functional associations to the user-defined query profile. Since these 
user-defined query profiles can be built according to the users specific requirements (in 
terms of species distribution and domain/protein occurrence identification method), they 
provide a readily accessible and easily interrogated resource. Initial analysis using ras 
query profiles (a well established signal transduction cascade protein) identified proteins 
known to be involved in ras-associated systems, such as signal transduction and 
transcription regulation. Additionally, 60 eukaryotic proteins with presently unknown 
functions were identified that are likely to have a functional association with ras. These 
proteins would make good targets for further study.
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6.2 Future Work
Expansion of the Gene3D resource to include all completely sequenced genomes 
as they are completed would provide a more comprehensive resource for biologists 
interested in particular genomes. Addition of novel archaea and eukaryota genomes 
will permit a more rigorous analysis of these Kingdoms. Development of an efficient 
protocol for the automated inclusion of these additional genomes would therefore be of 
benefit.
As protein sequence databases increase in size, they produce an increase in the 
sensitivity of profile based methods of domain assignment. Additionally, source 
databases (for example Pfam and CATH) are updated; this necessitates regular updating 
of Gene3D data not only to incorporate expansions to domain family classifications, but 
also to reflect increases in performance of profile based methods. Development of 
efficient, fully automated protocols for updating domain assignments would be 
extremely beneficial to the resource.
The recent addition of Gene3D to the InterPro resource (which integrates major 
protein family classifications and provides regular mappings from major resources 
(UniProt, PROSITE, PRINTS, Pfam, ProDom, SMART, TIGRFAMs, PIR SuperFamily 
and SUPERFAMILY)) permits Gene3D families to be integrated with definitions from 
other InterPro member databases and provides integration between InterPro domains 
and the CATH classification. Gene3D domain mappings can thus be supplemented 
with domain mappings from InterPro to further increase genome coverage and perhaps 
better define domain architectures, by including resources such as SCOP and 
TIGRFAMs. In addition, building HMMs from the largest Newfam domain families 
identified using Gene3D, would also contribute to increasing genome coverage and 
enable additional complete domain architectures to be identified. The use of recent 
profile-profile HMMs methods for the identification of distant relatives, which have 
been shown to be more sensitive than the HMM methods used in this thesis, would also 
increase domain assignment genome coverage, and hence allow a greater 
characterisation of completed genomes.
A program to compare domain strings using dynamic programming would be 
advantageous in identifying protein families having similar domain architectures, and
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identifying similar domain architectures that have been defined using different domain 
family resources. This program could also help to identify protein families in Gene3D 
that contain multiple domain architectures. Although low in number, untangling these 
protein families may produce insight into the evolution of domain architectures. In 
order to facilitate identification of specific domain architecture families, HMMs 
representing complete domain architectures and partial domain architectures that are 
highly recurrent in the genomes should be developed. These HMMs would not only 
allow rapid classification of new genomes, but can be used to untangle protein families 
containing poorly defined domain architectures.
Further analysis of domain family subcluster phylogenetic profile correlations 
may permit identification of the mechanisms underlying the evolution of domain 
networks in bacterial genomes, and also identify biologically and medicinally important 
clusters. Inclusion of Gene3D derived data, such as domain occurrence profile cluster 
information, and phylogenetic profiles derived from protein families and domain 
architecture superfamilies, as well as addition of protein-protein interaction data would 
make the Gene3D resource more useful to biologists. However, it is important that the 
database and user interface is capable of rapid retrieval of user query results. The 
addition of genomes, domain assignments, additional functional resources and data 
derived from Gene3D analysis will only be of benefit if this data can still be accessed 
quickly.
With the recent advances in the field of bioinformatics, it might be wise, when 
considering the massive amount of different associations gleaned from current genomic 
data, to remember that currently we can only see a very tiny fraction of genome space. 
Only by exploring this genome space further can we hope to fully comprehend the 
myriad of evolutionary processes involved in the struggle for life.
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APPENDICES
Appendix I — Genome Coverage in Gene3D. Coverage shown for each genome in Gene3D, 
identified by NCBI Taxonomy taxon identifier and organism name. Coverage is calculated as percentage 
of total proteins/residues in genome assigned only a CATH domain (Class 1-4), overlapping CATH and 
Pfam domains, and only a Pfam domain. The percentage of total annotated proteins/residues is also 
shown.
Taxon
Id Organism Kingdom
% Coverage by Total Proteins % Coverage by Total Residues
CATH CATH & Pfam Pfam
Total
Annotated CATH
CATH 
& Pfam Pfam
Total
Annotated
56636 Aeropyrum pemix A 36.4 1.5 14.8 52.7 31.7 0.0 11.2 42.9
2234 Archaeoglobus fulgidus A 41.4 2.8 17.3 61.5 36.6 0.0 14.0 50.6
54091 Haiobacterium sp. NRC-1 A 37.4 2.6 15.6 55.6 32.2 0.0 12.1 44.4
2190 Methanocaldococcusannaschii A 40.0 2.4 19.2 61.5 33.1 0.0 14.3 47.5
190192 Methanopyrus kancNeri AV19 A 35.4 3.7 26.9 66.0 28.8 0.0 19.7 48.5
188937 Methanosardna aceth/orans C2A A 36.2 3.9 24.0 64.1 31.3 0.0 18.3 49.7
1929S2 Methanosardna maze! Goal A 36.0 4.3 27.4 67.7 31.3 0.0 20.7 52.1
187420 Methanothermobacterthermautotroph. A 42.3 2.3 17.2 61.9 35.4 0.0 14.1 49.6
13773 Pyrobaculum aerophilum A 32.0 2.6 22.5 57.0 30.7 0.0 17.9 48.6
29292 Pyrococcus abyssi A 43.3 2.9 21.8 68.0 35.3 0.0 15.7 51.0
186497 Pyrocoocus furlosus DSM 3638 A 38.7 4.2 30.0 72.9 34.9 0.0 23.1 58.1
53953 Pyrocoocus horikoahii A 39.3 2.6 20.7 62.6 32.9 0.0 15.1 48.0
2287 Suifolobus solfataricus A 36.1 2.5 30.7 69.3 32.1 0.0 24.4 56.5
111955 Sulfotobus tokodaii A 34.5 2.5 28.4 65.4 31.8 0.0 22.6 54.4
2303 rhermoplasma addophHum A 46.5 2.0 19.4 67.9 38.4 0.0 16.0 54.4
50339 rhermoplasma volcanium A 45.5 1.9 18.9 66.3 38.1 0.0 15.6 53.7
181661 Agrobacterium tumefadens C58 Cereon B 45.5 5.1 28.6 79.1 37.8 0.0 22.6 60.4
180835 Agrobacterium tumefadens C58 U.Wash B 44.9 4.7 28.2 77.7 38.3 0.0 22.9 61.2
53363 Aquifex aeoiicus B 48.4 3.1 19.8 71.3 38.5 0.0 14.1 52.6
86665 BadHus halodurans B 42.7 2.4 16.1 61.1 36.2 0.0 13.4 49.6
1423 BadHus subtHte B 42.6 2.6 16.3 61.4 36.7 0.0 13.9 50.6
206672 Bifidobacterium iongum NCC2705 B 44.2 5.3 27.9 77.3 34.3 0.1 19.9 54.2
139 Borrelia burgdorferi B 26.3 1.2 18.3 45.8 24.7 0.0 15.2 39.8
375 Bradyrhizobium japonicum B 43.0 3.8 25.5 72.3 34.6 0.0 20.6 55.2
29459 Brucella melitensis B 43.8 5.0 27.9 76.7 38.4 0.1 23.1 61.6
204722 Brucella suis 1330 B 41.1 4.6 26.9 72.6 38.5 0.1 23.2 61.7
135842 Buchnera aphidicola B 58.1 8.7 30.2 97.0 51.3 0.2 23.4 74.9
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198804 Buchnera aphkJicola str. Sg B 56.7 8.8 31.4 96.9 50.2 0.2 24.7 75.1
107806 3uchnera sp. APS B 1 63.8 3.1 16.6 83.4 50.8 0.0 10.4 61.2
197 Campylobacter Jejuni B 45.5 2.6 18.1 66.1 35.8 0.0 13.6 49.4
190650 Caulobacter crescentus CB15 B 44.8 4.6 25.5 75.0 39.0 0.1 20.2 59.2
33560 Chlamydia muridarum B 43.6 2.2 18.7 64.4 33.0 0.0 12.6 45.6
B13 Chlamydia trachomatis B 42.9 2.7 20.2 65.8 33.0 0.0 14.5 47.5
115711 ChlamydophHa xieumoniae AR39 B 36.1 1.9 18.3 56£ 29.5 0.0 13.7 43.2
115713 ChlamydophHa xieumoniae CWL029 B 38.1 2.0 19.4 59.5 29.7 0.0 13.8 43.5
138677 ChlamydophHa xieumoniae J138 B 37.6 2.0 19.2 58.7 29.4 0.0 13.7 43.0
194439 Chkxobium tepidum TLS B 39.5 4.8 23.0 67.3 38.9 0.1 20.5 59.4
1488 Clostridium acetobutylicum B 39.6 5.6 26.9 72.1 34.2 0.1 21.8 56.1
1502 Clostridium perfringens B 39.0 6.6 29.5 75.1 34.3 0.1 24.1 58.5
212717 Clostridium tetani E88 B 38.6 7.0 31.1 78.6 32.6 0.1 23.6 56.2
196164 Corynebacterium effidens YS-314 B 39.4 4.8 26.1 70.3 32.6 0.0 20.4 53.0
196627 Corynebacteriumjlutamicum B 41.9 4.3 24.9 71.1 34.8 0.0 20.2 55.1
1299 Deinococcus radiodurans B 42.9 2.1 14.4 59.4 34.4 0.0 10.2 44.6
199310 Escherichia coll CFT073 B 36.0 4.6 30.5 71.1 34.2 0.1 27.3 61.6
33333 Escherichia coll K12 B 45.4 2.7 19.3 67.4 37.1 0.0 15.9 53.0
33334 Escherichia coli 0157:H7 B 37.5 4.0 28.7 70.3 32.9 0.0 23.7 56.6
155864 Escherichia coii 0157:H7 EDL933 B 39.7 2.3 19.3 61.3 33.2 0.0 15.6 48.8
190304 Fusobacterium nudeatum B 37.1 5.3 27.5 68.9 32.7 0.1 23.1 55.8
71421 Haemophilus influenzae Rd B 49.7 2.9 20.0 72.5 41.5 0.0 14.9 56.5
35962 Helicobacter pylori 26695 B 38.6 2.4 19.2 60.2 31.0 0.0 15.1 46.1
35963 Helicobacter pylori J99 B 40.7 2.5 20.6 63.8 31.6 0.0 15.6 47.3
220668 Lactobacillus plantarum WCFS1 B 42.7 5.7 27.9 76.3 36.4 0.1 23.9 60.3
1360 Lactococcus lactis subsp. lactte B 46.8 2.2 16.2 65.2 37.8 0.0 12.5 50.4
189518 Leptospira interrogans serovar tai 56601 B 27.4 3.2 17.3 48.0 27.6 0.0 16.6 44.2
1642 Listeria innocua B 41.7 5.5 28.7 75.9 35.7 0.1 23.4 59.2
169963 Listeria monocytogenes EGD-e B 44.4 6.1 29.6 80.1 37.9 0.1 24.5 62.4
381 Mesorhizobium loti B 45.1 1.9 14.3 61.3 36.6 0.0 11.6 46.2
1769 Mycobacterium leprae B 48.3 2.4 14.0 64.6 40.7 0.0 9.5 50.2
B3331 Mycobacterium tuberculosis CDC1551 B 38.1 4.2 25.9 68.2 34.2 0.0 19.1 53.3
33332 Mycobacterium tuberculosis H37Rv B 44.3 2.0 16.1 62.4 34.7 0.0 11.0 45.8
2097 Mycoplasma genitalium B 50.0 3.9 18.6 72.5 34.9 0.0 10.4 45.3
28227 Mycoplasma penetrans B 36.8 5.7 18.1 60.7 25.1 0.0 14.1 39.3
2104 Mycoplasma pneumoniae B 38.6 3.2 22.4 64.2 27.8 0.1 12.2 40.1
2107 Mycoplasma pulmonis B 37.2 6.8 26.1 70.1 28.3 0.1 18.4 46.8
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12258dNeisseria meningitidis MC58 B 38.1 4.9 28.6 71.7 35.5 0.1 25.1 60.6
122587 Neisseria meningitidis Z2491 B 37.9 4.7 28.6 71.2 35.7 0.1 25.4 61.2
103690 Nostocsp. PCC 7120 B 34.6 5.4 23.1 63.0 31.5 0.1 17.7 49.2
182710 Oceanobacillus iheyensis B 42.0 5.3 28.7 75.9 38.4 0.1 24.3 62.7
747 Pasteurella multocida B 49.7 3.0 20.0 72.7 39.5 0.0 14.2 53.7
208964 Pseudomonas aeruginosa PA01 B 47.7 2.8 17.7 68.1 37.0 0.0 14.3 51.3
160488 Pseudomonas putida KT2440 B 43.2 5.3 29.8 78.3 36.0 0.0 24.6 60.6
305 Ralstonia soianacearum B 42.2 4.3 27.1 73.7 33.9 0.0 22.0 56.0
781 Rickettsia conorii B 29.4 4.2 23.3 56.9 31.3 0.1 22.5 53.9
782 Rickettsia prowazekii B 47.4 3.1 21.1 71.6 36.7 0.0 14.8 51.5
90370 Salmonella enterica B 37.4 5.1 32.0 74.5 33.8 0.1 28.1 62.0
99287 Salmonella typhimurium LT2 B 40.7 5.6 34.7 81.1 35.4 0.1 29.6 65.0
211586 Shewaneila oneidensis MR-1 B 37.9 5.7 28.6 72.2 32.8 0.0 23.8 56.6
198214 Shigella flexneri 2a str. 301 B 41.0 4.9 37.9 83.8 36.0 0.1 29.6 65.6
382 Sinorhizobium meliloti B 45.8 4.7 28.2 78.8 38.5 0.0 23.0 61.6
158878 Staphylococcus aureus Mu50 B 40.0 5.7 29.5 75.2 36.0 0.1 25.4 61.5
196620 Staphylococcus aureus MW2 B 40.3 5.3 30.3 75.9 36.2 0.1 25.3 61.6
158879 Staphylococcus aureus N315 B 42.1 5.9 29.9 77.9 37.1 0.1 25.5 62.7
176280 Staphylococcusspidermidis B 40.4 5.2 27.7 73.3 37.8 0.1 24.1 62.0
208435 Streptococcus agalactiae 2603V/R B 41.4 5.6 28.5 75.6 37.1 0.1 23.1 60.2
211110 Streptococcus agalactiae NEM316 B 42.5 6.1 27.2 75.7 36.3 0.1 21.3 57.7
210007 Streptococcus mutans LIA159 B 44.0 6.1 26.3 76.5 39.6 0.1 21.8 61.5
171101 Streptococcus pneumoniae R6 B 41.3 6.3 26.9 74.4 38.2 0.1 22.9 61.2
170187 Streptococcus pneumoniae TIGR4 B 40.2 6.0 27.4 73.5 37.8 0.1 23.5 61.4
160490 Streptococcus pyogenes M1 GAS B 42.9 6.5 28.8 78.1 37.4 0.1 23.2 60.6
186103 Streptococcus pyogenes MGAS8232 B 40.8 6.0 27.3 74.1 36.5 0.1 23.3 59.9
198543 Streptococcus pyogenes phage 315.6 B 40.0 5.8 27.6 73.5 35.8 0.1 23.4 59.3
100226 Streptomyces coelicolor A3(2) B 41.8 4.3 23.9 70.1 33.5 0.0 18.3 51.8
1148 Synechocystis sp. PCC 5803 B 43.5 3.0 15.3 61.8 34.2 0.0 10.5 44.8
119072 TTiermoanaerobactertengcongensis B 39.2 6.7 28.7 74.6 35.7 0.1 22.9 58.7
197221 Thermosynechococcus Blongatus BP-1 B 40.2 6.0 26.3 72.5 35.8 0.1 21.0 56.9
2336 Thermotoga maritima B 45.6 2.9 20.1 68.6 36.8 0.0 14.4 51.2
160 Treponema pallidum B 40.1 1.9 15.2 57.1 29.7 0.0 10.1 39.8
2130 Ureapiasma urealyticum B 40.6 2.4 14.0 57.0 26.1 0.0 7.7 33.8
DOO Vibrio choierae B 41.1 2.8 17.5 61.4 34.1 0.0 13.5 47.6
164609 Wigglesworthia brevipalpis B 52.1 7.3 31.2 90.7 48.2 0.2 24.7 73.1
190486 Xanthomonas axonopodis B 42.2 5.2 26.9 74.3 35.6 0.0 20.9 56.6
190485 Xanthomonas campestris B 42.3 5.4 27.9 75.5 35.8 0.0 21.5 57.4
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160492 Kyletta fastidiosa 9a5c B 33.9 2.2 13.2 49.3 33.2 0.0 11.3 44.6
183190 Xylella fastidiosa Temeculal B 40.2 6.3 28.0 74.5 36.0 0.1 21.9 58.0
532 Yersinia pestis B 40.1 5.2 34.0 79.3 34.6 0.1 27.2 61.9
187410Yersinia pestis KIM B 38.4 5.1 32.0 75.4 34.2 0.1 26.4 60.6
7165 Anopheles gambiae E 40.8 7.0 19.9 67.8 26.4 0.0 14.3 40.8
3702 Arabidopsis thaliana E 40.8 5.9 26.1 72.9 27.1 0.0 16.2 43.4
5239 Caenorhabditis eiegans E 33.0 5.7 26.2 65.0 21.8 0.0 17.3 39.2
7955 Dank) redo E 42.1 5.6 11.6 59.2 37.0 0.0 11.7 48.7
7227 Drosophila melanogaster E 39.9 6.7 21.4 67.9 22.7 0.0 13.8 36.5
5035 Encephalitozoon cuniculi E 36.4 3.3 18.6 58.4 24.0 0.0 12.1 36.2
55529 Quillardia theta polymorph E 39.8 4.3 23.2 67.2 32.3 0.1 14.9 47.3
9606 Homo sapiens E 41.8 9.0 19.3 70.2 27.9 0.0 14.2 42.1
10090 Mus musculus E 45.6 10.2 18.5 74.3 33.5 0.0 14.6 48.1
36329 Plasmodium falciparum 3D7 E 28.3 3.3 20.8 52.5 9.8 0.0 11.4 21.2
10116 Rattus norvegicus E 35.2 5.4 13.1 53.7 24.1 0.0 9.7 33.9
4932 Saccharomyces cerevisiae E 36.9 3.6 16.5 57.0 21.6 0.0 11.1 32.7
4896 Schizosaccharomycesxxnbe E 40.5 5.9 27.2 73.7 25.7 0.0 17.4 43.1
31033 laldfugu rubripes E 32.9 5.3 13.5 51.7 30.6 0.0 14.4 45.1
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Appendix II -  Universal Domain Families in Gene3D. The 212 universal CATH and 
Pfam domain families, where each domain family is universal to all three Kingdoms in 
Gene3D. Universal domain families are found to occur in a minimum o f 70% o f the 
genomes from a Kingdom, so these domain families are found in at least 70% o f the 
genomes o f each Kingdom in Archaea, Bacteria and Eukaryota. Domain families 
denoted by their CATH or Pfam identification are shown with the percentage o f 
genomes in each Kingdom in which they are identified: %A(rchaea), %B(acteria) and
%E(ukaryota) and the most common GO function associated with the domain family.
Domain
Family %A %B %E 0 0  Function
1.10.10.10 100 98 100 regulation of transcription; DNA-dependent;transcription factor activity
1.10.10.250 100 100 93 structural constituent of ribosome;intracellular; ribosome
1.10.10.60 100 81 100 regulation of transcription; DNA-dependent;transcription factor activity
1.10.1030.10 81 82 79 carbamoyl-phosphate synthase actMty,ATP binding;cytopiasm
1.10.1060.10 100 83 79 electron transport; electron transporter activity
1.10.1140.10 100 93 93 ATP-binding and phosphorylation-dependent chloride channel activity
1.10.1160.10 88 99 86 giutamate-tRNA Kgase acth/ity-ATP bindlng;glutamyl-tRNA aminoacyiation
1.10.15.10 100 94 86 base-excision repair; DNA binding
1.10.150.30 81 99 79 intracellular; DNA binding
1.10.260.10 100 88 86 DNA binding;regulation of transcription; DNA-dependent
1.10.260.30 100 99 71 RNA binding;GTP binding;signal recognition particle
1.10.275.10 100 93 79 catalytic activity;lyase activity
1.10.287.10 100 99 93 protein biosynthesis;structural constituent of ribosome
1.10.287.310 100 99 93 structural constituent of ribosome;intracellular; ribosome
1.10.287.40 81 100 71 tRNA ligase activity;serine-tRNA ligase activity;ATP binding
1.10.290.10 100 98 86 DNA topoisomerase type I activity;nucieic acid binding
1.10.340.10 100 96 86 base-excision repair; DNA binding
1.10.40.30 94 92 71 catalytic activity;lyase activity
1.10.455.10 100 100 93 structural constituent of rft)06ome;intraceilular,ribosome
1.10.460.10 100 98 86 nucleic acid binding; DNA topoisomerase type 1 activity; DNA modification
1.10.560.10 100 98 93 chaperone activity;ATP binding;protein folding
1.10.600.10 100 93 86 isoprenoid biosynthesis;transferase activity
1.10.730.10 100 100 86 tRNA ligase actMty,ATP binding;
1.10.8.50 94 100 93 RNA binding;structurai constituent of ribosome; intracellular
1.10.8.60 100 100 100 ATP binding;nucleotide binding
1.20.1010.10 100 100 86 ATP binding;arginine-tRNA ligase activity
1.20.120.140 94 99 86 GTP binding;signal recognition particle;protein targeting
1.20.200.10 100 93 79 catalytic activity;lyase activity
1.20.58.100 88 73 79 electron transport;oxidoreductase activity;
1.25.40.10 81 94 100 nudeus;intracellular
2.10.230.10 75 100 86 chaperone activfty.protein folding;
2.130.10.10 88 84 100 nucleus;membrane
2.160.10.10 88 94 79 transferase activity;acyitransferase activity
2.170.120.12 94 100 93 DNA binding; DNA-directed RNA polymerase activity;transcription
2.20.29.10 100 100 86 translation elongation factor activity;GTP binding;translational elongation
2.30.30.30 100 99 93 structural constituent of ribosome;intracellular;i1bosome
2.30.35.20 100 100 86 structural constituent of ribosome;intracellular, ribosome
2.30.35.30 100 94 79 ligase activity;ATP binding
2.30.42.10 94 94 100 protein binding;proteoiysis and peptidolysis
2.40.10.80 94 93 93 ATP-binding and phosphorylation-dependent chloride channel activity
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2.40.150.20 100 100 93 structural constituent of ribosomejintraeellular; ribosome
2.40.240.10 100 80 86 protein biosynthesis;structural constituent of ribosome
2.40.30.10 100 100 93 GTP binding;translation elongation factor activity
2.40.33.10 81 92 86 pyruvate kinase activityglycolysis;
2.40.40.30 100 99 93 DNA binding;DNA-directed RNA polymerase activity,nucleus
2.40.50.100 94 99 86 membrane;protein secretion
2.40.50.140 100 100 93 protein biosynthesis; RNA binding
2.40.50.150 100 99 93 structural constituent of ribosome;intracellular, ribosome
2.70.150.10 81 86 93 ATP binding;membrane
2.70.20.10 81 96 79 DNA binding; DNA topoisomerase type I activity; DNA topological change
2.70.40.10 100 87 86 dUTP metabolism;hydrolase activity
3.10.129.10 88 93 79 catalytic actfvitymetabolism
3.10.180.10 81 81 79 lactoyiglutathione lyase activity;cart>ohydrate metabolism
3.10.20.30 88 93 93 electron transporter activity;electron transport
3.10.20.70 100 74 71 glutamate-ammonia ligase acttvity;nitrogen fixation
3.10.290.10 100 100 93 RNA binding;pseudouridytate synthase activity
3.10.50.40 88 98 93 protein folding;isomerase activity
3.20.19.10 100 72 79 metabolism;lyase activity
3.20.20.100 81 72 93 oxidoreductase activity,electron transporter activity
3.20.20.105 100 87 71 queuine tRNA-ribosyttransferase activityqueuosine biosynthesis
3.20.20.120 100 98 86 catalytic activity;metabolism
3.20.20.140 100 100 86 hydrolase acting on carbon-nitrogen (but not peptide) bonds; in cyclic amides
3.20.20.150 100 83 71 endonuclease activity; DNA repair
3.20.20.170 81 100 79 lyase activityfructose-bisphosphate aldolase activity
3.20.20.60 100 100 86 kinase activitytransferase activity
3.20.20.70 100 92 86 lyase activity carbohydrate metabolism
3.20.20.90 100 100 93 oxidoreductase activity; electron transport
3.30.160.30 100 98 93 structural constituent of ribosome;intracellular;ribosome
3.30.190.20 100 100 93 structural constituent of ribosome;intracellular; ribosome
3.30.200.20 88 90 100 ATP binding;protein amino acid phosphorylation
3.30.230.10 100 100 100 protein bk>synthesis;ATP binding
3.30.230.20 100 100 93 structural constituent of ribosome;lntracellular;ribosome
3.30.300.20 100 100 79 nucleic acid binding; RNA binding
3.30.360.10 75 89 93 oxidoreductase activfty;electron transport
3.30.390.10 100 98 86 catalytic activity;metaboiism
3.30.390.30 100 94 79 electron transport; oxidoreductase activity
3.30.420.10 100 100 93 DNA binding; DNA recombination
3.30.420.100 100 100 93 structural constituent of ribosome;intracellular; ribosome
3.30.420.40 81 100 100 ATP binding; heat shock protein activity
3.30.420.80 100 99 93 protein biosynthesis;structural constituent of ribosome
3.30.428.10 94 99 86 transferase activity; UTP-hexose-1 -phosphate uridylyltransferase activity
3.30.470.20 100 97 79 ligase activityATP binding
3.30.499.10 100 72 79 metaboiism;lyase activity
3.30.540.10 88 88 71 inositol/phosphatidylinositol phosphatase activity,hydrolase activity
3.30.550.10 100 94 79 gtyceraldehyde-3-phosphate dehydrogenase (phosphoryiating) activity
3.30.56.20 94 97 86 phenyialanine-tRNA ligase activitytRNA ligase activity
3.30.565.10 100 100 100 ATP binding;kinase activity
3.30.70.100 100 81 71 metal ion transport; metal ion binding
3.30.70.141 100 80 86 nucleoside-diphosphate kinase activityATP binding;GTP biosynthesis
3.30.70.160 100 100 86 transaminase activity;transferase activity
3.30.70.20 100 77 93 electron transport; electron transporter activity
3.30.70.210 100 92 86 nucleic acid binding;RNA binding
3.30.70.240 100 100 93 translation elongation factor activity; GTP binding;translational elongation
3.30.70.330 100 98 100 nucleic acid binding;RNA binding
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3.30.70.350 100 100 86 structural constituent of ribosome;lntracellular, ribosome
3.30.70.460 100 83 71 catalytic activity; ligase activity
3.30.70.530 100 100 93 DNA binding; DNA-directed RNA polymerase activity;transcription
3.30.70.580 81 94 86 pseudouridylate synthase activitytRNA processing
3.30.70.60 100 98 86 protein biosynthesis;structural constituent of ribosome
3.30.70.600 100 97 93 structural constituent of ribosome;intracellular; ribosome
3.30.70.660 81 96 86 pseudouridylate synthase activitytRNA processing
3.30.70.780 100 100 93 structural constituent of ribosome;intracellular; ribosome
3.30.70.810 88 98 79 arginine-tRNA ligase activityATP WncHng;arginyl-tRNA aminoacyiation
3.30.860.10 100 96 93 structural constituent of ribosome;intracellular,ribosome
3.30.930.10 100 100 86 tRNA ligase activityATP binding
3.40.1010.10 100 94 86 metabolism;methyitransferase activity
3.40.1060.10 100 70 79 metabolism;lyase activity
3.40.120.10 100 98 86 carbohydrate metabolism; phosphotransferases
3.40.190.10 100 99 93 transporttransporter activity
3.40.190.80 88 87 71 inositoi/phosphatidyiinositol phosphatase activity; hydrolase activity
3.40.225.10 88 70 79 isomerase activity; lyase activity
3.40.250.10 75 92 86 transferase activity;thiosulfate sulfurtransferase activity
3.40.30.10 94 100 93 electron transport;electron transporter activity
3.40.309.10 81 84 71 oxidoreductase activitymetabolism
3.40.350.10 81 79 71 proteolysis and peptidoiysis;metalloexopeptidase activity
3.40.367.20 100 87 93 structural constituent of cytoskeieton;actin cytoskeleton
3.40.430.10 75 94 86 5-amino-6-(5-phosphoribosylamino)uracil reductase activity
3.40.440.10 94 84 71 GTP binding;purine nucleotide biosynthesis
3.40.460.10 100 98 86 carbohydrate metabolism; phosphotransferases
3.40.47.10 100 93 86 transferase actMtyfatty add biosynthesis
3.40.470.10 81 98 86 DNA repair,uracil DNA N-glycosyiase activity
3.40.50.1000 100 100 93 hydrolase activity; metabolism
3.40.50.10050 100 99 93 GTP binding;translation elongation factor activity
3.40.50.1010 100 100 86 DNA binding;nudease activity
3.40.50.1050 100 92 71 carbohydrate metabolism; phosphotransferases
3.40.50.1090 100 76 79 intracellulantranscription factor activity
3.40.50.1100 100 84 71 amino add metabdism;lyase activity
3.40.50.1140 88 83 86 electron transport;oxidoreductase activity
3.40.50.1220 100 86 93 regulation of transcription; DNA-dependent;electron transport
3.40.50.1260 100 98 86 phosphoglycerate kinase activityglycolysis
3.40.50.1270 100 98 86 phosphoglycerate kinase activityglycolysis
3.40.50.1370 100 88 79 amino add metabolism; carboxyl- and carbamoyltransferase activity
3.40.50.140 100 98 79 nucleic add binding; DNA modification
3.40.50.1400 75 80 79 ferrochelatase activityheme biosynthesis
3.40.50.1440 75 93 93 GTP binding;structural molecule activity
3.40.50.150 100 100 100 S-adenosyimethionine-dependent methyitransferase activity
3.40.50.1580 100 98 79 nucleoside metabolism;catalytic activity
3.40.50.1820 94 98 86 catalytic activity; hydrolase activity
3.40.50.1900 100 87 71 lyase activity amino acid metabolism
3.40.50.1940 100 96 86 sugar binding;carbohydrate metabolism
3.40.50.1950 100 89 71 lyase activity carboxy-lyase activity
3.40.50.1990 100 100 93 structural constituent of ribosome;irrtracellular; ribosome
3.40.50.20 94 94 79 ligase activityATP binding
3.40.50.2000 81 94 79 transferase activity; transferring hexosyt groups;metabolism
3.40.50.2020 100 98 86 nucleoside metabolism transferase activity
3.40.50.300 100 100 100 ATP bincHng;nudeotide binding
3.40.50.50 81 91 86 pyruvate kinase activityglycolysis
3.40.50.610 100 100 93 ATP binding; ligase activity
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3.40.50.620 100 100 93 nucleotidyltransferase activity; biosynthesis
3.40.50.720 100 100 100 oxidoreductase activitymetabolism
3.40.50.7700 94 79 71 phosphoribosyiaminoimidazoie carboxylase activityi'de novo1 IMP biosynthesis
3.40.50.790 100 100 86 structural constituent of ribosome;intraceliular,ribosome
3.40.50.800 100 100 86 tRNA Hgase activity;ATP binding
3.40.50.850 88 72 79 catalytic activity.metaboiism
3.40.50.880 100 98 86 catalytic activity;glutamine metabolism
3.40.50.920 100 99 86 oxidoreductase activity; electron transport
3.40.50.970 100 99 93 oxidoreductase activitymetabolism
3.40.510.10 100 100 86 ATP binding;tRNA ligase activity
3.40.605.10 81 86 71 oxidoreductase activitymetabolism
3.40.630.10 100 99 86 proteolysis and peptidoiysis;metaiiopeptidase activity
3.40.630.30 100 94 100 N-acetyttransferase activitytransferase activity
3.40.640.10 100 100 86 transaminase activitytransferase activity
3.40.718.10 100 73 79 oxidoreductase activity.metaboiism
3.50.30.20 81 82 71 catalytic activitycarbamoyt-phosphate synthase activityATP binding
3.50.50.60 100 100 86 electron transport;oxicloreductase activity
3.50.7.10 100 98 93 chaperone activityATP binding
3.60.15.10 100 100 93 hydrolase activttymolecular_function unknown
3.60.20.10 100 94 100 metaboiism;endopeptidase activity
3.60.21.10 100 92 93 hydrolase activttyprotein serine/threonine phosphatase activity
3.90.110.10 81 86 79 oxidoreductase activity L-lactate dehydrogenase activity
3.90.170.10 88 84 79 GTP binding;purine nucleotide biosynthesis
3.90.180.10 81 78 79 alcohol dehydrogenase activity zinc-dependent;zinc ion binding
3.90.188.10 88 91 79 ribonudeoside-diphosphate reductase activity; DNA replication
3.90.226.10 94 94 93 catalytic activity metabolism
3.90.230.10 100 100 93 proteolysis and peptidolysis;metalioexopeptidase activity
3.90.244.10 88 98 86 ribonudeoside-diphosphate reductase activity; DNA replication
3.90.269.10 100 82 79 giutamate-ammonia ligase activity nitrogen fixation
3.90.470.10 100 100 93 structural constituent of ribosome;intracellular; ribosome
3.90.550.10 100 100 86 transferase activity; nudeotidyitransferase activity
3.90.700.10 88 78 79 oxidoreductase activityelectron transport
3.90.740.10 100 100 86 tRNA ligase activityATP bindlng;amino add activation
3.90.77.20 100 92 86 kinase activitytransferase activity
3.90.79.10 100 92 86 hydrolase activity isoprenokJ biosynthesis
3.90.80.10 81 73 86 metabolism;membrane;pyrophosphatase activity
3.90.800.10 88 96 86 giutamate-tRNA ligase activityATP binding;glutamyi-tRNA aminoacyiation
3.90.870.10 100 98 79 3;4 dihydroxy-2-butanone-4-phosphate synthase activity
3.90.930.12 100 100 93 structural constituent of ribosome;intracellular; ribosome
4.10.910.10 100 100 93 RNA binding;structural constituent of ribosome;intracellular
4.10.950.10 100 99 93 structural constituent of ribosome;intracellular; ribosome
PF00083 100 99 93 transport; membrane
PF00324 81 88 86 amino add-poiyamine transporter activity amino acid transport;membrane
PF00344 100 100 93 protein secretion;protein translocase activitymembrane
PF00534 100 91 86 biosynthesis;transferase activity
PF00571 100 99 79 membrane.transport
PF00572 100 100 93 structural constituent of ribosome;intracellular; ribosome
PF00573 100 99 93 structural constituent of ribosome;intracellular;ribosome
PF00588 75 97 79 RNA binding; RNA processing; RNA methyttransferase activity
PF00673 100 100 93 structural constituent of ribosome;intracellular;ribosome
PF00999 100 79 93 regulation of pH;integral to membrane
PF01066 100 96 86 phospholipid biosynthesis;transferase activity
PF01192 100 77 93 DNA-directed RNA polymerase activitytranscription; DNA-dependent
PF01509 100 92 86 pseudouridylate synthase activityRNA processing
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PF01513 100 89 79 kinase activitytransferase activity
PF01725 100 88 86 hydrolase activity;mdecular_functk)n unknown
PF01842 75 78 71 metaboiism;amino add binding
PF01966 100 93 79 catalytic activity; hydrolase activity
PF01979 100 78 71 hydrolase activity;N-acetyiglucosamine-6-phosphate deacetylase activity
PF02272 100 100 71 nucleic acid binding;ATP binding
PF03946 88 100 93 structural constituent of ribosome.intracellular; ribosome
PF04560 100 100 93 DNA binding; DNA-directed RNA polymerase activity;transcription
PF04561 100 90 93 DNA-directed RNA polymerase activity transcript ion
PF05362 75 76 79 ATP-dependent peptidase activity; serine-type endopeptidase activity
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Appendix HI -  Universal Size-Dependent Superfamilies in Bacteria. The 66 universal 
size-dependant superfamilies used in this analysis are denoted by their CATH code and PDB 
representative. The total number of domain assignments, percentage of genomes containing these 
assignments and Spearman’s Rank correlation coefficient between domain occurrence and genome size is 
shown. The size distribution group (PI -  power law, L -  linear, Log -  logarithmic) and functional 
classification (R -regulatory, M -  metabolic, O -  other, P -  poorly characterised) are indicated.
CATH Code PDBRep.
Number
of
Domains
Universality
Spearmans
Rank
Coefficient
Size
Distiribution
Function
Func.
Code Functional Definition
1.10.10.10 1lea00 5695 98 0.951 PI R Winged helix (DNA-binding)
3.40.190.10 1anf02 4595 99 0.867 PI R SBP-bacterial 1 periplasm ic binding xotein
1.10.10.60 ImbeOO 3391 86 0.926 PI R Homeodomain-like (DNA-binding)
3.40.50.2600 Babp02 3101 85 0.865 PI R CheY receiver domain
3.30.565.10 1cuk03 2400 100 0.861 PI R Histidine kinase
3.40.50.1820 IdqzAO 2338 97 0.878 PI M/P Alpha and Beta hydrolases
1.10.260.10 IneqOO 1684 89 0.773 PI R l-repressor (DNA-binding)
2.40.50.100 IhtpOO 1056 98 0.742 PI M Biotin-requiring enzymes
3.10.180.10 1kw3B1 778 82 0.823 PI M Clyoxalase/bieomydn/dioxygenase
3.90.180.10 IqorAI 737 79 0.851 PI M Zinc-binding dehydrogenase
3.40.605.10 1ag8A1 663 85 0.879 PI M NADP-oxidoreductase
3.10.20.30 4fxc00 637 92 0.721 PI R TGS-domain (nuciotide bindingin regulation)
2.130.10.10 2bbkH0 555 84 0.76 PI R WD domain (Beta-transduction)
3.10.129.10 ImkaAO 535 93 0.824 PI M fhioesterase/Maoc-like domain
3.40.50.1420 ImJhAO 456 80 0.75 PI R Universal stress protein
3.40.50.1090 1cf9A3 323 79 0.843 PI R DJ-1-Pfpl transcription regulator
3.20.20.120 1oneA2 320 99 0.746 PI M Enoiase Ct-domain/methylaspartate ammonia-lyase
3.30.70.130 2chsA0 241 77 0.787 PI R Endoribonudease
3.40.50.850 InbaAO 234 75 0.77 PI M Isochorismatase family
3.30.43.10 1uxy02 172 80 0.7 PI M FAD-binding domain
3.40.50.300 1efuA1 18,292 100 0.958 L M P-loop containing nucleotide triphosphate
3.40.50.720 1evyA1 6880 100 0.939 L M NAD(P)-binding domain
3.40.50.150 1admA1 3844 100 0.87 L M Methyttransferase
3.50.50.60 3ladA2 3101 100 0.91 L M MADH-FAD oxidoreductases
3.40.640.10 1tplA2 2498 100 0.917 L M rype 1 PLP-dependent aspartate aminotransferase
3.40.30.10 labeOO 2098 99 0.86 L M Fhioredoxin-like domain
3.40.630.30 IcjwAO 1814 96 0.868 L M/R Acetyttransferase
3.90.550.10 1qg8A0 1805 100 0.801 L 0 SpsA-glycosyltransferase
3.30.420.10 1rthA5 1635 100 0.72 L O RNAase-H
3.40.50.970 1poxA3 1611 100 0.8 L M Thiamine diphosphate binding fold
3.40.50.980 1ld01 1583 81 0.79 L M Acetyl-CoA synthetase family
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3.40.47.10 1pxtA1 1118 94 0.804 L M 3eta-oxidation,lipid metabolism
3.90.226.10 1dubA1 871 94 0.758 L M Enoyl-CoA hydratase
3.40.710.10 2bttA0 842 85 0.768 L O 3eta-lactamases
3.40.630.10 2ctc00 819 99 0.808 L M Zinc-metallopeptidase domain
3.90.77.20 1rkd02 719 94 0.784 L M Carbohydrate kinase
1.10.443.10 1aihA0 714 93 0.734 L O Phage integrase domain
2.160.10.10 1lxa01 647 94 0.797 L M Acetyltransferase
2.30.42.10 IpdiOO 495 94 0.705 L R PDZ domain (signaling protein)
3.40.50.1900 1qoqB2 491 89 0.767 L M Amino acid metabolism
3.40.250.10 IrhsOI 488 89 0.791 L M Rhodanase domain
3.60.20.10 IgdoAO 478 95 0.736 L M Glutamine amidotransferase class-ll
3.20.20.100 1adsOO 434 73 0.795 L M Mdo/ketoreductases
3.20.20.60 1pkm02 430 100 0.771 L M Pyruvate kinases
3.20.20.140 1a4mA0 417 100 0.762 L M Metal-dependent hydrolases
3.40.50.1140 1aa8A1 398 83 0.812 L M FAD-dependent oxidoreductase
2.40.40.20 1eu1A4 378 72 0.706 L M VAT-N domain (binding protein)
3.30.499.10 1c96A3 364 76 0.714 L M Acotinase
3.20.20.10 1bdOA1 356 83 0.716 L M Alanine racemase/pyridoxal binding
1.20.200.10 1fupA2 343 95 0.739 L M Lyase
3.90.230.10 1chmA2 338 100 0.72 L M/O M24 metallopeptidase family
3.40.109.10 InoxOO 297 83 0.755 L M MAD-NADPH oxidoreductase
3.40.50.170 IgarAO 241 90 0.723 L M Formyttransferase
3.30.1090.10 1qdlA2 199 84 0.714 L M Chorismate binding enzyme
3.40.718.10 1isoOO 179 77 0.76 L M Isocitrate/isopropyi malatede tiydrogenase
3.90.269.10 1lgr01 171 85 0.772 L M Glutamine synthetase
3.20.20.20 1ad4B0 153 90 0.748 L M Pterin binding enzyme fmethyltransferases)
3.30.470.10 3daaA1 146 77 0.75 L M Aminotransferases class IV
2.40.50.140 1ckmA2 2292 100 0.709 Log 0 RNA-binding domain
3.20.20.90 ItpfAO 2049 100 0.898 Log M FMN-dependent enzymes
3.40.50.1000 1jud01 1642 100 0.838 Log M Dehalogenase
3.30.470.20 1k>w02 1150 97 0.894 Log M ATP-grasp fold
3.40.50.880 IgpmAI 840 98 0.751 Log M Glutamine am idotransf erase class I
3.90.79.10 ImutOO 729 94 0.889 Log 0 DNA repair domain
3.40.50.620 IdnpAI 675 100 0.712 Log 0 DNA repair
3.60.21.10 4kbpA2 560 94 0.723 Log R/O Calcineurin-like phosphoesterase
188
REFERENCES
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. and Lipman, D. J. (1990) Basic 
local alignment search tool. J Mol Biol Oct 5;215(3):403-410
Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W. and 
Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of 
protein database search programs. Nucleic Acids Res. Sep l;25(17):3389-3402
Andreeva, A., Howorth, D., Brenner, S. E., Hubbard, T. J., Chothia, C. and Murzin, 
A. G. (2004) SCOP database in 2004: refinements integrate structure and 
sequence family data. Nucleic Acids Res. Jan l;32:D226-229
Anscombe, J. F. (1973) Graphs in statistical analysis. Am Stat. 27,17-21
Apic, G., Gough, J. and Teichamnn, S. A. (2001) Domain combinations in archaeal, 
eubacterial and eularyotic proteomes. J  Mol Biol. Jul 6;310(2):311-325
Ashbumer, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, 
A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Hairis, M. A., Hill, D. P., Issel- 
Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., 
Ringwald, M., Rubin, G. M. and Sherlock, G. (2000) Gene Ontology: tool for 
the unification of biology. Nature Genet. 25:25-29
Atkinson, A. C. (1985) Plots, transformations, and regression: an introduction to 
graphical methods of diagnostic regression analysis. In (Copas, J. B. et al.y eds). 
Oxford University Press.
Attwood, T. K., Bradley, P., Flower, D. R., Gaulton, A., Maudling, N., Mitchell, A. 
L., Moulton, G., Nordle, A., Paine, A. K., Taylor, P., Uddin, A. and Zygouri, 
C. (2003) PRINTS and its automatic supplement, prePRINTS. Nucleic Acids 
Res. 31:400-402
189
Avery, O. T., MacLeod, C. and McCarty, M. (1944) Studies on the chamical nature of 
the substance inducing transformation of pneumococcal types. Journal of 
Experimental Medicine 79(2): 137-158
Babu, M. M. and Teichmann, S. A. (2003) Evolution of transcription factors and the 
gene regulatory network in Escherichia coli. Nucleic Acids Res. 31:1234-1244
Bairoch, A. and Apweiler, R. (2000) The SWISS-PROT protein sequence database and 
its supplement TrEMBL in 2000. Nucleic Acids Res. 28:45-48
Bairoch, A., Apweiler, R., Wu, C. H., Barker, W. C., Boeckmann, B., Ferro, S., 
Gasteiger, E., Huang, H., Lopez, R., Magrane, M., Martin, M. J., Natale, D. 
A., O'Donovan, C., Redaschi, N. and Yeh, L. S. (2005) The Universal Protein 
Resource (UniProt). Nucleic Acids Res. Jan l;33(database issue):D154-159
Baldessari, D., Shin, Y., Krebs, O., Konig, R., Koide, T., Vinayagam, A., Fenger, U., 
Mochii, M., Terasaka, C., Kitayama, A., Peiffer, D., Ueno, N., Eils, R., Cho, 
K. W. and Niehrs, C. (2005) Global gene expression profiling and cluster 
analysis in Xenopus laevis. Mech. Dev. Mar;122(3):441-475.
Bansal, a. K. (1999) An automated comparative analysis of 17 complete microbial 
genomes. Bioinformatics Nov 15(ll):900-908
Barbazuk, W. B., Korf, I., Kadavi, C., Heyen, J., Tate, S., Wun, E., Bedell, J. A., 
McPherson, J. D. and Johnson, S. L. (2000) The syntenic relationship of the 
zebrafish and human genomes. Genome Res. Sept 10(9): 1351-1358
Barrett, T., Suzek, T., Troup, D., Wilhite, S., Ngau, W., Ledoux, P., Rudnev, D., Lash, 
A., Fujibuchi, W. and Edger, R. (2005) NCBI GEO: mining millions of 
expression profiles - database and tools. Nucleic Acids Res. 33(datbase 
issue):D562-D566
190
Bateman, A., Coin, L., Durbin, R., Finn, R. D., Hollich, V., Griffiths-Jones, S., 
Khanna, A., Marshall, M., Moxon, S., Sonnhammer, E. L., Studholme, D. J>, 
Yeats, C. and Eddy, S. R. (2004) The Pfam protein families database. Nucleic 
Acids Res. Jan 1(32):D138-141
Benson, D. A., Karsch-Mizrachi, L, Lipman, D. J., Ostell, J., Rapp, B. A. (2000) 
GenBank. Nucleic Acids Res. Jan l;28(database issue):D15-18
Benson, D. A., Karsch-Mizrachi, I., Lipman, D. J., Ostell, J., Wheeler, D. L. (2005) 
GenBank. Nucleic Acids Res. Jan l;33(database issue):D34-38
Bernal, A. Ear, U. and Kyrpides, N. (2001) Genomes Online Database (GOLD): a 
monitor of genome projects world-wide. Nucleic Acids Res. Jan 1;29(1):126- 
127
Bernstein, F. C., Koetzle, T. F., Williams, G. J., Meyer, E. F. Jr., Brice, M. D., Rodgers, 
J. R., Kennard, O., Shimanouchi, T. and Tasumi, M. (1977) The Protein Data 
Bank: a computer-based archival file for macromolecular structures. J Mol Biol. 
May 25 112(3):535-542
Bird, A. P. (1995) Gene number, noise reduction and biological complexity. Trends 
Genet. 11:94-100
Boeckmann, B., Bairoch, A., Apweiler, R., Blatter, M. C., Estreicher, A., Gasteiger, 
E., Martin, M. J., Michoud, K., O'Donovan, C., Phan, L, Pilbout, S., 
Schneider, M. (2003) The SWISSPROT protein knowledgebase and its 
supplement TrEMBL in 2003. Nucleic Acids Res. Jan l;31(l):365-370
Bork, P. and Koonin, E. V. (1998) Predicting functions from protein sequences -  
where are the bottlenecks? Nature Genet. Apr 18(4):313-318
Borodovsky, M. and Mclninch, J. (1993) Recognition of genes in DNA sequence with 
ambiguities. Biosystems 30(1-3): 161-171
191
Bray, J. E., Todd, A. E., Pearl, F. M., Thornton, J. M. and Orengo, C. A. (2000) The 
CATH Dictionary of Homologous Superfamilies (DHS): a consensus 
approach for identifying distant structural homologues. Protein Eng. 
Mar;13(3): 153-165
Bryant, S. H. and Lawrence, C. E. (1993) An empirical energy function for threading 
protein sequence through the folding motif. Proteins May 16(1):92-112
Buchan, D. W., Rison, S. C., Bray, J. E., Lee, D., Pearl, F. M., Thornton, J. M. and 
Orengo, C. A. (2003) Gene3D: structural assignments for the biologist and 
bioinformaticist alike. Nucleic Acids Res. Jan l;31(l):469-473
Buchan, D. W., Shepherd, A. J., Lee, D., Pearl, F. M., Rison, S. C., Thornton, J. M. 
and Orengo, C. A. (2002) Gene3D: structural assignments for whole genes and 
genomes using the CATH domain structure database. Genome Res. 
Mar;12(3):503-514
Burge, C. and Karlin, S. (1997) Prediction of complete gene structure in human 
genomic DNA. J Mol Biol. Apr 25 268(l):78-94
Campbell, J. A., Davies, G. J., Bulone, V. and Henrissat, B. (1998) A classification of 
nucleotide-diphospho-sugar glycosyltransferases based on amino acid 
sequence similarities. Biochem J. Sep 15;326:929-939
Chandonia, J. M. and Brenner, S. E. (2005) Implications of structural genomics target 
selection strategies: Pfam5000, whole genome, and random approaches. 
Proteins Janl;58(l): 166-179
Chen, J., Anderson, J. B., DeWeese-Scott, C., Fedorova, N. D., Geer, L. Y., He, S., 
Hurwitz, D. I., Jackson, J. D., Jacobs, A. R., Lanczycki, C. J., Liebert, C. A., 
Liu, C., Madej, T., Marchler-Bauer, A., Marchler, G. H., Mazumder, R., 
Nikolskaya, A. N., Rao, B. S., Panchenko, A. R., Shoemaker, B. A., 
Simonyan, V., Song, J. S., Thiessen, P. A., Vasudevan, S., Wang, Y., 
Yamashita, R. A., Yin, J. J. and Bryant, S. H. (2003) MMDB: Entrez's 3D- 
structure database. Nucleic Acids Res. Jan l;31(l):474-477
192
Cherkasov, A. and Jones, S. J. (2004) Structural characterization of genomes by large 
scale sequence-structure threading. BMC Bioinformatics. 2004 Apr 3;5:37
Chothia, C. (1992) Proteins. One thousand families for the molecular biologist. Nature 
357:543-544
Chothia, C., Gough, J., Vogel, C. and Teichmann, S. A. (2003) Evolution of the 
protein repertoire. Science 300:1701-1703
Chothia, C. and Lesk, A. M. (1986) The relation between the divergence of sequence 
and structure in proteins. EMBO J  Apr;5(4):823-6
Coleman, M. L., Marshall, C. J. and Olson, M. F. (2003) Ras promotes p21 
(W afl/Cipl) protein stability via a cyclin D1-imposed block in proteasome- 
mediated degradation. EMBO J. May l;22(9):2036-2046.
Cope, L. M., Irizarry, R. A., Jaffee, H. A., Wu, Z. and Speed, T. P. (2004) A 
benchmark for Affymetrix GeneChip expression measures. Bioinformatics 
20(3):323-331
Copley, R. R. and Bork, P. (2000) Homology among (betaalpha)(8) barrels: 
implications for the evolution of metabolic pathways. J Mol Biol 303:627-641
Coulson, A. F. W. and Moult, J. (2002) A Unifold, Mesofold and Superfold Model of 
Protein Fold Use. Proteins 46:61-71
Dandekar, T., Snel, B., Huynen, m. and Borl, P. (1998) Conservation of gene order: a 
fingerprint of proteins that physically interact. TIBS Sept 23:324-328
Date, S. and Marcotte, E. M. (2003) Discovery of uncharacterised cellular systems by 
genome-wide analysis of functional linkages. Nature Biotech. 21(9): 1055- 1062
Dayhoff, M. O. (ed) 1965-1978. Atlas of protein sequence and structure. National 
Biomedical Research Foundation, Washington.
193
Dayhoff, M. O., Schwartz, R. M. and Orcutt, B. C. (1978) A model of evolutionary 
change in proteins. In: Atlas of protein sequence and structure 5(3) M. O.
de Bruijn, F. J. et al. (1998) Bacterial Genomes: Physical Structure and Analysis. 
Structure and Sizes of Genomes of the Archaea and Bacteria. Kluwer 
Academic Publishers.
Deshpande, N., Addess, K. J., Bluhm, W. F., Merino-Ott, J. C., Townsend-Merino, 
W., Zhang, Q., Knezevich, C., Xie, L., Chen, L., Fend, Z., Green, R. K., 
Flippen-Anderson, J. L., Westbrook, J., Berman, H. M. and Bourne, P. E. 
(2005) The RCSB Protein Data Bank: a redesigned query system and 
relational database based on the mmCIF schema. Nucleic Acids Res. Jan 
l;33(database issue):D233-237
Devos, S. and Valencia, A. (2000) Practical limits of function prediction. Proteins: 
Structure, Function, and Genetics.41:98-107 
Dietmann, S., Park, J., Notredame, C., Heger, A., Lappe, M. and Holm, L. (2001) A 
fully automatic evolutionary classification of protein folds: Dali Domain 
Dictionary version 3. Nucleic Acids Res. Jan l;29(l):55-7
Dobrindt, U. and Hacker, J. (2001) Whole-genome plasticity in pathogenic bacteria. 
Curr Opin Microbiol. Oct;4(5):550-557
Doolittle, R. F. (1990) Searching through sequence databases. Methods Enzymol. 
183:99-110
Doolittle, R. F. (1995) The multiplicity of domains in proteins. Annu Rev Biochem. 
64:287-314
Eddy, S. R. (1998) Profile hidden Markov models. Bioinformatics 14:755-763
Eisenberg, D., Marcotte, E. M., Xenarios, I. and Yeates, T. O. (2000) Protein function 
in the post-genomic era. Nature June 405:823-826
194
Elofsson, A. and Sonnhammer, E. L. (1999) A compairson of sequence and structure 
protein domain families as a basis for structural genomics. Bioinformatics 
Jun;15(6):480-500
Enright, A. J. and Ouzounis, C. A. (2000) GeneRAGE: a robust algorithm for 
sequence clustering and domain detection. Bioinformatics May 16(5):451- 457
Enright, A. J., Kunin, V. and Ouzounis, C. A. (2003) Protein families and TRIBES in 
genome sequence space. Nucleic Acids Res. Aug l;31(15):4632-4638
Enright, A.J., van Dongen, S. and Ouzounis, C.A. (2002) An efficient algorithm for 
large-scale detection of protein families. Nucleic Acids Res. 30:1575-1584
Fang, K. S., Barker, K., Sudol, M. and Hanafusa, H. (1994) A transmembrane protein- 
tyrosine phosphatase contains spectrin-like repeats in its extracellular domain. 
J  Biol Chem. 1994 May 13;269(19): 14056-63.
Fiers, W., Contreras, R., Duerinck, F., Haegeman, G., Iserentant, D., Merregaert, J., 
Min Jou, W., Molemans, F., Raeymaekers, A., Van DEN Berghe, A., 
Volckaert, G. and Ysebaert, M. (1976) Complete nucleotide sequence of 
bacteriophage MS2 RNA: primary and secondary structure of the replicase 
gene. Nature Apr 8 260(5551):500-507
Fleischmann, R. D., Adams, M. D., White, O., Clayton, R. A., Kirkness, E. F., 
Kerlavage, A. R., Bult, C. J., Tomb, J. F., Dougherty, B. A., Merrick, J. M., 
McKenney, K., Sutton, G. G., FitzHugh, W., Fields, C. A., Gocayne, J. D., 
Scott, J. D., Shirley, R., Liu, L. L, Glodek, A., Kelley, J. M., Weidman, J. F., 
Phillips, C. A., Spriggs, T., Hedblom, E., Cotton, M. D., Utterback, T., Hanna, 
M. C., Nguyen, D. T., Saudek, D. M., Brandon, R. C., Fine, L. D., Fritchman, 
J. L., Fuhrmann, J. L., Geoghagen, N. S., Gnehm, C. L., McDonald, L. A., 
Small, K. V., Fraser, C. M., Smith, H. O. and Venter, J. C. (1995) Whole- 
genome random sequencing and assembly of Haemophilus influenzae Rd. 
Science 269(5223):496-512
195
Fleming, K., Muller, A., MacCallum, R. M. and Sternberg, M. J. (2004) 30- 
GENOMICS: a database to compare structural and functional annotations of 
proteins between sequenced genomes. Nucleic Acids Res. Jan l;32:D245-250
Franklin, R. E. and Gosling, R. G. (1953) Molecular configuration in sodium 
thymonucleate. Nature 171:740-741
Frizelle, G. (1998) The Management of Complexity in Manufacturing. Business 
Intelligence Press.
Gamov, G., Rich, A., Yeas, M. (1956) The problem of information transfer from the 
nucleic acids to proteins. Adv Biol Med Phys. 4:23-68
Gibrat, J. F., Madej, T. and Bryant, S. H. (1996) Surprising similarities in structure 
comparison. Curr Opin Struct Biol. Jun;6(3):377-385
Goldovsky, L., Cases, L, Enright, A. J. and Ouzounis, C. A. (2005) BioLayout(Java): 
Versatile Network Visualisation of Structural and Functional Relationships. 
Appl Bioinformatics 4(l):71-74
Goudreau, P. N. and Stock, A. M. (1998) Signal transduction in bacteria: molecular 
mechanisms of stimulus-response coupling. Curr Opin Microbiol. 1:160-169
Gough, J., Karplus, K., Hughey, R. and Chothia, C. (2001) Assignment of homology 
to genome sequences using a library of hidden Maikov models that represent 
all proteins of known structure. J Mol Biol. Nov 2;313(4):903-919
Govindarajan, S. and Goldstein, R. A. (1996) Why are some proteins structures so 
common? Proc Natl Acad Sci USA 93:3341-3345
Govindarajan, S., Recabarren, R. and Goldstein, R. A. (1999) Estimating the total 
number of protein folds. Proteins 35:408-414
Groft, C. M., Beckmann, R., Sali, A., Burley, s. K. (2000) Crystal structure of 
ribosome anti-association factor If6. Nature Struct Biol. 7:1156
196
Grant, A. D., Lee, D. and Orengo, C. (2004) Progress towards mapping the universe of 
protein folds. Genome Biol. 5(5): 107
Guan, X. (1997) Domain identification by clustering sequence alignments. Proc Int 
Conflntell SystMol Biol. 5:124-130
Haft, D.H., Selengut, J.D. and White, O. (2003) The TIGRFAMs database of protein 
families. Nucleic Acids Res. Jan l;31(l):371-373
Harrison, A., Pearl, F. Sillitoe, I., Slidel, T., Mott, R., Thornton, J. and Orengo, C. 
(2003) Recognising the fold of a protein structure. Bioinformatics Sep 
22;19(14): 1748-1759
Harrison, A., Pearl, F., Mott, R., Thornton, J. and Orengo, C. (2002) Quantifying the 
similarities within fold space. J Mol Biol. Nov 8;323(5):909-926
Harrison, P. M. and Gerstein, M. (2002) Studying genomes through the aeons: protein 
families, pseudogenes and proteome evolution. J Mol Biol. May 
17;318(5): 1155-1174
Heger, A. and Holm, L. (2003) Exhaustive Enumeration of Protein Domain Families. 
J  Mol Biol. 328:749-767
Hegyi, H. and Gerstein, M. (2001) Annotation transfer for genomics: measuring 
functional divergence in multi-domain proteins. Genome Res. Oct 11(10): 1632- 
1640
Hegyi, H., Lin, J., Greenbaum, D. and Gerstein, M. (2002) Structural genomes 
analysis: characteristics of atypical, common, and horizontally transferred folds. 
Proteins 2:126-141
Henikoff, S., Greene, E. A., Pietrokovski, S., Bork, P., Attwood, T. K. and Hood, L.
(1997) Gene families: the taxonomy of protein paralogs and chimeras. Science 
Oct 24;278(5338):609-614
197
Hofmann, E., Wrench, P. M., Sharpies, F. P., Hiller, R. G., Welte, W. and Diederichs, 
K. (1996) Structural basis of light harvesting by carotenoids: peridium- 
chlorophyll-protein from Amphidinium carterae. Science 272:1788
Holm, L. and Sander, C. (1993) Protein structure comparison by alignment of distance 
matrices. J  Mol Biol. Sep 5;233(1): 123-138
Holm, L. and Sander, C. (1994) Parser for protein folding units. Proteins 
Jul;19(3):256-268
Holm, L. and Sander, C. (1996) The FSSP database: fold classification based on 
structure-structure alignment of proteins. Nucleic Acids Res. Jan 1;24(1):206- 
209
Huang, H., Barker, W. C., Chen, Y. and Wu, C. H. (2003) iProClass: an integrated 
databse of protein family, function and structure information. Nucleic Acids 
Res. Jan l;31(l):390-392
Hubbard, T., Andrews, D., Caccamo, M., Cameron, G., Chen, Y., Clamp, M., Clarke, 
L., Coates, G., Cox, T., Cunningham, F., Curwen, V., Cutts, T., Down, T., 
Durbin, R., Femandez-Suarez, X. M., Gilbert, J., Hammond, M., Herrero, J., 
Hotz, H., Howe, K., Iyer, V., Jekosch, K., Kahari, A., Kasprzyk, A., Keefe, D., 
Keenan, S., Kokocinsci, F., London, D., Longden, L, McVicker, G., Melsopp, 
C., Meidl, P., Potter, S., Proctor, G., Rae, M., Rios, D., Schuster, M., Searle, 
S., Severin, J., Slater, G., Smedley, D., Smith, J., Spooner, W., Stabenau, A., 
Stalker, J., Storey, R., Trevanion, S., Ureta-Vidal, A., Vogel, J., White, S., 
Woodwark, C. and Bimey, E. (2005) Ensembl s005. Nucleic Acids Res. Jan 
l;33:D447-453
Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. and van Lohuizen, M. (1999) 
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and 
senescence through the ink4a locus. Nature Jan 14;397(6715): 164-168.
Jones, D. T., Taylor, W. R. And Thornton, J. M. (1992) A new approach to protein 
fold recognition. Nature Jul 2;358(6381):86-89
198
Jones, S., Stewart, M., Michie, A., Swindells, M. B., Orengo, C. and Thornton, J. M.
(1998) Domain assignment for protein structures using a consensus approach: 
characterisation and analysis. Protein Sci 7:233-42
Jordan, I. K., Makarova, K. S., Spouge, J. L., Wolf, Y. I. and Koonin, E. V. (2001) 
Lineage-specific gene expansions in bacterial and archaeal genomes. Genome 
Res. Apr;ll(4):555-565
Kanehisa, M., Goto, S., Kawahima, S., Okuno, Y. and Hattori, M. (2004) The KEGG 
resource for deciphering the genome. Nucleic Acids Res 32(database 
issue):D277-D280
Kanz, C., Aldebert, P., Althorpe, N., Baker, W., Baldwin, A., Bates, K., Browne, P., 
van den Broek, A., Castro, M., Cochrane, G., Duggan, K., Eberhardt, R., 
Faruque, N., Gamble, J., Diez, F. G., Harte, N., Kulikova, T., Lin, Q., 
Lombard, V., Lopez, R., Mancuso, R., McHale, M., Nardone, F., Silventoinen, 
V., Sobhany, S., Stoehr, P., Tuli, M. A., Tzouvara, K., Vaughn, R., Wu, D., 
Zhu, W. and Apweiler, R. (2005) The EMBL nucleotide sequence database. 
Nucleic Acids Res. Jan l:33(database issue):D29-33
Kaplan, N. and Linial, M. (2005) Automatic detection of false annotations via binary 
property clustering. BMC Bioinformatics Mar 8;6(1):46
Kaplan, N., Sasson, O., Inbar, U., Friedlich, M., Fromer, M., Fleischer, H., Portugaly,
E., Linial, N. and Linial M. (2005) ProtoNet 4.0: hierarchical classification of 
one million protein sequences. Nucleic Acids Res. Jan 1;33(1):D216-218
Karev, G. P., Wolf, Y. I. and Koonin, E. V. (2003) Simple stochastic birth and death 
models of genome evolution: was there enough time for us to evolve? 
Bioinformatics 19:1889-1900
Karev, G. P., Wolf, Y. I., Rzhetsky, A. Y., Berezovskaya, F. S. and Koonin, E. V. 
(2002) Birth and death of protein domains: A simple model of evolution 
explains power law behaviour. BMC Evol Biol 2: 8
199
Karp, P. D., Raley, S. and Zhu, J. (2001) Database verification studies of SWISS- 
PROT and GenBank. Bioinformatics 17(6):526-532.
Karplus, K., Barrett, C. and Hughey, R. (1998) Hidden Markov models for detecting 
remote protein homologies. Bioinformatics 14(10):846-856
Kendall, M. and Gibbons, J. D. (1990) Rank Correlation Methods (5th edition), 
Oxford University Press.
Kinch, L. N., Wrabl, J. O., Krishna, S. S., Majumdar, I., Sadreyev, R. I., Qi, Y., Pei, 
J., Cheng, H. and Grishin, N. V. (2003) CASP5 assessment of fold recognition 
target predictions. Proteins 53(6):395-409.
Klewer, D. A., Hoskins, A., Zhang, P., Davisson, V. J., Bergstrom, D. E., Liwang, A.
C. (2000) NMR structure of a DNA duplex containing nucloeside analog l-(2'- 
deoxy-beta-d-ribofuranosyl)-3-nitropyrrole and the structure of the unmodified 
control. Nucleic Acids Res. 28:4514
Kolesov, G., Mewes, H. W. and Frishman, d. (2001) SNAPping up functionally 
related genes based on context information: a colinearity-free approach. J  Mol 
Biol. Aug 24;311(4):639-656
Koonin, E. V., Wolf, Y. I. and Karev, G. P. (2002) The structure of the protein 
universe and genome evolution. Nature 420:218-223
Krogh, A., Brown, M., Mian, I. S., Sjolander, K. and Haussler, D. (1994) Hidden 
Markov models in computational biology. Applications to protein modelling. J  
Mol Biol. Feb 235(5): 1501-1531
Kunin, V., Cases, I., Enright, A. J., deLorenzo, V. and Ouzounis, C. A. (2003) 
Myriads of protein families, and still counting. Genome Biol. Jan 29;4(2):401
Kunin, V., Teichmann, S. A., Huynen, M. A. and Ouzounis, C. A. (2005) The 
properties of protein family spcae depend on experimental design. 
Bioinformatics Jun 1;21(11):2618-2622
200
Kurland, C. G., Canback, B. and Berg, O. G. (2003) Horizontal gene transfer: a 
critical view. Proc Natl Acad Sci USA Aug 19;100(17):9658-9662
Leder, P. and Nirenberg, M. W. (1964) RNA codewords and protein synthesis, 3. On 
the nucleotide sequence of a cysteine and a leucine DNA codeword. PNAS 
Dec 52:1521-1529
Lee, D., Grant, A., Marsden, R. L. and Orengo, C. (2005) Identification and 
distribution of protein families in 120 completed genomes using Gene3D. 
Proteins May 15;59(3):603-615
Leonov, H., Mitchell, J. S. B. and Arkin, I. T. (2003) Monte Carlo Estimation of the 
Number of Possible Protein Folds: Effects of Sampling Bias and Folds 
Distributions. Proteins 51:352-359
Letunic, L, Goodstadt, L., Dickens, N. J., Doerks, T., Schultz, J., Mott, R., Ciccarelli,
F., Copley, R. R., Ponting, C. P. and Bork, P. (2002) Recent improvements to 
the SMART domain-based sequence annotation resource. Nucleic Acids Res. 
Jan 1;30(1)242-244
Lipman, D. J. and Pearson, W. R. (1985) Rapid and sensitive protein similarity 
searches. Science Mar 22;227(4693): 1435-1441
Liu, J. and Rost, B. (2002) Target space for structural genomics revisited. 
Bioinformatics Jul;18(7):922-933
Liu, J. and Rost, B. (2003) Domains, motifs and clusters in the protein universe. Curr 
Opin Chem Biol 7:5-11
Liu, J. and Rost, B. (2004) CHOP proteins into structural domain-like fragments. 
Proteins 55(3):678-688
201
Luscombe, N. M., Qian, J., Zhang, Z., Johnson, T. and Gerstein, M. (2002) The 
domainance of the population by a selected few: power-law behaviour applies 
to a wide variety of genomic properties. Genome Biol. Jul 25;3(8):Epub 
RESEARCH0040
Maclean, J. A., Rao, M. K., Doyle, K. M., Richards, J. S. and Wilkinson, M. F. (2005) 
Regulation of the Rhox5 Homeobox Gene in Primary Granulosa Cells: 
Preovulatory Expression and Dependence on SP1/SP3 and GABP. Biol 
Reprod. Dec;73(6): 1126-1134.
Madera, M. and Gough, J. (2002) A comparison of profile hidden Markov model 
procedures for remote homology detection. Nucleic Acids Res 30(19):4321- 
4328
Madera, M., Vogel, C., Kummerfeld, S. K., Chothia, C. and Gough, J. (2004) The 
SUPERFAMILY database in 2004: additions and improvements. Nucleic Acids 
Res. Jan l;32:D235-239
Mankiw, N. G. (1998) Principles of Microeconomics, 2nd edition. Dryden Press.
Maxam, A. M. and Gilbert, W. (1977) A new method for sequencing DNA. PNAS 
Feb 74(2):560-564
McGuffin, L. J. and Jones, D. T. (2003) Improvement of the GenTHREADER method 
for genomic fold recognition. Bioinformatics May 1;19(7):874-81
McGuffin, L. J., Street, S. A., Bryson, K., Sorensen, S. A. and Jones, D. T. (2004) 
The Genomic Threading Database: a comprehensive resource for structural 
annotations of the genomes from key organisms. Nucleic Acids Res. Jan 
1;32:D196-199
McShane, L. M., Radmacher, M, D., Freidlin, B., Yu, R., Li, M. and Simon, R. (2002) 
Methods for assessing reproducibility of clustering patterns observed in 
analyses of microarray data. Bioinformatics 18(11): 1462-1469
202
Meinel, T., Krause, A., Luz, H., Vingron, M. and Staub, E. (2005) The SYSTERS 
Protein Family Database in 2005. Nucleic Acids Res. Jan l;33:D226-229
Meinel, T., Vingron, M. and Krause, A. (2003) The SYSTERS Protein Family 
Database: taxon-related protein family size distributions and singleton 
frequencies. Proc Ger ConfBioinf. Belleville, Munich, Germany, ppl03-108
Mira, A., Ochman, H. and Moran, N. A. (2001) Deletional bias and the evolution of 
bacterial genomes. Trends Genet. Oct; 17(10):589-596
Mizuguchi, K., Deane, C. M., Blundell, T. L. and Overington, J. P. (1998) 
HOMSTRAD: a database of protein structure alignments for homologous 
families. Protein Sci. Nov;7(ll):2469-2471
Mobley, H. L. T., Island, M. D. and Hausinger, R. P. (1995) Molecular biology of 
microbial ureases. Microbiological Rev. Sep;59(3):451-480.
Moran, N. A. (2002) Microbial minimalism: genome reduction in bacterial pathogens. 
Cell 108:583-586
Mrowka, R. Patzak, A. and Herzel, H. (2001) Is there a bias in proteome research? 
Genome Research 11:1971-1973
Mulder, N. J., Apweiler, R., Attwood, T. K., Bairoch, A., Bateman, A., Binns, D., 
Bradley, P., Bork, P., Bucher, P., Cerutti, L., Copley, R., Courcelle, E., Das, 
U., Durbin, R., Fleischmann, W., Gough, J., Haft, D., Harte, N., Hulo, N., Kahn,
D., Kanapin, A., Krestyaninova, M., Lonsdale, D., Lopez, R., Letunic, I., 
Madera, >., Maslen, J., McDowall, J., Mitchell, A., Nilolskaya, A. N., 
Orchard, S.E., Pagni, M., Ponting, C. P., Quevillon, E., Selengut, J., Sigrist, C. 
J., Silventoinen, V., Studholme, D. J., Vaughan, R. and Wu, C. H. (2005) 
InterPro, progress and status in 2005. Nucleic Acids Res. Jan 1;(33):D201-205
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G. and Erlich, H. (1986) Specific 
enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold 
Spring Harb Symp Quant Biol 51 Ptl:263-273
203
Murzin, A. G., Brenner, S. E., Hubbard, T. arid Chothia, C. (1995) SCOP: a structural 
classification of proteins database for the investigation of sequences and 
structures. J  Mol Biol Apr 7;247(4):536-540
Nagano, N., Orengo, C. A. and Thornton, J. M. (2002) One fold with many functions: 
the evolutionary relationships between TIM barrel families based on their 
sequences, structures and functions. J Mol Biol 321:741-765
Needleman, S. B. and Wunsch, C. D. (1970) A general method applicable to the 
search for similarities in the amino acid sequence of two proteins. J Mol Biol. 
Mar 48(3):443-453
Nirenberg, M. and Leder, P. RNA codewords and protein synthesis. The effect of 
trinucleotides upon the binding of sRNA to ribosomes. Science Sep 
25(145): 1399-1407
Nirenberg, M. W. and Matthaei, J. H. (1961) The dependence of cell-free protein 
synthesis in E. coli upon naturally occurring or synthetic polyribonucleotides. 
PNAS Oct 15(47): 1588-1602
Ochman, H., Lawrence, J. G. and Groisman, E. A. (2000) Lateral gene transfer and 
the nature of bacterial innovation. Nature May 18;405(6784):299-304
Orengo, C. A., Sillitoe, I., Reeves, G. Pearl, F. M. (2001) Review: what can structural 
classifications reveal about protein evolution? J  Struct Biol. 134:145-165.
Orengo, C. A. (1999) CORA - topological fingerprints for protein structural families. 
Protein Sci. Apr,8(4):699-715
Orengo, C. A. and Taylor, W. R. (1996) SSAP: sequential structure alignment 
program for protein structure comparison. Methods Enzymol. 266:617-635
Orengo, C. A. and Thornton, J. M. (2005) Protein Families and their Evolution -  A 
Structural Perspective. Annu. Rev. Biochem. 74:867-900
204
Orengo, C. A., Jones, D. T., Thornton, J. M. (1994) Protein superfamilies and domain 
superfolds. Nature 372:631-634
Orengo, C. A., Michie, A. D., Jones, S., Jones, D. T., Swindells, M. B. and Thornton, 
J. M. (1997) CATH - A hierarchical classification of protein domain 
structures. Structure 5:1093-1108
Orr, H. A. (2000) Adaptaion and the cost of complexity. Evolution Int. J. Org. 
Evolution. Feb 5 ;54:13-20
Overbeek, R., Fonstein, M., D'Souza, M., Pusch, G. D. and Maltsev, N. (1999) The 
use of gene clusters to infer functional coupling. PNAS 96:2896-2901
Pagel, P., Wong, P. and Frishman, D. (2004) A domain interaction map based on 
phylogenetic profiling. J Mol Biol. Dec 10;344(5): 1331-1346
Papageorgiou, A. C., Shapiro, R. and Acharya, K. R. (1997) Molecular recognition of 
human angiogenin by placental ribonuclease inhibitor - an X-ray 
crystallographic study at 2.0 A resolution. EMBO J  16:5162
Park, J. and Teichmann, S. A. (1998) DIVCLUS: an automatic method in the 
GEANFAMMER package that finds homologous domains in single and multi­
domain proteins. Bioinformatics 14(2): 144-150
Park, J., Karplus, K., Barrett, C., Hughey, R., Haussler, D., Hubbard, T. and Chothia, 
C. (1998) Sequence comparisons using multiple sequences detect three times 
as many remote homologues as pairwise methods. J Mol Biol. 284:1201-1210
Patthy, L. (1999) Genome evoution and the evolution of exon-shuffling - a review. 
Gene Sep 30 238(1): 103-114
Pavlidis, P. and Noble, W. S. (2001) Analysis of strain and regional variation in gene 
expression in mouse brain. Genome Biology 2(10):RESEARCH0042 Epub
205
Pawlowski, K., Rychlewski, L., Zhang, B. and Godzik, A. (2001) Fold predictions for 
Bacterial Genomes. J Struct Biol. 134:219-231
Pearl, F., Lee, D., Bray, J. E., Buchan, D. W., Shepherd, A., J. and Orengo, C. A.
(2002) The CATH extended protein family database: providing structural 
annotations for genome sequences. Protein Sci. Feb;ll(2):233-244
Pearl, F., Todd, A., Sillitoe, L, Dibley, M., Redfem, O., Lewis, T., Bennett, C., 
Marsden, R., Grant, A., Lee, D., Akpor, A., Maibaum, M., Harrison, A., 
Dallman, T., Reeves, G., Diboun, I., Addou, S., Lise, S., Johnston, C., Sillero, 
A., Thornton, J. and Orengo, C. (2005) The CATH Domain Structure 
Database and related resources Gene3D and DHS provide comprehensive 
domain family information for genome analysis. Nucleic Acids Res. Jan 
1;33:D247-251
Pellegrini, M., Marcotte, E. M., Thompson, M, J., Eisenberg, D. and Yeates, T. O.
(1999) Assigning protein functions by comparative genome analysis: protein 
phylogenetic profiles. PNAS 96:4285-4288
Peloponese, J. M., Gregoire, C., Opi, S., Esquireu, D., Sturgis, J., Lebrun, E., Meurs, 
E., Collette, Y., Olive, D., Aubertin, A. M., Witvrow, M., Pannecouque, C., 
De Clercq, E., Bailly, C., Lebreton, J. and Loret, E. P. (2000) 1H-13C nuclear 
magnetic resonance assignment and structural characterisation of HIV-1 tat 
protein. C.R.Acad. Sci. HI 323:883
Prober, J. M., Trainor, G. L., Dam, R. J., Hobbs, F. W., Robertson, C. W., Zagursky, 
R. J., Cocuzza, A. J., Jensen, M. A and Baimeister, K. (1987) A system for 
rapid DNA sequencing with fluorescent chain-terminating dideoxynucloetides. 
Science Oct 16 238(4235):336-341
Pruitt K. D., Tatusova, T., Maglott, D. R. (2005) NCBI reference sequence (RefSeq): 
a curated non-redundant sequence datbase of genomes, transcripts and 
proteins. Nucleic Acids Res. Jan l;33(database issue):D501-504
206
Qian, J., Luscombe, N. M. and Gerstein, M. (2001) Protein family and fold 
occurrence in genomes: power-law behaviour and evolutionary model. J  Mol 
Biol 313: 673-681
Ranea et al., manuscript submitted.
Reese, M. G., Hartzell, G., Harris, N. L., Ohler, U., Abril, J. F. and Lewis, S. E.
(2000) Genome annotation assessment in Drosophila melanogaster. Genome 
Res. Apr 10(4):483-501
Reeves et al., manuscript in preparation.
Romero, M. F. (2005) Molecular pathophysiology of SLC4 bicarbonate transporters. 
Curr Opin Nephrol Hypertens. Sep;14(5):495-501.
Rossmann, M. G. and Argos, P. (1976) Exploring the structural homology of proteins. 
J Mol Biol. Jul 25;105(l):75-95
Rost, B. (2002) Enzyme function less conserved than anticipated. J  Mol Biol. Apr 
26;318(2):595-608
Rost, B. and Liu, J. (2003) The PredictProtein server. Nucleic Acids Res 31:3300- 3304
Rufino, S. D. and Blundell, T. L. (1994) Structure-based identification and clustering 
of protein families and superfamilies. J Comput Aided Mol Des. Feb 8(l):5-27
Russell, R. B. and Barton, G. J. (1992) Multiple protein sequence alignment from 
tertiary structure comparison: assignment of global and residue confidence 
levels. Proteins Oct 14(2):309-323
Saito, R., Suzuki, H. and Hayashizaki, Y. (2003) Construction of reliable protein- 
protein interaction networks with a new interaction generality measure. 
Bioinformatics 19(6):756-763
207
Sali, A. and Blundell, T. L. (1990) Definition of general topological equivalence in 
protein structures. A procedure involving comparison of properties and 
relationships through simmulated annealing and dynamic programming. J  Mol 
Biol Mar 20;212(2):403-428
Salzberg, S. L., Delcher, A. L., Kasif, S. and White, O. (1998) Microbial gene 
identification using interpolated Markov models. Nucleic Acids Res. Jan 15 
26(2):544-548
Sanger, F., Coulson, A. R., Hong, G. F., Hill, D. F., Peterson, G. B. (1982) Nucleotide 
sequence of bacteriophage lambda DNA. J Mol Biol. Dec 25;162(4):729-73
Sanger, F., Nicklen, S. and Coulson, A. R. (1977) DNA sequencing with chain- 
terminating inhibitors. PNAS Dec 74(12):5463-5467
Sasson, O., Vaaknin, A., Fleischer, H., Portugaly, E. Bilu, Y., Linial, N. and Linial M.
(2003) ProtoNet: hierarchical classification of the protein space. Nucleic Acids 
Res. Jan l;31(l):348-352
Schaffer, A. A., Wolf, Y. L, Ponting, C. P., Koonin, E. V., Aravind, L. and Altschul, 
S. F. (1999) IMPALA: matching a protein sequence against a collection of 
PSI-BLAST-constructed position-specific score matrices. Bioinformatics Dec 
15(12): 1000-1011
Schwartz, D. C. and Cantor, C. R. (1984) Separation of yeast chromosome-sized 
DNAs by pulsed field gradient gel electrophoresis. Cell May 37(l):67-75
Sears, R. C. (2004) The life cycle of C-myc: from synthesis to degradation. Cell Cycle 
Sep;3(9): 1133-1137.
Servant, F., Bra, C., Carrere, S., Courcelle, E., Gouzy, J., Peyrac, D. and Kahn, D. 
(2002) ProDom: automated clustering of homologous domains. Brief 
Bioinform. Sep 3:246-251
208
Service, R. (2005) Structural biology. Structural genomics, round 2. Science Mar 
11;307(5715)1554-1558
Shaanan, B. (1983) Structure of human oxyhaemoglobin at 2.1 A resolution. J  Mol 
Biol. 171:31
Shindyalov, I. N. and Bourne, P. E. (1998) Protein structure alignment by incremental 
combinatorial extension (CE) of the optimal path. Protein Eng. Sep 11(9):739- 
747
Sillitoe, L, Dibley, M., Bray, J., Addou, S. and Orengo, C. (2005) Assessing strategies 
for improved superfamily recognition. Protein Sci. Jul; 14(7): 1800-1810
Smith, L. M., Sanders, J. Z., Kaiser, R. J., Hughes, P., Dodd, C., Connell, C. R., Heiner, 
C., Kent, S. B. and Hood, L. E. (1986) Fluorescence detection in automated 
DNA sequence analysis. Nature Junl2-18;321(6071):674-679
Smith, L. M., Sanders, J. Z., Kaiser, R. J., Hughes, P., Dodd, C., Connell, C. R., 
Heiner, C., Kent, S. B. and Hood, L. E. (1986) Fluorescence detection in 
automated DNA sequence analysis. Nature 321(6071):674-9
Smith, T. F. and Waterman, M. S. (1981) Identification of common molecular 
subsequences. J Mol Biol. Mar 25; 147(1): 195-197
Smith, T. F. and Zhang, X. (1997) The challenges of genome sequence annotation or 
the devil is in the details. Nature Biotechnology Nov 15(12): 1222-1223
Soding, J. and Lupas, A. N. (2003) More than the sum of their parts: on the evolution 
of proteins from peptides. Bioessays 25:837-46
Sowdhamini, R., Burke, D. F., Huang, J. F., Mizuguchi, K., Nagarajaram, H. A., 
Srinivasan, N., Steward, R. E. and Blundell, T. L. (1998) CAMPASS: a 
database of structurally aligned protein superfamilies. Structure Sep 
15;6(9): 1087-1094
209
Srinivas, H., Juroske, D. M., Kalyankrishna, S., Cody, D. D., Price, R. E., Xu, X. C., 
Narayanan, R., Weigel, N. L. and Kurie, J. M. (2005) c-Jun N-terminal kinase 
contributes to aberrant retinoid signalling in lung cancer cells by 
phosphorylating and inducing proteasomal degradation of retinoic acid 
receptor alpha. Mol Cell Biol. Feb;25(3): 1054-1069.
Steigemann, W. and Weber, E. (1979) Structure of erythrocruorin in different ligand 
states refined at 1.4 A resolution. J Mol Biol. 127:309
Swindells, M. B. (1995) A procedure for the sutomatic determination of hydrophobic 
cores in protein structures. Protein Sci. 4(1):93-102
Tatusov, R. L., Fedorova, N. D., Jackson, J. D., Jacobs, A. R., Kiryutin, B., Koonin,
E. V., Krylov, D. M., Mazumder, R., Mekhedov, S. L., Nickolskaya, A. N., 
Rao, b. S., Smirnov, S., Sverdlov, A. V., Vasudevan, S., Wolf, Y. I., Yin, J. J., 
and Natale, D. A. (2003) The COG database: an updated version includes 
eukaryotes. BMC Bioinformatics Sep 11;4(1):41
Taylor, W. R. and Orengo, c. A. (1989) Protein structure alignment. J Mol Biol. Jul 
5;208(l):l-22
Todd, A. E., Orengo, C. A. and Thornton, J. M. (2001) Evolution of function in 
protein superfamilies, from a structural perspective. J Mol Biol. Apr 
6;307(4): 1113-1143
Todd, A. E., Marsden, R. L., Thornton, J. M. and Orengo, C. A. (2005) Progress of 
structural genomics initiatives: an analysis of solved target structures. J  Mol 
Biol. May 20;348(5): 1235-60
Tronrud, D. E. and Matthews, B. W. (1993) Refinement of the structure of a water- 
soluble antenna complex from green photosynthetic bacteria by incorporation 
of the chemically determined amino acid sequence. Photosynthetic Reaction 
Center 1:13
210
Uberbacher, E. C. and Mural, R. J. (1991) Locating protein-coding regions in human 
DNA sequences by a muliple sensor-neural network approach. PNAS Dec 15 
88(24): 11261-11265
Valencia, A. (2005) Automatic annotation of protein function. Current Opinion in 
Structural Biology 15(3):267-274
van Dongen, S. (2000) Graph Clustering by Flow Simulation. PhD thesis, University 
of Utrecht http://www.library.uu.nl/digiarchief/dip/diss/1895620/inhoud.htm
Venter, J. C., Smith, H. O. and Hood, L. (1996) A new strategy for genome 
sequencing. Nature May 30;381(6581):364-366
Viterbi, A. J. (1967) Error bounds for convolutional codes and an asymptotically 
optimum decoding algorithm. IEEE Transactions on Information Theory April 
13(2):260-267
Vitkup, D., Melamud, E., Moult, J. and Sander, C. (2001) Completeness in structural 
genomics. Nature Struct Biol. Jun;8(6):559-566
Vogel, C., Berzuini, C., Bashton, M., Gough, J. and Teichmann, S. A. (2004) Supra- 
domains: evolutionary units larger than single protein domains. J Mol Biol. 
Feb 20;336(3):809-823
Vogel, C., Teichmann, S. A. and Pereira-Leal, J. (2004) The relationship between 
domain duplication and recombination. J  Mol Biol. 346:355-365
von Mering, C., Jensen, L. J., Snel, B., Hppoer, S. D., Krupp, M., Foglierini, M., 
Jouffre, N., Huynen, M. A. and Bork, P. (2005) STRING: known and 
predicted protein-protein associations, integrated and transferred across 
organisms. Nucleic Acids Res. 33(database issue):D433-D437
von Mering, C., Krause, R., Snel, B., Cornell, M., Oliver, S. G., Fields, S. and Borl, P. 
(2002) Comparative assessment of large-scale data sets of protein-protein 
interactions. Nature May 471:399-403
211
Wang, Y., Geer, L. Y., Chappey, C., Kands, J. A. and Bryant, s. H. (2000) Cn3D: 
sequence and structure views for Entrez. Trends Biochem Sci. 25:300-302
Watson, J. D. and Crick, F. H. (1953) A structure for deoxyribose nucleic acid. Nature 
171:737-738
Webb, E. C. (1992) Recommendations of the Nomenclature Committee of the 
International Union of Biochemistry and Molecular Biology. Enzyme 
Nomenclature. Academic Press, New York
Weisstein, E. W. (1999) Correlation Coefficient. From MathWorld — A Wolfram Web 
Resource.
Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Church, D. M.,
DiCuccio, M., Edgar, R., Federhen, S., Helmberg, W., Kenton, D. L.,
Khovayko, O., Lipman, D. J., Madden, T. L., Maglott, D. R., Ostell, J., 
Pontius, J. U., Pruitt, K. D., Schuler, G. D., Schriml, L. M., Sequeira, E.,
Sherry, S. T., Sirotkin, K., Starchenko, G., Suzek, T. O., Tatusov, R.,
Tatusova, T. A., Wagner, L. and Yaschenko, E. (2005) Database resources of 
the National Center for Biotechnology Information. Nucleic Acids Res. Jan 
l;33:D39-45
Wieser, D., Kretschmann, E. and Apweiler, R. (2004) Filtering erroneous protein 
annotation. Bioinformatics 20(l):342-347
Wilkins, M. H. F., Stokes, A. R. and Wilson, H. R. (1953) Molecular structure of 
deoxypentose nucleic acids. Nature 171:738-740
Wolf, E. I., Grishin, N. V. and Koonin, E. V. (2000) Estimating the Number of 
Protein Folds and Families from Complete Genome Data. J Mol Biol. 
299:897-905
Wu, C. and Nebert, D. W. (2004) Update on genome completion and annotation: 
Protein Information Resource. Hum Genomics Mar l(3):229-233
212
Wu, C. H., Huang, H., Nikolskaya, A., Hu, Z. and Barker, W. C. (2004) The 
iProClass integrated database for protein functional analysis. Comput Biol 
Chem. Feb 28(l):87-96
Wuchty, S. and Almaas, E. (2005) Evolutionary cores of domain co-occurrence 
networks. BMC Ecol Biol Mar 23;5(1):24
Yona, G. and Levitt, M. (2000) Towards a complete map of the protein space based 
on a unified sequence and structure analysis of all known proteins. Proc Int 
Conflntell Syst Mol Biol 8:395-406
Zhang, C. and DeLisi, C. (1998) Estimating the number of protein folds. J  Mol Biol 
284:1301-1305
Zhang, S. Q., Yang, W., Kontaridis, M. I., Bivona, T. G., Wen, G., Araki, T., Luo, J., 
Thompson, J. A., Schraven, B. L., Philips, M. R. and Neel, B. G. (2004) Shp2 
regulates SRC family kinase activity and Ras/Erk activation by controlling 
Csk recruitment. Mol Cell. Feb 13;13(3):341-55.
Zomorodipour, A. and Andersson, S. G. E. (1999) Obligate intracellular parasites: 
Rickettsia prowazekii and Chlamydia trachomatis. FEBS Letters 452:11-15
213
